10-K 1 f10k2013final.htm ABAKAN 10-K 31ST MAY 2013 Converted by EDGARwiz

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

þ     ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended May 31, 2013.

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

_to

.

Commission file number: 000-52784

ABAKAN INC.

(Exact name of registrant as specified in its charter)

Nevada

98-0507522

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)

2665 S. Bayshore Drive, Suite 450, Miami, Florida 33133

(Address of principal executive offices)    (Zip Code)

Registrant’s telephone number, including area code:  (786) 206-5368

Securities registered under Section 12(b) of the Act: None.

Securities registered under Section 12(g) of the Act: common stock (title of class), $0.0001 par value.

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes o No þ

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes o No þ

Indicate by check mark whether the registrant (1) has filed all reports required  to be filed  by Section  13 or 15(d) of the Securities

Exchange  Act  of  1934  during  the  preceding  12  months  (or  for  such  shorter  period  that  the  registrant  was  required  to  file  such

reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate  by  check  mark  whether  the  registrant  has  submitted  electronically  and  posted  on  its  corporate  Web  site,  if  any,  every

Interactive  Data  File  required  to  be  submitted  and  posted  pursuant  to  Rule  405  of  Regulation  S-T    232.405  of  this  chapter)

during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes þ No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not

contained  herein,  and  will  not  be  contained,  to  the  best  of  registrant’s  knowledge,  in  definitive  proxy  or  information  statements

incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. þ

Indicate by check mark  whether the registrant is a large  accelerated filer, an accelerated  filer, a non-accelerated  filer, or a  smaller

reporting  company.  See  the  definitions  of  “large  accelerated  filer,”  “accelerated  filer”  and  “smaller  reporting  company”  in  Rule

12b-2 of the Exchange Act. Accelerated filer þ

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o    No þ

The  aggregate  market  value  of  the  registrant’s  common  stock,  $0.0001  par  value  (the  only  class  of  voting  stock),  held  by  non-

affiliates  (41,554,855  shares)  was  $106,588,203  based  on  the average of  the bid  and  ask price ($2.565)  for the common  stock  on

August 27, 2013.

At  August  29,  2013,  the  number  of  shares  outstanding  of  the  registrant’s  common  stock,  $0.0001  par  value  (the  only  class  of

voting stock), was 64,284,855.

1



TABLE OF CONTENTS

PART I

Item1.

Business

3

Item 1A.      Risk Factors

27

Item 1B.      Unresolved Staff Comments

31

Item 2.

Properties

31

Item 3.

Legal Proceedings

32

Item 4.

Mine Safety Disclosure

32

PART II

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of

33

Equity Securities

Item 6.

Selected Financial Data

38

Item 7.

Management's Discussion and Analysis of Financial Condition and Results of  Operations

39

Item 7A.      Quantitative and Qualitative Disclosures about Market Risk

46

Item 8.

Financial Statements and Supplementary Data

47

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

48

Item 9A.

Controls and Procedures

48

Item 9B.      Other Information

49

PART III

Item 10.

Directors, Executive Officers, and Corporate Governance

50

Item 11.

Executive Compensation

58

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder

62

Matters

Item 13.

Certain Relationships and Related Transactions, and Director Independence

63

Item 14.

Principal Accountant Fees and Services

64

PART IV

Item 15.

Exhibits, Financial Statement Schedules

65

Signatures

66

2



As used herein the terms “Company,” “we,” “our,” and “us” refer to Abakan Inc. unless context

indicates otherwise.

ITEM 1.

BUSINESS

Corporate History

The Company was incorporated in the State of Nevada on June 27, 2006 under the name “Your Digital

Memories Inc.”

Waste to Energy Group Inc., a wholly-owned subsidiary of the Company, was incorporated in the State

of Nevada on August 13, 2008. Waste to Energy Group Inc., and the Company entered into an

Agreement and Plan of Merger on August 14, 2008. The board of directors of Waste to Energy Group

Inc. and that of the Company deemed it advisable in the best interests of their respective shareholders

that Waste to Energy Inc. be merged into the Company with the Company being the surviving entity as

“Waste to Energy Group Inc.”

Abakan Inc., a wholly-owned subsidiary of the Company, was incorporated in the state of Nevada on

November 6, 2009. Abakan Inc. and the Company entered into an Agreement and Plan of Merger on

November 6, 2009. The board of directors of Abakan Inc. and that of the Company deemed it advisable

in the best interests of their respective shareholders that Abakan Inc. be merged into the Company with

the Company being the surviving entity as “Abakan Inc.”

We are a development stage company.

Our corporate office is located at 2665 S. Bayshore Drive, Suite 450, Miami, Florida, 33133 and our

telephone number is (786) 206-5368. Our registered agent is EastBiz.com, Inc., located at 5348 Vegas

Drive, Las Vegas, Nevada, 89108, and their telephone number is (702) 871-8678.

Our common stock is quoted on the OTCQB electronic quotation system under the symbol “ABKI”.

The Company

The Company designs, develops, manufactures, and markets advanced nanocomposite materials,

innovative fabricated metal products, highly engineered metal composites, and engineered

reactive materials for applications in the oil and gas, petrochemical, mining, aerospace and defense,

energy, infrastructure and processing industries. Our technology portfolio currently includes high-speed,

large-area metal cladding technology, long-life nanocomposite anti-corrosion and-wear coating

materials, high-strength, lightweight metal composites, and energetic materials. Operations are

conducted through our subsidiary, MesoCoat, Inc. (“MesoCoat”) and our affiliate, Powdermet, Inc.

(“Powdermet”).

The Company holds a 52.5% controlling interest in MesoCoat and a 41% non-controlling interest in

Powdermet. Powdermet directly owns the remaining 47.5% of MesoCoat.  The Company’s interest in

Powdermet represents an additional 19.5% indirect interest in MesoCoat.  The combined direct and

indirect interest equals a total 72.0% ownership of MesoCoat by the Company.

3



MesoCoat, Inc.

On December 11, 2009, the Company executed an Investment Agreement, dated  December 9, 2009, with

MesoCoat and Powdermet in order to purchase 79,334 newly issued MesoCoat shares, equal to a fully

diluted 34% equity interest in MesoCoat for $1,400,030.   Prior to the Investment Agreement, MesoCoat

was owned 100% by Powdermet.  Powdermet was owned 52% by Andrew Sherman, 41% by

Kennametal, Inc. (an unrelated company) and 7% by other unrelated parties.  Andrew Sherman was the

CEO and director of both MesoCoat and Powdermet and became a director of the Company on August

20, 2010.

On March 21, 2011, the Company purchased 596,813 shares of Powdermet from Kennametal equal to a

41% interest in Powdermet.

On July 11, 2011 the Company placed MesoCoat and Powdermet on notice of its intent to complete the

purchase of an additional equity interest in MesoCoat in accordance with the Investment Agreement. The

Company completed the purchase of 86,156 newly issued shares, equal to a fully diluted 18.5% equity

interest for $2,800,000 on July 13, 2011 thereby increasing its direct ownership of MesoCoat to a fully

diluted 52.5% interest.

The Investment Agreement, as amended, provides us with additional options to increase our equity

interest in MesoCoat, as follows:

§     An option which entitles the Company to purchase an additional 24% equity interest in exchange

for $16,000,000, of which approximately $4,000,000 has been provided to MesoCoat as of May

31, 2013. The exercise of this option would increase the Company’s direct holdings to a fully

diluted 75% of MesoCoat and entitle the Company’s management to appoint a fourth member to

MesoCoat’s five person board of directors (the Company currently has a right to appoint three of

MesoCoat’s directors, one of which must be independent).

§     An option which entitles minority shareholders of MesoCoat, for a period of 12 months after the

exercise of the option detailed above, to cause the Company to pay an aggregate amount of

$14,600,000, payable in shares of the Company’s common stock or a combination of cash and

shares, in exchange for all remaining outstanding shares of MesoCoat.

MesoCoat’s Business

MesoCoat is an Ohio based materials science company intending to become a technology leader in metal

protection and repair based on its metal coating and metal cladding technologies designed to address

specific industry needs related to conventional oil and gas, oil sands, mining, aerospace, defense,

infrastructure, and shipbuilding. The company was originally formed as a wholly owned subsidiary of

Powdermet, known as Powdermet Coating Technologies, Inc., to focus on the further development and

commercialization of Powdermet’s nanocomposite coatings technologies. The company was renamed as

MesoCoat in March of 2008. Thereafter, in July of 2008, the coatings and cladding assets of Powdermet

were conveyed to MesoCoat through an asset transfer, an IP license and technology transfer, and a

manufacturing support agreement.

4



MesoCoat has exclusively licensed and developed a proprietary metal cladding application process as

well as advanced nano-composite coating materials that combine corrosion and wear resistant alloys, and

nano-engineered cermet materials with proprietary high-speed coating or cladding application systems.

The result is protective cladding solutions that will be offered on a competitive basis with existing market

solutions. The coating materials unite high strength, hardness, fracture toughness, and a low coefficient of

friction into one product structure. Ten of MesoCoat’s products (3 Corrosion Resistant Alloy (CRA)

materials (625,825, 316L), 3 Wear Resistant Alloy (WRA) material. (Tungsten Carbide (WC), Chrome

Carbide (CRC), Structurally Amorphous Metal (SAM) Alloys) and 3 PComP product families

(PComPT, PComP S and PComP M) are currently undergoing extensive testing by oil and gas

majors, pipe manufacturers, oil field equipment manufacturing and service companies, original equipment

manufacturers (OEMs) and other end users.

MesoCoat’s commercial revenues are comprised of sales of the PComP powder and thermal spray

applications. The company also generates revenue from grants that are awarded to further the

development of various products.  PComP is a family of nanocomposite cermet coating materials that

are used to impart wear and corrosion resistance, and to restore dimensions, of worn metal components.

CermaCladTM clad products are in the development and qualification stage and are nearing

commercialization, including the cladding of the inside of a full length pipe for the oil and gas industries.

MesoCoat has expanded its technical team to complete the various developments and is working towards

the expansion of the PComP powder and coating services.

PComP

PComP is a family of nanocomposite cermet coating materials that are used to impart wear and

corrosion resistance and to restore dimensions of worn metal components.  Named for its particulate

composite powders, PComP, is the result of over a decade of nanoengineered materials development,

and is now one of the few commercially viable industry replacement solutions for hard chrome and

carbides.

PComP competes against thermally sprayed carbide and other coatings such as chrome and nickel

plating in the $32 billion dollar (source, BCC Inc.) inorganic metal finishing market.  Competing

materials like hexavalent chrome, carbides and tungsten carbide-cobalt have become a major concern for

industrial producers in the metal finishing industry since these materials are on the EPA’s hazardous

materials watch list and are legally banned in many countries. While businesses grapple with the need to

transition away from these harmful products, they continue to spend billions on these materials despite the

harm done to the environment. The adoption of green products and processes such as PComP thermal

spray coatings would place the business at a competitive advantage over destructive solutions while at the

same time mitigating environmental liabilities. PComP thermal spray coatings comprise a performance

leading solution platform which has shown order of magnitude improvements in head to head wear and

corrosion performance tests while offering a significantly better value proposition over other hard chrome

alternatives.

5



Under the PComP platform, MesoCoat has developed and patented a family of corrosion resistant and

wear resistant coating solutions that combine extreme corrosion and/ or wear resistance, fracture

toughness (resiliency), and a low friction coefficient all in one product.   In conventional materials science

toughness normally decreases as hardness and wear resistance increases. However, by combining nano-

level structure control and advanced ductile phase toughening materials science, MesoCoat has developed

a material structure that can be both very tough and very wear resistant (hard). Equally important, the

hardness of a wear coating normally limits the ease with which it can be machined. The unique

hierarchical structure of the PComP coating solutions results in a coating that can be machined through

a finish grinder much faster than a product with a traditional carbide coating which needs to be diamond

ground. The speed of coating application and final machining results in higher productivity and lower

costs in metal finishing operations.

The unique nano-structure of the PComP coatings produces a coating that is self-smoothing in service,

resulting in friction properties approaching those of diamond-like carbon films and solid lubricants, with

the ability to be used structurally and applied to large components at a fraction of the cost of coatings

such as diamond-like carbon.  This low friction property reduces wear, and improves energy efficiency

and life in sliding components such as drilling rotors, plungers, mandrels, ball and gate valves, rotating

and sliding seals, and metal processing equipment.

The PComP product platform, combined with metal finishing applications of the large area weld

overlay technologies underlying the CermaClad clad steel product family provides a high degree of

product differentiation and a sustainable competitive advantage, which includes OEM components and

the maintenance, repair, and overhaul of industrial assets and machinery in the “components

manufacturing and repair” segment of MesoCoat’s business (as opposed to the clad steel business lines

discussed under the CermaClad product line below).

MesoCoat is completing expansion of its production capacity for PComP powders from 3 tons to 18

tons/year, to meet initial demand from current customers and intends to further expand the PComP

production capacity from 18 tons to 180 tons/year to serve the expected demand of prospective customers.

The process of installing the equipment necessary to meet this objective is underway in MesoCoat’s

Euclid, Ohio plant.

MesoCoat now has a 1-cell thermal spray coating facility operational in Ohio for coating mid-sized

components that has been used for qualifying coatings with early adopters. The plan is to expand this

capacity to set-up two additional thermal spray coating cells and other pre- and post-finishing equipment

to provide full coating service for large components like mandrels, plungers, valves, rods, stabilizer rolls,

mine truck wheels and other equipment.  MesoCoat’s wholly-owned subsidiary MesoCoat Coating

Services, Inc. was formed in June 2013 to extract maximum value from the PComP family by offering

high margin coating services starting late 2013.

6



MesoCoat is currently selling PComP advance coating materials through different channels that are

appropriate to the specific market. Large OEM’s and government agencies like the U.S. Air Force procure

raw powders and apply them for their specific products under license as such agencies are vertically

integrated to perform their own thermal spray and coating applications using dedicated maintenance and

repair depots. Recently, several defense organizations have been given congressional mandates to make

better use of their existing equipment (planes, helicopters, jets, tanks and other armored vehicles, etc.) as

budgets for the purchase of new equipment is to be limited over the next few years. MesoCoat’s low-cost,

long-life coating materials appeal to government buyers striving to meet budgetary restrictions.

An effort to expand geographically the market for our coating services is now underway. MesoCoat is

actively qualifying licensed application partners that have an existing customer base, in certain territories

(Houston, Alberta, and Los Angeles), to provide coating services in territories in which it is not currently

able to service directly. We believe that this strategy is the fastest way to gain market entry into these

territories, while supporting economies of scale for the powder production needed to meet product cost

targets.  Eventually, we expect that the majority of MesoCoat’s commercial sector accounts will be able

to order coating application services from it on a regional basis.

The PComP family of nanocomposite coatings currently consists of five products, not including

variation in composition, all of which have shown in testing by third parties to provide better wear,

corrosion and mechanical properties at a lower life cycle cost than these, and several other alternatives are

as follows:

Wear and Corrosion Resistance and Dimensional Restoration

PComP T is a titanium carbo-nitride based high corrosion/wear resistant, low friction high velocity

oxygen fuel (HVOF) coating that competes with hard chrome and diamond like carbon PVD (physical

vapor deposition) alternatives for hydraulic cylinders, piston rings, bearings, rotating shafts, and valve

components where low stick-slip, corrosion, and modest wear resistance are required. PComP provides

both wear and corrosion resistance (unlike chrome), and significantly reduces environmental safety and

health liabilities.  Furthermore, in many applications, thermal spray coatings such as PComP provide

life multiples over chrome (80 times in cylinder liner application in testing reported by Caterpillar).

Lower coefficient of friction protects seals from premature wear and reduces energy consumption in

rotating components through lower friction losses, and the lower coating stresses and higher toughness

enable thicker coatings to be applied than chrome or other alternatives, meaning component life can be

extended through enabling additional repair cycles. PComP T-HT has significantly higher build-up

rates than that of carbides, and grinding and finishing can be done faster and cheaper with conventional

grinding techniques compared to the expensive diamond finishing process used for competing carbide

coatings.

PComP S is a silicon-nitride based hard chrome replacement solution for aerospace applications that

exhibits high toughness, wear resistance and displays increased spallation resistance. PComP S also has

the lowest density of any chrome alternative, enabling significant fuel savings to be realized in

transportation markets.

7



PComP W is MesoCoat’s “nano-engineered” tungsten carbide coating solution that offers industry

leading toughness and wear resistance for thermal spray coatings, making it better for critical high wear

applications such as gate valves and downhole drilling tools. PComP W replaces conventional tungsten

carbide cobalt in the thermal spray industry and provides increased wear resistance, design allowable

(stress levels), and reduced friction in abrasive wear applications, with higher toughness and impact

resistance than ceramic alternatives such as alumina-titania. PComP W is also significantly more robust

and lower cost than competing detonation gun and alternate coatings, achieving excellent results with

much higher throughput and lower operating cost equipment such as standard HVOF guns.

Liquid Metal Corrosion

PComP -M is a hierarchically structured molybdenum boride coating designed for use in liquid metal

corrosion application, especially the rolls used in galvanizing baths.  PComP -MB has completed

laboratory and initial field testing with several end users, such as CAL-steel, confirming internal results

showing more than two and one half times the life of other developmental coatings in galvanizing lines,

and ten times the resistance of widely used tungsten carbide (“WC”) coatings to molten metal erosion and

wear. MesoCoat is introducing its PComP -MB product line into the $150+ million primary metals

production equipment coatings market, with an initial focus on zinc pot stabilizer roll and pot bearing roll

refurbishment market in conjunction with MesoCoat’s market entry into the coating services market.

Thermal Barrier Coatings

ZComP is MesoCoat’s nanocomposite thermal barrier coatings that offers 50% lower thermal

conductivity, with improved toughness and cyclic thermal life compared to conventional thermal barrier

coatings in the $500 million thermal barrier coatings market.  MesoCoat has been actively forming

partnerships to introduce ZComP materials into the turbine engine market, and is working with its

Powdermet affiliate under completed or in-progress contracts with the Department of Energy for power

turbines, the Air Force (Oklahoma Air Logistics Center), the Ohio Aerospace Institute (OAI), General

Dynamics Information Systems, and under a Space Act agreement with NASA for propulsion turbine

applications of engineered nanocomposite thermal barrier coatings.

CermaClad

CermaClad is a multiple award winning technology used to produce coatings that protect metal,

primarily carbon steel, from wear and corrosion, that offers the benefits of corrosion resistant alloys such

as stainless steel, nickel, or titanium and wear resistant alloys such as tungsten carbide and chrome

carbide at a significantly lower cost by permanently altering, or cladding, the surface of a high strength,

low cost carbon steel with a layer of a much higher cost wear or corrosion resistant alloy.  The result is a

hybrid product offering the wear and corrosion performance of costly alloys with the ease of fabrication

and the lower cost of traditional steel material.

8



Cladding refers to the process where a high performance wear or corrosion resistant metal alloy or

composite (the cladding material) is applied through the use of high pressure and/ or high temperature

processes onto another dissimilar metal (the base metal or substrate) to enhance its durability, strength or

appearance. The majority of clad products produced today use carbon steel as the substrate and nickel

alloys, stainless steel, or various hard materials such as chrome carbides as the clad layer to protect that

underlying steel base metal from the environment it resides in.  MesoCoat is utilizing a unique, patented,

“High Density Infrared” or HDIR technology, exclusively licensed from Oak Ridge National Laboratory

(“ORNL”) to produce clad steel.  Testing by ORNL has shown that this HDIR technology is capable of

applying a very high quality cladding at 10 to 40 times higher productivity (100’s of Kg’s versus 3-

20Kg/hr) than traditional laser bead or weld cladding techniques, in current wide commercial use.

MesoCoat believes that this HDIR process represents the first truly scalable, large area cladding

technology.  Scalable, low capital cost cladding technology then enables the production of large volumes

of customized, premium, high margin clad steel products.

CermaClad clad steel is a premier, metallurgically bonded, clad carbon steel materials solution that is

optimized to manage the risks and consequences of wear and corrosion damage and the failure of large

assets including oil and gas risers and flowlines, refinery/chemical processing towers and transfer lines,

power plant heat exchanger tubes, and other steel infrastructure. In corrosive environments, including

seawater, road salt, mining slurry transport lines, unprocessed oil containing water, sulphides and carbon

dioxide, chemical processing and transportation equipment, metals production, and other large industrial

applications, asset owners and operators either need to continually maintain and replace major assets, or

fabricate these assets using expensive, corrosion resistant alloy (CRA) materials, which substantially

increase capital costs.  Clad steel, and CermaClad in particular, offer a competing, lower cost solution

to these exotic alloys, allowing the owner or operator to use clad carbon steel which typically costs about

half of solid CRA.  Combining the reduced material cost with reduced fabrication, installation, and

maintenance costs, cladding solutions such as CermaClad are estimated to save up to 75% over the cost

of using solid alloys, while still providing essentially maintenance free corrosion lifetimes equal to the life

of the asset. In the last 20 years, clad steel pipe has gained wide acceptance and continually increased its

market share in oil and gas exploration and production, marine transportation, mining, petrochemical

processing and refining, nuclear, paper and pulp, desalination, and power generation industries.  The oil

and gas industry is the largest consumer of clad steel products. In order to meet growing global energy

demands, oil companies continue to extend their offshore drilling efforts into deeper waters farther from

shore. The higher temperatures and corrosivity (carbon dioxide, sea water, and hydrogen sulfide content)

of these new reserves are resulting in a significantly increased use of corrosion resistant alloys - and there

lower-cost clad steel alternatives.

Currently used cladding processes include weld overlay, roll-bonding, co-extrusion, explosion cladding,

and mechanical lining. While cladding carbon steel pipes is cheaper than using a solid stainless steel

alloy, current production technologies still have significant limitations which CermaClad is believed to

overcome.  Directly comparable Metallurgical clad pipes are primarily manufactured using roll-bonded

clad plate which is then bent and welded to form a pipe.   Though a higher productivity process, Roll-

bonded pipe involves a lot of welded area and the failure of that weld is the single most common reason

for pipeline leaks.  Furthermore, current bimetal rolling mills are limited to around 5ft in width by 40ft in

length, limiting the size of pipe that can be fabricated without extensive welds.  Expanding roll mill size

to enable the production of larger diameter pipe needed for large gas projects in Southeast Asia would

require very large investments, estimated to be in excess of a $1billion compared to a planned $40M

investment in an 8-line CermaClad large diameter pipe production facility expected to be constructed

on Bantam Island, Indonesia.

9



Mechanically lined (bi-metal) pipe now makes up a significant portion of the clad pipe market.  Bimetal

pipe is lower in cost than metallurgically clad pipe, but provides only a mechanical attachment between

the inner and outer pipe.  This reduced bonding results in a higher risk of buckling, wrinkling and

disbonding when under stress, such as during bending, reeling, or application of external coatings on

these pipes. Mechanically lined pipes also raise concerns with respect to uniformity and reliability in that

the gap between the inner and outer pipes, coupled with the mixture of materials, leads to challenges in

NDT (non-destructive testing) inspections. Co-extrusion is another process that involves extruding a

bimetal billet into a clad pipe.  Co-extrusion has not been successful in producing long lengths of larger

diameter pipes, and would require significant capital investment and further technology development to

meet growing demand for the thicker wall and larger diameter clad pipes that CermaClad is targeted.

The remaining production process, weld overlay, does not have the productivity needed to meet clad pipe

demand, and is primarily used for smaller diameter and complex shapes, such as manifolds and

“Christmas tree’s” used in oil and gas, although weld overlay is a dominant technology for wear resistant

overlays that cannot be produced by the other techniques.

Worldwide, there is a large and growing need for clad pipes as deeper and hotter, corrosive reserves come

into production.   Current production methods not only have the above limitations, but plants are

operating at capacity, creating an increasing tight supply and lead-times of 2 years or more to delivery. A

number of organizations have stated that the market for clad pipe is expected to grow from $1.5 billion to

$2 billion per year currently, to $4 billion to $8 billion within 3 to 4 years.

CermaClad clad steel utilizes MesoCoat’s proprietary cladding process based on the use of a high-

intensity arc lamp to rapidly melt, fuse, and metallurgically bond (make inseparable) the protective,

proprietary cladding materials onto steel pipes and tubes (internal and external surfaces), plates, sheets,

and bars. The CermaClad clad steel product portfolio combines this high-speed fusion cladding process

with proprietary corrosion resistant alloy (“CRA”) and wear resistant alloy (“WR”) coating materials

which incorporate patented microstructural and compositional modifications.   The HDIR process melts

and fuses material onto the inside of a pipe within seconds to produce the CermaClad product that offers a

seamless metallurgical bond, a smooth surface, low porosity, and minimal dilution of the overlay, along

with good strength retention of the substrate . More importantly, CermaClad clad pipe is easier to

inspect and install (reel) irrespective of the size and thickness of the pipe compared to current alternatives.

Today, clad steel is a specialized, profitable segment of the steel industry where demand has outstripped

supply and margins are high as a result.  Management believes that the CermaClad process is scalable

to large volumes with a modest capital investment that is lower than that invested in existing production

methods.

Historically, the typical contract for clad pipe was for 3 to 5 kilometers of product with larger contracts

for 20 to 30 kilometres of product. Currently, typical requirements are for tens of kilometres with growing

numbers of projects needing hundreds of kilometres per project. As a result the clad pipe market is

growing rapidly and the limitations of current solutions in terms of installation, inspectability, quality, and

availability are restraining this growth. Full commercialization of CermaClad clad pipes can address

these constrains to clad pipe market growth.

Management believes the competitive advantages of CermaClad over current competing technologies

and products are:

§     CermaClad and other clad steel products are typically used where they are offered at a 25% to

more than 50% lower cost than solid alloy products.

10



§     CermaClad clad steel provides a metallurgically bonded overlay, making the clad pipes easier

to inspect, bend, reel, and install compared to the widely used and slightly lower cost

mechanically bonded clad pipes.

§     CermaClad clad steel offers a seamless metallurgical cladding requiring only girth welds,

unlike the pipes made from metallurgically clad plates which have longitudinal welds

§     CermaClad application technology utilizes a 30cm wide, high density, infrared “lamp”

compared to a 0.7 cm wide laser “torch” for laser or inert gas welding torches, resulting in

application rates between one and two orders of magnitude higher than current weld overlay

technologies.

§     The proprietary process used to make CermaClad clad steel products is more flexible (it can do

both wear and corrosion resistant alloys, for example), and has relatively low capital costs for

initial and added capacity.  This provides the advantage of being able to respond to customer

needs, such as meeting local content requirements, faster and with less investment risk than

currently established alternatives.

§     CermaClad products exceed the requirements of the defining API 5LD and DNV OS F101

standard requirements for clad pipe.

§     CermaClad offers a smoother surface, minimal dilution, greater flexibility in materials, and the

ability to do thinner, lower cost claddings than current production technologies.

The CermaClad clad steel product lines under development include:

§     CermaClad CRA (Corrosion Resistant Alloys). 1-4mm thick CRA clad steel that offers a lower

cost alternative to solid nickel, stainless steel, and titanium alloys for oil and gas, mining,

desalination, pulp and paper, and chemical process.

§     CermaClad WR (Wear Resistant). 1-15mm thick carbide, metal matrix composite, structurally

amorphous metal, and nanocomposite wear resistant clad steel that extends the life of steel

structures such as hydrotransport slurry lines, pump components, valve components, spools, T’s,

and elbows for oil sands, heavy oil, mining and mineral processing.

§     CermaClad HT (High Temperature). Steel clad with nickel-chromium and metal-chromium-

aluminum alloys for high temperature applications such as heat exchanger tubing, boiler

waterwalls, and other energy production components offering greater compositional control

(higher performance) and lower cost than solid alloys or traditional weld overlays.

§     CermaClad LT (Low Thickness). Lower cost thin-clad steel that exploits the unique high purity

capabilities of the HDIR application process to provide thin (less than 0.5mm) claddings that

provide 50-200 year corrosion free life in atmospheric and seawater corrosion environments.

This “stainless steel paint” is applicable to the outside diameter transportation pipelines, marine

structures, fuel and cargo tanks, bridges, architectural steel, and transportation structures.

Product Development Timeline

MesoCoat’s PComP-W high performance materials are now established with initial customers and

adoption is expected to increase through qualified regional application partners, with capacity being

expanded to match growing demand. PComP-T best-value chrome plating products are still in

qualification and limited to beta release though coating applicators have been partnered with an original

equipment manufacturer. A six fold capacity expansion and the introduction of higher value application

(component) services is underway to be completed in the second half of 2013. The CermaClad

corrosion resistant (CRA) product is expected to enter the market in the fourth quarter of 2013.

11



PRODUCT

COMMERCIAL TIMELINE

TIME

(MONTHS)

PComP W

Growth and expansion

Current

PComP T

Partner sales

Current

PComP M

Market entry

2

PComP S

Qualification

12

ZComP

Development

24

CermaClad WR

Development

14

CermaClad LT

Development

24

ZComP

Development

24

CermaClad HT

Incubation

36

Product Commercial Expansion Timeline

Our near term plan is to expand the presence of our products into Brazil and the Asia-Pacific market. We

remain in the process of negotiating the terms of a “build to suit” agreement to construct a manufacturing

plant in the Recife, Brazil free trade zone that might give us direct access to Brazilian markets.

Meanwhile, we have incorporated an Asian operating subsidiary, PT MesoCoat Indonesia, which is

currently negotiating the terms of a “build-to-suit” agreement to construct a manufacturing plant on the

island of Batam, Indonesia. The expected time-frame for the completion of each project has not yet been

finalized.

PRODUCT

COMMERCIAL EXPANSION

TIME

TIMELINE

(MONTHS)

PComP Coating Services      Market entry

3

CermaClad CRA

Market entry

4

License agreement with Powdermet, Inc.

On July 22, 2008, MesoCoat entered into a license agreement with Powdermet. The agreement gives

MesoCoat a royalty-free, exclusive, perpetual license to PComP intellectual property, certain

equipment, and contracts and business lists, including seven supporting patents, the trademark, and

supporting confidential and trade secret information, including formulations, processes, customer lists and

contracts, for all Powdermet technologies in the field of wear and corrosion resistant coatings. MesoCoat

was at the time of licensing a wholly owned subsidiary of Powdermet, and Powdermet currently retains a

47.50% ownership position in MesoCoat.  The agreement also includes Powdermet’s commitment to

provide manufacturing expertise and technical capabilities supporting PComP powders on a priority

basis.  Powdermet retains the exclusive manufacturing rights for producing the first 50 tons of PComP

powders. The license agreement will end upon the last valid claim of licensed patents to expire unless

terminated earlier with the terms of the agreement.

12



MesoCoat's exclusivity agreement with Mattson Technology, Inc.

On April 7, 2011, MesoCoat and Mattson Technology Inc. (“Mattson”) entered into an Exclusivity

Agreement whereby MesoCoat agreed to exclusively purchase, and Mattson agreed to exclusively supply,

plasma arc lamps systems. The Exclusivity Agreement contemplated that the MesoCoat and Mattson

would enter into a separate supply agreement that fixed additional terms of the sale and purchase of the

plasma arc lamps. Mattson has to date failed to enter into a supply agreement with MesoCoat and has

been noticed to be in breach of the terms of the Exclusivity Agreement and related purchase orders.

Mattson has committed to rectify the problems outlined in MesoCoat’s breach letter.

MesoCoat’s exclusive patent license agreement with UT-Battelle LLC.

MesoCoat has obtained a two stage, exclusive license from UT-Battelle, LLC to utilize two patents in its

processes to develop products for wear and corrosion applications. The initial non-commercial exclusive

license was entered into on September 22, 2009, which enabled MesoCoat to conduct development work

to prove out the technology within the field of use. The second stage of the agreement comprises a

commercial exclusive license, executed on March 7, 2011, that permits MesoCoat to conduct commercial

sales utilizing the licensed process and technology. The license is valid through the expiration of the last

patent in 2024 and required that MesoCoat invest in additional research and development of the

technology and the market for products that stem from the technology by committing to a certain level of

personnel hours and $350,000 in expenditures. MesoCoat has met the aforesaid conditions of the license

agreement.

Stage I and II license fees of $50,000 have been paid against the agreement and a royalty of $15,000 or

2.5% of revenues generated in the United States that utilize the technology, minus allowable costs as

defined by contract, whichever is greater, are due March 31 on an annual basis beginning after the first

commercial sale. For the first calendar year after the achievement of a certain milestone and the following

two calendar years during the term of the agreement, MesoCoat is obligated to pay a minimum annual

royalty payment of $10,000, $15,000 and $20,000 respectively.

Cooperation agreement with Petroleo Brasileiro S.A

MesoCoat entered into a Cooperation Agreement dated January 7, 2011, with Petroleo Brasileiro S.A

(“Petrobras”) for the purpose of carrying out development work and conducting validation tests in

connection with applying the CermaClad process to coating the internal surfaces of pipes for use in the

oil and gas industry. The term of the Cooperation Agreement was initially for 18 months during which

MesoCoat, with the assistance of Petrobras, carried out development work and a series of tests divided

into two phases with the prospect of a third phase. Phase I was a feasibility demonstration designed to

verify that the CermaClad process and resultant materials were compliant with industry standards and

acceptable for clad pipe use. Phase II was the development of a prototype pipe cladding facility that could

clad the inner surface of a 10 inch diameter pipe, and then verify that the CermaClad process as applied

to prototype pipes was suitable for application to line pipe in accordance with current industry standards.

The prospective third phase would be to finalize the design and construction of a clad pipe manufacturing

facility in Brazil with the capacity of producing cladding on the interior diameter of pipes and tubes with

section lengths of 12 meters.

13



The immediate objective of the Cooperation Agreement, subject to obtaining successful results, in each of

Phase I and II, is that the CermaClad product and samples meet the  American Petroleum Institute

(API) 5LD and Det Norte Veritas (DNV) OS F101 standard requirements. API and DNV approvals

would, assuming the completion of a suitable manufacturing facility as anticipated by the prospective

third phase, permit MesoCoat’s market entry into the oil and gas industry and cause full scale production

activities.

MesoCoat has successfully completed Phase I of the Cooperation Agreement by demonstrating that the

CermaClad process is capable of producing clad steel products that meet API 5LD and DNV OS F101 -

Specifications for CRA clad steel pipe on flat plate coupons.

MesoCoat completed the major objectives of Phase II with the design, fabrication, installation, and initial

operation of a prototype ID cladding system in our Eastlake, Ohio facility, which became operational in

April, 2012.  Clad sections of pipe were prepared and tested against API and DNV standards, resulting in

proof of capability that the pipe cladding system could produce sections of clad pipe product compliant

with industry standards.  To expand the time available for testing, the development agreement was

extended by six months until January, 2013.  The Phase II final report was submitted in November 2012,

including equipment and facility designs and plant layouts for a 4-line Brazilian production facility.

In January of 2013 Petrobras and MesoCoat agreed to a further nine month extension and an expanded

scope of development work to include the addition of thermal modeling and imaging to enhance

instrumentation and other controls of the pipe cladding process, prior to the delivery of clad pipe sections

for qualification testing. This expanded scope was designed to provide defect-free larger sections of clad

pipe, and is part of MesoCoat’s overall manufacturing development program which continues to be

supported by Petrobras internal support.  This work has been progressing and MesoCoat expects

completing the expanded program in the 4th quarter of 2013. Results to date from these activities resulted

in improvements to our ability to monitor the thermal “effects” through the use of high temperature

sensors and cameras along with developing and validating simulation software to analyze the results to

support improving the process quality.   In addition to supporting prototype development and defect

elimination efforts, the added data generation, imaging, calibration, simulation, and analysis techniques

support the development of quality and manufacturing process control systems necessary to ensure the

highest quality clad products.

Outside of the Cooperative Agreement, but supporting the Phase III manufacturing objectives of the

cooperative agreement, MesoCoat further expanded the scope through the design, procurement,

installation, and ramp up of a full-scale, 12-meter clad pipe manufacturing facility in Euclid, Ohio that is

validating the production, quality, and economics of cladding the inside diameter of 10, 18 & 24 inch

diameter, 12 meter pipe. This facility is part of manufacturing scale-up, verification, and de-bugging of

full scale production equipment, and to support further automation of the cladding process to achieve high

level of process control.

A construction and installation team is being added to work on Phase III for facility design as well the

design and manufacturing of the plant operating equipment.

14



Powdermet

Powdermet’s Business

Powdermet was formed in 1996 and has since developed a product platform of advanced materials

solutions derived from nano-engineered particle agglomerate technology and derived hierarchically

structured materials. These advanced materials include energy absorbing ultra-lightweight syntactic- and

nano-composite metals, and energetic materials in addition to the PComP nanocomposite cermets (a

cermet is a metal-ceramic composite) exclusively licensed to MesoCoat. The business has historically

financed itself non-dilutively through revenues from corporate engineering consulting and development

fees, government and private sector contracts and grants and recently through partnerships with prime

contractors and systems integrators.  Powdermet operates as a commercial technology incubator with a

subsidiary, spin-out, or license model for major commercial markets (such as with Mesocoat), while

retaining and supporting the supply of critical nanocomposite powders to licensees, spin-outs, and

through toll production, equipment sales, and engineering services.  The company provides

nanoengineered materials, technology development services, and specialized production equipment in the

nano- and engineered particle space”.

While MesoCoat’s product focus is on market development and commercialization of advanced cermets

to address corrosion and wear coating needs, Powdermet’s product differentiation is based on its ability to

build advanced nano-structured metal formulations to address energy efficiency, energy absorption and

release, reduction in hazardous materials, and life cycle cost reduction. Powdermet’s technologies are

particularly useful in crash and ballistic energy management markets since they offer weight reduction

and the ability to dissipate substantially more impact energy than the aluminum alloys and foamed metals

currently available.

Powdermet has four materials solution families under development:

(1)  SComP - A family of syntactic metal composites known for their light weight properties and

ability to absorb more impact energy than any other known material. SComP can provide

weight savings over aluminum and magnesium alloys without magnesium’s corrosion and wear

limitations, reducing structural weight by 10-30% in targeted aerospace, consumer electronics,

and transportation applications.   One new patent applications was filed this quarter on low

density, mill product and method of manufacture.

(2)  MComP - A family of hierarchically structured, rare earth free, nanocomposite metal and metal

matrix composites that provide higher strength and temperature capability compared to traditional

aluminium and magnesium allows. MComP is designed to be a market replacement for

beryllium, aluminum and magnesium in structural applications, without relying on scare and

expensive rare earths to produce high strength and thermal stability. Targeted applications include

aerospace and defense and transportation market segments, as well as electrical transmission and

distribution.

15



(3)  EnComP - A diverse family of nano-engineered particle based solutions for energy

storage. Current developments include record setting energy density nanoparticle filled films for

capacitors, structured nanocomposite anode and cathode materials for thermal and lithium ion

batteries, and inflatable hydrogen storage media capable of energizing power fuel cells down to -

34C.   A new patent application was filed related to environmentally-triggered reactive

composites, with applications to well perforation devices, reactive warheads, and dissolvable

frack balls for shale gas field completions for new product launches in the EnComP product

family

(4)  SynFoam - A family of structural, thermally insulating syntactic ceramic composites

combining strength, high temperature functionality and low thermal conductivity into one

multifunctional material. Applications include rocket propulsion and re-entry vehicle systems,

and structural insulation for high temperature energy production and use including flowlines and

heat treatment furnaces.   Two new patent applications were filed for high temperature structural

insulation, and for high temperature insulation for production flowlines to support new product

releases in the Synfoam Product line.

Powdermet’s two developmental products closest to commercialization are SynFoam syntactic foams

and EnComP energetic nanocomposites.

Powdermet also produces custom-engineered powders and nanopowders, provides advanced materials

contract research and development services, and derives significant revenues from tolls and contract

development and manufacturing services.

Powdermet has recently demonstrated considerable success in providing a record setting energy density

of over 10J/cc in its nanocomposite films for film-foil capacitors, and has been awarded a greater than

$1M contract for further device development and demonstration (prototyping).  Powdermet continues to

receive significant interest in its nanocomposite lithium anode and cathode production capabilities, and

has secured a Department of Energy contract to develop materials for the next generation magnesium,

multivalent cationic batteries which theoretically can provide 4X the power density of lithium cells.

Working with Purdue University and Michigan State University, Powdermet is scaling up its reversible

nanocomposite liquid hydrogen storage media that has exhibited particular promise as a transportable,

renewable source for hydrogen fuel cells exposed to temperatures below -10C.

Powdermet’s MComP metal nanocomposite development group continues to work on reducing the cost

of record-breaking light metal nanocomposites.  Nanocomposite metals which have been engineered with

specific distributions of nano- and micro-scale features have been shown to possess previously

unachievable combinations of strength and ductility, with nanocomposite aluminum approaching the

strength of steel at 11/3rd the density/weight.  These nanoengineered metals are highly sought after for

weight reduction and fuel economy benefits in transportation vehicles, including armoured military, high

speed rail, and large truck applications.   Powdermet has more recently made significant advances in its

joint venture with Oshkosh defense, Eck industries, and the University of Wisconsin to develop a low

cost (compared to powder metallurgy routes) castable aluminum nanocomposite exhibiting record-

breaking combinations of strength and ductility along with improved fabricability.   Powdermet is

working with its partners to demonstrate scalable production, and our next major milestone is to produce

a several hundred pound casting suitable for use in a heavy transport vehicle.

16



Powdermet’s SComP solution addresses a large market need for crash energy management and reduced

weight for fuel economy and portability.  Today’s engineered materials market offers nothing like

SComP and its closest competition would be engineered honeycomb structures and foamed metals,

neither of which have SComP’s energy absorption capabilities, metal-like aesthetics and ease of use.

One of the largest benefits of these syntactic metal composites is their ability to absorb energy from

impacts and ballistic events through deformation.  Powdermet is aware of one firm, APS, Inc., started by

a former employee that offers a similar product. Powdermet’s current development focus for SComP

products are on scalable processing to reduce costs necessary to enter larger, shorter sell cycle markets, as

well as product design and insertion into defense markets which have a long acceptance cycle.  Market

competition may come from nanotube companies which are attempting to build energy absorption

features using this type of technology but without the same property characteristics as Powdermet’s

products, especially in the area of thermal resistance.  SComP is expected to fare well when introduced

to the commercial market.

Terves, Inc.

On July 23, 2013, Powdermet announced the launch of its wholly owned subsidiary Terves Inc., to

commercialize proprietary reactive materials technology for the shale gas and oil industry. Terves’

TervAlloy technology was initially developed by Powdermet’s ENComP energetic nanocomposite

development group to build reactive warheads for the US Department of Homeland Security.

TervAlloy technology has since been reconfigured and customized into engineered reactive materials

that can significantly improve the efficiency, oil recovery, and safety of well isolation, perforation and

completion for oil and gas companies operating in shale and tight rock formations in the United States

and across the globe.

TervAlloy is a class of patent pending, environmentally responsive, lightweight metallic materials

manufactured from magnesium and other light metals such as lithium that are high strength, machinable,

and also respond in an engineered and controlled manner to environmental stimuli such as changes in

fluid, pH, temperature or electrical or magnetic fields to induce material changes such as decoherence

(disintegration), gas generation, or heat generation. TervAlloy is engineered for various market

applications including oil and gas tools for well isolation and completion (frac-balls, sleeves, and seats),

well perforation, and fracturing, lightweight electronic packaging, beryllium replacement, airframe

structures, missile airframes and rocket motor cases, and transportation The primary application of

TervAlloy for oil and gas include controlled disintegration well completion tools and reactive tooling

that provides for the generation of heat and gas pressure inside a formation.

AMP Distributors Inc. SEZC and AMP Distributors, Inc.

AMP Distributors Inc. SEZC (“AMP SEZC”)(formerly AMP Distributors, Inc.) and AMP Distributors,

Inc. (“AMP FL”) were formed by the Company in June 2011 and July 2012, as a Cayman Islands

company and a Florida corporation respectively.  In April 2013, AMP SEZC filed for a Trade Certificate

which was approved in full in May 2013 to begin operations as a Special Economic Zone Company. Fully

staffed offices have been established by AMP SEZC in the Cayman Enterprise City. The primary purpose

of these entities is to negotiate, execute and administer the set up of overseas operations as well as

handling some international sales of MesoCoat's products. AMP SEZC and AMP FL will also be tasked

with acquiring equipment and coating materials for the Company’s international transactions. AMP SEZC

has acquired a Work Certificate for its General Manager (with over 30 years of experience in the overseas

financial services industry) and has also retained Kariola Limited, a consultancy organization, to assist it

with technical advice and entry into Asian markets.

17



Industry Overview

External Environment: Corrosion

The U.S. Department of Commerce monitors a large number of industry sectors that face problems with

corrosion, which is a growing issue faced by companies worldwide. Metallic corrosion is the degradation

that results from interaction of metals with various environments such as air, water, naturally occurring

bacteria, chemical products and pollutants. Steel accounts for almost all of the world’s metal consumption

and therefore an astoundingly high percentage of corrosion issues involve steel products and by-products.

These issues affect many sectors of the worldwide economy. According to NACE International, the cost

of corrosion to the global economy is $2.2 trillion annually, or roughly 3% of the world’s GDP.

Although worldwide corrosion studies began in earnest in the 1970s, there has never been a standardized

way for countries to measure corrosion costs. As a result, estimates of economic damage are difficult to

compare. What is clear, however, is that the impact of corrosion is serious and severe. As a result of

corrosion, manufacturers and users of metallic products incur a wide range of costs, including:

§     painting, coating and other methods of surface preparation;

§     utilizing more expensive corrosion resistant materials;

§     downtime costs;

§     larger spare parts inventories; and

§     increased maintenance costs.

There are also related costs that may be less obvious. For instance, some of the nation’s energy demand is

generated by firms fixing metallic degradation problems. Studies have shown that this increased energy

demand would be avoidable if corrosion was addressed at the preventable stage. Some of this demand

could be reduced through the economical, best-practice application of available corrosion control

technology.

External Environment: Wear

Corrosion is not the only concern of engineers and material scientists. In most industries, the deterioration

of surfaces is also a huge problem. Wear is often distinct from corrosion and describes the deterioration of

parts or machinery due to use. The effects of wear can generally be repaired. However, it is also usually

very expensive. Prevention and wear protection is the most economical way to offset the high costs

associated with component repair or replacement. To accomplish this, hard-face coatings are applied to

problematic wear surfaces for the purpose of reducing wear and/or the loss of material through abrasion,

cavitation, compaction, corrosion, erosion, impact, metal-to-metal, and oxidation. Some companies focus

on the prevention side of the business (applying coatings to prevent wear) while others focus on the repair

side of the business (reforming metal or applying coatings to fix metal substrate problems).

In order to properly select a coating alloy for a specific requirement, it is necessary to understand what

has caused the surface deterioration. The various types of wear can be categorized and defined as follows:

§     Abrasion is the wearing of surfaces by rubbing, grinding, or other types of friction that usually

occurs due to metal-to metal contact. It is a scraping, grinding wear that rubs away metal surfaces

and can be caused by the scouring action of sand, gravel, slag, earth, and other gritty material.

§     Cavitation wear results from turbulent flow of liquids that carry small suspended abrasive

particles.

18



§     Compression is a deformation type of wear caused by heavy static loads or by slowly increasing

pressure on metal surfaces. Compression wear causes metal to move and lose dimensional

accuracy.

§     Corrosion wear is the gradual deterioration of unprotected metal surfaces, caused by the effects

of the atmosphere, acids, gases, alkalis, etc. This type of wear creates pits and perforations and

may eventually dissolve metal parts.

§     Erosion is the wearing away or destruction of metals and other materials by the abrasive action of

water, steam, slurries which carry abrasive materials. Pump parts are subject to this type of wear.

§     Impact wear is the striking or slamming contact of one object against another and this type of

wear causes a battering, pounding type of wear that breaks, splits, and deforms metal surfaces.

§     Metal–to-Metal wear is a seizing and/or galling type of wear that rips and tears out portions of

metal surfaces. It is often caused by metal parts seizing together because of lack of lubrication. It

usually occurs when the metals moving together are of the same hardness. Frictional heat

promotes this type of wear.

§     Oxidation is a type of wear causing flaking or crumbling layers of metal surfaces when

unprotected metal is exposed to a combination of heat, air and moisture. Rust is an example of

oxidation.

Generally, the initial coating selected to protect a product against wear is also the same product applied to

correct the problem once the product is worn. However, at that time, engineers can determine whether

some of the characteristics they set for the initial preventative coating have withstood the environment or

other pressures initially assumed in the product’s design. If it is determined that the initial coating

selection was not adequate, material scientists can change the application parameters of the prior coating

material (like amount or width of coating material applied) or select a new coating material that has new

properties. For instance once the type of wear is identified, a material engineer might determine that a

new coating material with better lubricity and other characteristics is needed for repair.

Presently there is no governmental standardized method to classify or specify degrees of wear. Nor is

there a central agency that collects market data on the cost of wear-based issues, primarily because firms

account for repair costs differently. Each industry sector has its own means of evaluation and approach to

repair, based on the type of part that needs repair, the urgency of that repair, the availability of a coating

solution and the cost associated with downtime. In general, companies already have plans in place on how

to fix a part once it goes down. However, if an unexpected problem occurs, firms utilize the expertise of

experienced materials engineers that have worked with numerous coating suppliers to evaluate a solution.

Sometimes this evaluation is done by reviewing vendor data only (suppliers typically provide complete

data product information worksheets which detail product properties, testing specifications, best

applications methods and conditions). If self-review is insufficient, consultants and vendors are flown it to

help assist companies in their material selection or solution repair needs. Those solutions then go through

review to determine their merit and cost benefit. Sometimes, parts cannot be repaired and new ones are

required.

Competition

The companies in which the Company has invested can expect to face intense competition within their

respective market segments upon product commercialization. The industrial coatings industry is highly

fragmented by companies with competing technologies each seeking to develop a standard for the

industry. Industrial coatings research and development has been ongoing for some time and several firms

are perceived as the industry leaders.

19



MesoCoat

PComP

PComP nanoenginered cermet products have few directly comparable competitors. Although there are

established thermal spray coating material manufacturers such as Deloro Stellite, Sulzer Metco, Hoganas;

and a few emerging companies like Nanosteel, Integran, Inframat, Xtallic, and Modumetal that offer

solutions for corrosion and wear competition, no competitor has yet been able to engineer the

combination of properties that MesoCoat has built into its PComP product line.

MesoCoat has been able to manufacture a corrosion resistant product that has high strength, hardness, and

fracture toughness.  Toughness and hardness are normally inversely proportional characteristics and no

other company has been able to reverse the nature of these properties which is what makes the PComP

products unique in the market place. MesoCoat has also increased the ductility factor in the PComP

products so basically not only has PComP shown to provide a harder coating surface, but the hard

objects are able to bend more without breaking.

One good example of how the PComP family of products have a competitive edge over existing

alternatives is PComP W, MesoCoat’s tungsten cobalt carbide replacement solution. PComP W

exhibits high deposition efficiency and at a Vickers hardness similar to that of tungsten carbide while

being stronger than the conventional carbide coatings it is designed to replace. Good toughness tolerates

more flexing of the part than other HVOF WC coatings without the usual cracking of the coating. The

structure of the PComP coatings generally also allow for conventional grinding techniques, eliminating

the expensive diamond finishing process needed for conventional materials used in tungsten carbide and

cobalt coating solutions.

The PComP family of products are expected to fare well among existing competitors on market entry.

CermaCladTM

A handful of large companies cater to this market segment – JSW Steel Co., Voest Alpine and Sulzer-

Metco are heavily involved in the clad plate market with a significant portion of the market share, Butting

GmbH and Cladtek International Pty Ltd. are large participants in the mechanically clad pipe market, and

ProClad Group is important in the metallurgically clad pipe market. Most of the large companies

participating in the cladding market have very similar technologies and impact the market mostly on their

scale of production (availability), relationships, and price.

Several smaller companies spread across the globe are also involved in this market segment, like Arc

Energy Resources, IODS, High Energy Metals, and Kladarc LLC (acquired by PCC), all of which offer

weld overlay services for the oil and gas industry which we believe generate less than $25 million in

annual revenues. Other examples include Matrix Wear Technologies, Cladtech Canada, Brospec LP,

Almac, and Clearwater Welding and Fabrication LP all of which offer weld overlay processes to those

working in the Canadian oil sands which we believe generate between $15-50 million in revenues. The

higher revenues for the Canadian weld overlay companies is primarily due to their presence in Canada

where oil sands operations require large amounts of clad pipe and components, and the emphasis is on

local shops and faster turnaround times

20



CermaClad is a seamless metallurgical clad product which is cost competitive with existing

metallurgically clad products and exhibit better properties in almost every parameter when compared to

competing technology.  A superior product and the fact that several multi-billion dollar oil and gas

projects across the globe have been delayed due to availability of high-quality clad pipes may facilitate

the ready adoption of CermaClad clad pipes. Spearheaded by more than trillion dollars of spending to

exploit oil and gas reserves, the clad pipe market is expected to increase exponentially over the years

leading to an increasing demand-supply gap for clad pipes. Unlike our competition that have to spend

$200 million to $1 billion to set-up new clad pipe/plate manufacturing facilities or expand production

capability; the very high productivity of the CermaClad technology  and lower equipment costs enables

MesoCoat to set-up clad pipe manufacturing facilities at a much lower capital cost  than competing

technologies with similar production capacity. This competitive advantage would permit MesoCoat to set-

up multiple facilities across the globe to serve the regional market and fulfill the growing local content

requirements in the Asia Pacific, Middle East, South America, Gulf of Mexico and Africa with

significantly lower capital requirements. Even with considering the global shortage of cladding capacity

and the endemic quality problems the industry is suffering, the Company believes that it can achieve

significant sales without taking any business away from the current participants in the market.

Other specific competitive advantages supported by the application of the CermaClad products include:

Time and productivity

§     Much   higher   material   application   rate   than   weld/laser   cladding,   >100Kg   vs   3-10Kg/hr

application rates.  more scalable for production volume

§     Capital  investment  significantly  lower  than  mechanical  cladding  or  metallurgical  cladding

(roll bonding) for similar capacity, reducing fixed costs

§     Ability to provide local content in scalable manner at reasonable capital investment levels

§     Reduces   lead   times   for   new   capacity   compared   to   current   market,   and   provides   high

scalability  for  market  flexibility.   Potentially  enables  distribution  and  customization  of  pipe

for fast-turnaround project needs

§     CermaClad  solves  many  industry limitations  for  large  diameter  (14”  diameter  and  up)  and

thick   walled   (more   than   1”   wall   thickness)   where   both   the   mechanically   clad   and

metallurgical clad plate to pipe do not provide an ideal solution.

Performance risk

§     True  metallurgical  bond  coupled  with  a  smoother  surface  enables  easier  inspection  thus

reducing risk of failure

§     Smoother   surface   enables   ease   in   fluid   flow   reducing   operating   costs   incurred   in

transportation of fluids

§     Crack-free hard coatings up to 15mm thickness enable performance multiples in hardfacing

§     Better properties than weld overlay due to lower dilution or dissolution.

§     Cermaclad  enables  the  use  of  metallurgically bonded  clad  seamless  pipe,  eliminating  90%

or more of the welds compared to other product offerings.

21



Cost

§     Faster  Application  and  high  throughput  lowers  cost  basis  for  metallurgically  bonded  clad

product

§     Technology  allows  the  application  of  thinner  clad  layers,  potentially  enabling  dramatic  cost

reduction at sustained margins

§     High  productivity  and  scalability  can  enable  reduced  lead  times,  reducing  capital  costs  for

large projects.

§     Lower  capital  costs  also  enable  the  set-up  of  regional  clad  pipe  manufacturing  facilities  to

meet  the  growing  local  content  requirement,  positioning  us  as  the  preferred  vendor  for  the

region and to avoid import duties.

Powdermet

Powdermet’s SComP solution addresses a large market need for crash energy management and reduced

weight for fuel economy and portability.  Today’s engineered materials market offers nothing like

SComP and its closest competition would be engineered honeycomb structures and foamed metals,

neither of which have SComP’s energy absorption capabilities, metal-like aesthetics and ease of use.

One of the largest benefits of these syntactic metal composites is their ability to absorb energy from

impacts and ballistic events through deformation.  Powdermet is aware of one firm, APS, Inc., started by

a former employee that offers a similar product. Powdermet’s current development focus for SComP

products are on scalable processing to reduce costs necessary to enter larger, shorter sell cycle markets, as

well as product design and insertion into defense markets which have a long acceptance cycle.  Market

competition may come from nanotube companies which are attempting to build energy absorption

features using this type of technology but without the same property characteristics as Powdermet’s

products, especially in the area of thermal resistance.  SComP is expected to fare well when introduced

to the commercial market.

General Company Competitive Advantages

The following general factors serve as keys to the Company’s success:

§     Management    A  well-balanced,  experienced  management  team  provides  the  Company  and  its

subsidiaries with the guidance and strategic direction to successfully gain market entry.

§     Products – The Company’s  products represent innovations in multi-billion dollar markets.

§     Intellectual  Property    The  intellectual  property  of  MesoCoat  and  Powdermet  includes  owned

patents,   exclusive   licensing   rights,   and   proprietary   processes   that   make   market   penetration

effective and feasible.

§     Qualification   and   Testing      As   leading   companies   in   multiple   industries   as   well   as   U.S.

government agencies test and qualify MesoCoat and Powdermet’s products, significant barriers to

entry are automatically created for potential competitors.

§     Fundraising  -  As  a  publicly  traded  entity,  the  Company  gains  financing  from  public  equity

markets which provide more liquidity and easier access to capital in the fundraising process.

22



The Company has also constructed the following barriers for potential competitors:

§     Product development expertise in both MesoCoat and Powdermet;

§     Exclusive global license for the high density fusion cladding process from Oak Ridge National

Laboratory; and several additional design and utility patents filed by the companies coupled with

several product and process trade secrets

§     Strong product pipeline that would be ready for market in the next 2-3 years;

§     Strong R&D.

The Company will encounter the following barriers to entry:

§     American Petroleum Institute (API) certification for its CermaClad products. In order to

successfully sell to the oil and gas industry, MesoCoat’s coatings must receive official approval

and certification, a process that generally requires major oil and gas entities to qualify our

products for use, followed by qualification for specific projects. MesoCoat’s Cooperation

Agreement with Petroleo Brasileiro S.A. has demonstrated product suitability at the laboratory

scale, and is in the final stages of a prototype clad pipe product qualification. The construction of

our Euclid, Ohio 12 meter pipe plant, at a cost of over $6,000,000 (including funding from Joint

Development Agreements (“JDA’s”) and federal grants) and subsequent quality certification of

the facility and its products represent the final steps towards entry of this pioneering product in

the oil and gas sector.

§     Market acceptance of MesoCoat’s CermaClad’ product line that would encourage entry into

markets such as the oil sands development in Alberta, Canada. MesoCoat is currently pursuing

the establishment of a research and development facility in Alberta, Canada to accelerate the

acceptance of its CermaClad WR clad pipe and components.

§     Developing the best product with the best value.

§     Protecting proprietary technology.

Marketability

The ultimate success of any product will depend on market acceptance in its many forms, including cost,

efficiency, convenience and application. The market for MesoCoat’s prospective products is potentially

enormous and will require the Company to apply a significant portion of its focus on how to best initiate

market introductions and into which segments. The commercial possibilities for those products currently

under development at Powdermet are no less expansive and will likewise require that significant

resources are dedicated to an effective marketing strategy as commercialization draws near.

MesoCoat Overview

A tremendous need exists today to find better corrosion protection and wear prevention technologies to

replace many of the limited life, high cost coating and alloy materials used today to solve operational

problems in industrial and infrastructure applications.

The inorganic metal finishing industry currently is one of the largest industrial users of hazardous and

carcinogenic chemicals, and produces hundreds of millions of gallons of contaminated wastewater and

toxic by-products annually. Hazardous metals such as lead, cadmium, chromium, and to a lesser extent,

cobalt, tungsten carbide, and volatile organic compounds used to strip rust and repair large steel structures

are being phased out or subjected to increasingly strict environmental regulations, creating opportunities

for innovation. U.S. companies annually spend billions of dollars on coatings and surface treatments

23



made from hazardous materials. Private companies and government defence agencies often use harmful

products like chrome because these solutions have been the lowest cost, most available corrosion and

wear resistant products available for the last 50 years. However, private and public users are now

recognizing the environmental problems these materials cause and the potential safety issues for those

who come in contact with these materials.  Many companies would stop using these hazardous materials

if a cost effective substitute product could be brought to market.  Legally, users may soon have no choice

but to desist from using hazardous materials as the EPA and other international environmental

organizations are moving to ban their use.

Manufacturers are now modifying their product’s bill of materials list and seeking substitute coating

products with similar or better corrosion and wear resistant properties in advance of impending legal

changes. Many are turning to next generation coatings made from alternative technologies like

nanotechnology-based materials to accomplish their goals. Innovative companies, such as MesoCoat, that

can develop non-toxic and longer life coating alternatives that have equal or superior corrosion and wear

protection capability at equal or lower cost relative to today’s solutions stand to reap significant financial

rewards in the next several decades.

PComP

MesoCoat has been working with major fortune 100 clients like Boeing, Caterpillar, B.F. Goodrich, and

several OEM's from the oil and gas industry for product insertion into their product lines.  In addition to

these large clients which have long sell cycles (2-5 years not atypical), MesoCoat has worked through

certified application partners in Alberta, Los Angeles, and Houston to capture short cycle sales and gain

initial market share.  MesoCoat has signed a long term production agreement in Alberta, and is in

advanced field testing with partners in Houston.  With the robust pipeline of major OEM’s well

underway, MesoCoat is now entering the short cycle “job shop” application services (coatings) market in

the Midwest, and preparing to launch is PComP MB (molybdenum boride) nanocomposite coatings for

the metals processing industry.  The company has recently added regional sales forces in western Canada

and the Midwest to drive coating application service sales beginning next quarter. Application services

will be sold on a “per square inch” basis and pricing will be reflective of market pressures and the volume

of work received from each commercial customer. Pricing variables will be taken into consideration for

each application service order.

MesoCoat’s forecast for PComP growth is conservative due to the initial emphasis placed on sales of

the CermaClad product line, and the long sell cycle of major multimillion accounts. Nevertheless,

management’s forecast could be understated if sales adoption times to large OEM’s and military

maintenance and repair organizations exceed expectations. The military spends billions each year to

address wear and corrosion issues associated with new and used equipment. The U.S. Department of

Defense has widely publicized that in the future its budgets will be focused on sustaining current

platforms rather than developing or producing new ones. Based on input received from government

agencies, MesoCoat expects that it will be able to offer ideal environmentally friendly anti-corrosion/wear

resistant material solutions needed today to sustain current platforms.

CermaClad

MesoCoat’s market entry plans for Cermaclad are to clad the interior diameter of full length oil and gas

pipes with corrosion resistance alloys, and initially Alloy 625 and 825 using high productivity

CermaClad application technology.   In this market, MesoCoat is qualifying Cermaclad 625 and 825

to current industry standards, working with Petrobras and other oil and gas majors to ensure industry

24



acceptance of qualification data as the path to market acceptance.  Due to the large order size for clad

pipes, ranging from $2-500+ million per project, successful introduction of CermaClad CRA clad pipes

is expected to result in an immediate market success.

Management has made sizeable investments in redesigning and miniaturizing the technology to commit to

this initial market solution. The new inside diameter HDIR lamp head has now been operating for over a

year integrated into a subscale 6-ft CermaClad pipe coating system.  Using this prototype cladding

system, MesoCoat has completed initial product demonstration and sub-scale prototype development and

industry-standard product qualification milestones.  In April, 2013, Mesocoat completed the installation

of a full scale production cladding tool to demonstrate full scale manufacturing, with scale-up transition

anticipated to be completed by December, 2013.  As part of the full scale manufacturing demonstration,

MesoCoat has completed the construction of a new 11,000 sq ft one-line clad pipe manufacturing facility,

which was completed in April, 2013. The end result is that MesoCoat expects to be able to deliver initial

product for qualification with several oil majors in the first quarter of 2014 and expects to begin full-scale

manufacturing in a 4-line plant in 2015.  Completion of the full scale product facility and achieving

product quality certifications will enable MesoCoat to begin market roll-out and sales of clad pipe to the

oil and gas industry.

MesoCoat’s expansion within the market place will be tied to its ability to attract growth capital for

project financing to undertake global expansion, or attracting appropriate joint venture partners to build

fabrication plants to serve global demand. Given the projected profitability of such plants and the

anticipated short payback period anticipated, management foresees no problem attracting interested

market partners.

Patents, Trademarks, Licenses, Franchises, Concessions, Royalty Agreements and Labor Contracts

The Company has no patents, trademarks, licenses, franchises, concessions, royalty agreements or labor

contracts other than those held by MesoCoat and Powdermet.

MesoCoat's patents include: six exclusively licensed patents from Powdermet, the earliest of which

expires May 30, 2020 (see dates below); two exclusively licensed patents from Oak Ridge National

Laboratory, which expire on March 15, 2019 and July 30, 2024; and four pending U.S. Patents and three

pending global patents, all of which expire in 2030 or after.

Powdermet's patents include: six U.S. Patents, which have expiry dates of May 30, 2020, December 7,

2020, July 12, 2022, August 22, 2022, April 6, 2025 and June 23, 2026; and an exclusively licensed

patent from Ultramet Inc., which expires on February 21, 2016,  six pending US patents and two pending

international patents.  Powdermet also has trademarks and licenses which it will use to protect its assets as

necessary.

Patents in general remain in place 20 years from application and 17 years from issuance.

Governmental and Environmental Regulation

The Company is subject to local, state and national taxation. Additionally, the Company’s operations are

subject to a variety of national, federal, state and local laws, rules and regulations relating to, among other

things, worker safety and the use, storage, discharge and disposal of environmentally sensitive materials.

We believe that the Company is in full compliance will all laws, rules, regulations and requirements that

affect its business.

25



We believe that MesoCoat and Powdermet are in full compliance with the Resource Conservation

Recovery Act, the key legislation dealing with hazardous waste generation, management and disposal.

Nonetheless, under some of the laws regulating the use, storage, discharge and disposal of

environmentally sensitive materials, an owner or lessee of real estate may be liable for the costs of

removal or remediation of certain hazardous or toxic substances located on or in, or emanating from, such

property, as well as related costs of investigation and property damage. Laws of this nature often impose

liability without regard to whether the owner or lessee knew of, or was responsible for, the presence of

hazardous or toxic substances.

We further believe that MesoCoat and Powdermet are in compliance in all material respects with all laws,

rules, regulations and requirements that affect their respective businesses and that such compliance does

not impose a material impediment on either entities ability to conduct business.

Climate Change Legislation and Greenhouse Gas Regulation

A majority of the climate change related studies over the past couple decades have indicated that

emissions of certain gases contribute to warming of the Earth’s atmosphere. In response to these studies,

many nations have agreed to limit emissions of “greenhouse gases” or “GHGs” pursuant to the United

Nations Framework Convention on Climate Change, and the “Kyoto Protocol.” Although the United

States did not adopt the Kyoto Protocol, several states have adopted legislation and regulations to reduce

emissions of greenhouse gases.

The United States Supreme Court ruled, in Massachusetts, et al. v. EPA, that the EPA abused its

discretion under the Clean Air Act by refusing to regulate carbon dioxide emissions from mobile sources.

As a result of the Supreme Court decision the EPA issued a finding that serves as the foundation under

the Clean Air Act to issue other rules that would result in federal greenhouse gas regulations and

emissions limits under the Clean Air Act, even without Congressional action. Finally, acts of Congress,

the decisions of lower courts, large numbers of states, and foreign governments could widely affect

climate change regulation. Greenhouse gas legislation and regulation could have a material adverse effect

on our business, financial condition, and results of operations.

Research and Development

The Company is focused on the research and development of those entities in which it holds an interest.

MesoCoat and Powdermet have a history of working on critical R&D projects for the private and public

sector over a broad range of research fields, with further work extending into peripheral areas. MesoCoat

and Powdermet have adopted this approach because they believe that excellent products can be created

when a backdrop of diversified sciences and technologies exist. From this broad range, their respective

R&D staffs work closely with sales and operations management teams to establish priorities and

effectively manage individual projects.

Currently, MesoCoat and Powdermet are working on several critical and high risk-high reward R&D

projects primarily funded by the federal government, state government and end users. MesoCoat’s

PComP and Powdermet’s SComP product lines that are the end product of federally funded R&D.

26



Employees

As of August 28, 2013 the Company has one employee, five directors, seven advisors, one administrative

assistant and five contracted consultants. We use additional consultants, attorneys, and accountants as

necessary to assist in the development of our business.

As of August 28, 2013 MesoCoat had 27 employees.

As of August 28, 2013 Powdermet had 19 employees.

ITEM 1A.

RISK FACTORS

The Company’s operations and securities are subject to a number of risks. Below we have identified and

discussed the material risks that we are likely to face. Should any of the following risks occur, they will

adversely affect our business, financial condition, and/or results of operations as well as the future trading

price and/or the value of our securities.

The Company has a history of significant operating losses and such losses may continue in the future.

The Company incurred net losses of $13,545,788 for the period from June 27, 2006 (inception) to May

31, 2013. Since we have been without significant revenue since inception and have only recently

transitioned to producing limited revenue, as a result of the business combination with MesoCoat,

historical losses may continue into the future.

The Company has a history of uncertainty about continuing as a going concern.

The Company’s audits for the periods ended May 31, 2013 and 2012 expressed an opinion as to its ability

to continue as a going concern as a result of net losses of $13,545,788 since inception and a working

capital deficit of $2,222,670 as of May 31, 2013. Unless the Company is able to produce net income over

successive future periods its ability to continue as a going concern will be in jeopardy.

The Company requires additional capital funding.

The Company requires additional funds, either through equity offerings, debt placements or joint ventures

to develop our operations. Such additional capital will result in dilution to our current shareholders. Our

ability to meet long-term financial commitments will depend on future cash. There can be no assurance

that any future income will generate sufficient funds to enable us to meet our financial commitments.

The Company’s success is dependent on its ability to commercialize proprietary technologies to the

point of generating sufficient revenues to sustain and expand operations.

The Company’s near term future operation is dependent on its ability to commercialize proprietary

technologies to produce sufficient revenue to sustain and expand operations. The success of these

endeavors will require that sufficient funding be available to assist in the development of its business

interests. Currently, the Company’s financial resources are limited, which limitation may slow the pace at

which proprietary technologies can be commercialized. Should the Company be unable to improve its

27



financial condition through debt or equity offerings, the ability to successfully advance its business plan

will be severely limited.

We face significant commercialization risks related to technological businesses.

The industries in which MesoCoat and Powdermet operate and plan to operate are characterized by the

continual search for higher performance at lower cost. Our growth and future financial performance will

depend on the ability of MesoCoat and Powdermet to develop and market products that keep pace with

technological developments and evolving industry requirements. Further, the research and development

involved in commercializing products requires significant investment and innovation to keep pace with

technological developments. Should we be unable to keep pace with outside technological developments,

respond adequately to technological developments or experience significant delays in product

development, our products might become obsolete. Should these risks overcome our ability to keep pace

there is a significant likelihood that our ability to successfully advance our business will be severely

limited.

The coatings industry is likely to undergo technological change so our products and processes could

become obsolete at any time.

Evolving technology, updated industry standards, and frequent new product and process introductions are

likely to characterize the coatings industry going forward so our products or processes could become

obsolete at any time. Competitors could develop products or processes similar to or better than our own,

finish development of new technologies in advance of our research and development, or be more

successful at marketing new products or processes, any of which factors may hurt our prospects for

success.

MesoCoat and Powdermet compete with larger and better financed corporations.

Competition within the industrial coatings industry and other high technology industries is intense. While

each of MesoCoat and Powdermet’s products are distinguished by next-generation innovations that are

more sophisticated and cost effective than many competitive products currently in the market place, a

number of entities and new competitors may enter the market in the future. Some of MesoCoat’s and

Powdermet’s existing and potential competitors have longer operating histories, greater name recognition,

larger customer bases and significantly greater financial, technical and marketing resources than we do,

including well known multi-national corporations. Accordingly, MesoCoat’s and Powdermet’s products

could become obsolete at any time. Competitors could develop products similar to or better than our own,

finish development of new technologies in advance of either MesoCoat’s or Powdermet’s research and

development, or be more successful at marketing new products, any of which factors may hurt our

prospects for success.

Market acceptance of the products and processes produced by MesoCoat and Powdermet is critical to

our growth.

We expect to generate revenue and realize a gain on our interest in Powdermet from the development and

sale of products and processes produced by MesoCoat and Powdermet. Market acceptance of those

products is therefore critical to our growth. If our customers do not accept or purchase those products or

processes produced by MesoCoat and Powdermet, then our revenue, cash flow and operating results will

be negatively impacted.

28



General economic conditions will affect our operations.

Changes in the general domestic and international climate may adversely affect the financial performance

of the Company, MesoCoat and Powdermet. Factors that may contribute to a change in the general

economic climate include industrial disputes, interest rates, inflation, international currency fluctuations

and political and social reform. Further, the delayed revival of the global economy is not conducive to

rapid growth, particularly of technology companies with newly commercialized products.

MesoCoat and Powdermet rely upon patents and other intellectual property.

MesoCoat and Powdermet rely on a combination of patent applications, trade secrets, trademarks,

copyrights and licenses, together with non-disclosure and confidentiality agreements, to establish and

protect proprietary rights to technologies they develop. Should either of MesoCoat or Powdermet be

unable to adequately protect their intellectual property rights or become subject to a claim of

infringement, their businesses and that of the Company may be materially adversely affected.

MesoCoat and Powdermet expect to prepare patent applications in accordance with their respective

worldwide intellectual property strategies on acquiring new technologies. However, neither they nor the

Company can be certain that any patents will be issued with respect to future patents pending or future

patent applications. Further, neither they nor the Company know whether any future patents will be

upheld as valid, proven enforceable against alleged infringers or be effective in preventing the

development of competitive patents. The Company believes that MesoCoat and Powdermet have each

implemented a sophisticated internal intellectual property management system to promote effective

identification and protection of their products and know-how in connection with the technologies they

have developed and may develop in the future

We may not be able to effectively manage our growth.

We expect considerable future growth in our business. Such growth will come from the addition of new

plants, the increase in global personnel, and the commercialization of new products. Additionally, our

products should have an impact on the cladding industry; as companies learn that they can receive

materials with a short lead time at a higher quality and lower price, market demand should grow,

expanding the overall market itself. To achieve growth in an efficient and timely manner, we will have to

maintain strict controls over our internal management, technical, accounting, marketing, and research and

development departments. We believe that we have retained sufficient quality personnel to manage our

anticipated future growth though we are still striving to improve financial accounting oversight to ensure

that adequate reporting and control systems in place. Should we be unable to successfully manage our

anticipated future growth by adherence to these strictures, costs may increase, growth could be impaired

and our ability to keep pace with technological advances may be impaired which failures could result in a

loss of future customers.

Environmental laws and other governmental legislation may affect our business.

Should the technologies which each of MesoCoat and Powdermet have under development not comply

with applicable environmental laws then the Company’s business and financial results could be seriously

harmed. Furthermore, changes in legislation and governmental policy could also negatively impact us.

29



Although we are currently unaware of any introduced or proposed bills, or policy, that might cause us to

make specific changes to our operations, no assurance can be given that if new legislation is passed we

will be able to make the changes to comport our technologies with future regulatory requirements.

The Company and those entities in which it holds an interest may face liability claims.

Although MesoCoat and Powdermet intend to implement exhaustive testing programs to identify

potential material defects in technology they develop, any undetected defects could harm their reputation

and that of the Company, diminish their customer base, shrink revenues and expose themselves and us to

product liability claims. Any imposition of liability that is not covered by insurance or is in excess of

insurance coverage could have a material adverse effect on our business, results of operations and

financial condition.

The market for our stock is limited and our stock price may be volatile.

The market for our common stock has been limited due to low trading volume and the small number of

brokerage firms acting as market makers. Due to the limitations of our market and the volatility in the

market price of our stock, investors may face difficulties in selling shares at attractive prices when they

want to sell. The average daily trading volume for our stock has varied significantly from week to week

and from month to month, and the trading volume often varies widely from day to day.

The Company’s common stock is currently deemed to be “penny stock”, which makes it more difficult

for investors to sell their shares.

The Company’s common stock is and will be subject to the “penny stock” rules adopted under section

15(g) of the Exchange Act. The penny stock rules apply to companies whose common stock is not listed

on the NASDAQ Stock Market or other national securities exchange and trades at less than $5.00 per

share or that have tangible net worth of less than $5,000,000 ($2,000,000 if the company has been

operating for three or more years). These rules require, among other things, that brokers who trade penny

stock to persons other than “established customers” complete certain documentation, make suitability

inquiries of investors and provide investors with certain information concerning trading in the security,

including a risk disclosure document and quote information under certain circumstances. Many brokers

have decided not to trade penny stocks because of the requirements of the penny stock rules and, as a

result, the number of broker-dealers willing to act as market makers in such securities is limited. If the

Company remains subject to the penny stock rules for any significant period, it could have an adverse

effect on the market, if any, for our securities. If the Company’s securities are subject to the penny stock

rules, investors will find it more difficult to dispose of our securities.

The elimination of monetary liability against the Company’s directors, officers and employees under

Nevada law and the existence of indemnification rights to our directors, officers and employees may

result in substantial expenditures by the Company and may discourage lawsuits against our directors,

officers and employees.

The Company’s certificate of incorporation contains a specific provision that eliminates the liability of

directors for monetary damages to us and our stockholders; further, the Company is prepared to give such

indemnification to its directors and officers to the extent provided by Nevada law. The Company may

also have contractual indemnification obligations under its employment agreements with its executive

officers. The foregoing indemnification obligations could result in our incurring substantial expenditures

to cover the cost of settlement or damage awards against directors and officers, which the Company may

be unable to recoup. These provisions and resultant costs may also discourage us from bringing a lawsuit

30



against directors and officers for breaches of their fiduciary duties and may similarly discourage the filing

of derivative litigation by our stockholders against the Company’s directors and officers even though such

actions, if successful, might otherwise benefit the us and our stockholders.

ITEM 1B.

UNRESOLVED STAFF COMMENTS

None.

ITEM 2.

PROPERTIES

The Company maintains 800 sq. ft. of executive office space at 2665 S. Bayshore Drive, Suite 450,

Miami, Florida, 33133 on a month to month basis at a cost of $2,280 a month paid to Prosper Financial,

Inc., a related party. The Company does not believe that it will need to maintain a larger office at any time

in the foreseeable future in order to carry out its operations.

Powdermet maintains 48,000 sq. ft. of research and development space located at 24112 Rockwell Drive,

Euclid, Ohio 44117. The cost of the lease is $13,500 per month, adjustable on an annual basis, paid to

Sherman Properties LLC., a related party and the term of the lease runs through October 31, 2020 with

the right to sub-lease the premises.

MesoCoat maintains 22,000 sq. feet of the research and development space and a 11,000 sq. feet clad pipe

manufacturing facility located at 24112 Rockwell Drive, Euclid, Ohio 44117 leased from Powdermet on a

sub-lease basis that runs through May 31, 2020. The cost of the sub-lease for MesoCoat is $6,700 paid to

Powdermet per month.

MesoCoat maintains 10,000 sq. feet of research and development space at 34099 Melinz Pkwy, Eastlake,

Ohio 44095. The cost of the lease is $3,750 per month, paid to an unrelated third party and the term runs

through February 28, 2014.

31



ITEM 3.

LEGAL PROCEEDINGS

First Canadian Capital Corp.

The Company and Stratton S.A. (“Stratton”) initiated legal proceedings against First Canadian Capital

Corp. (“First Canadian”) on December 10, 2012, in the Circuit Court of the 6th Judicial Circuit in and For

Pinellas County, Florida. The claim was based on First Canadian’s alleged failure to perform according to

the terms of a consulting agreement dated December 1, 2011, pursuant to which First Canadian was to

provide services aimed at raising investor awareness, attracting investment and identifying prospective

financial parties in exchange for a monthly cash fee and Company shares. On May 8, 2013, the Company

and Stratton entered into a settlement agreement with First Canadian pursuant to which 51,000 of the

56,000 shares delivered to First Canadian were cancelled and returned to the Company’s authorized

common stock, On June 6, 2013 counsel for the Company and Stratton filed a notice of voluntary

dismissal with prejudice of the lawsuit.

Uptick Capital, LLC.

The Company initiated legal proceedings against Uptick Capital, LLC. (“Uptick”) on November 7, 2012,

in the United States District Court for the Southern District of New York Superior Court. The claim is

based on Uptick’s alleged failure to perform according to the terms of a consulting agreement dated

November 1, 2010, pursuant to which Uptick was to identify and introduce suitable investors to the

Company in exchange for certain consideration including 60,000 shares. The Company seeks the return of

the 60,000 shares delivered which were subsequently sold or in the alternative for a judgment in an

amount to be ascertained in excess of $1,000,000 for damages in addition to reasonable attorney’s fees

and court costs. The parties are currently in the process of exchanging document disclosure. The

Company believes that is will be successful in the pursuit of its claims.

Paloma Capital Group Ltd.

The Company initiated legal proceedings against Paloma Capital Group Ltd (“Paloma”) on July 2, 2013,

in the Circuit Court in and for Miami-Dade County. The claim is based on Paloma’s failure to perform

according to the terms of a consulting agreement dated May 2, 2011, pursuant to which Paloma was to

introduce suitable investors to the Company in exchange for certain consideration including 50,000 shares

of the Company and 150,000 stock options to purchase shares of the Company. The suit demands the

return of the Company shares and the stock options. Paloma is yet to be served with the complaint. The

Company believes it will be successful in the pursuit of its claims.

ITEM 4.

MINE SAFETY DISCLOSURE

Not applicable.

32



PART II

ITEM 5.

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED

STOCKHOLDER MATTERS, AND BUSINESS ISSUER PURCHASES OF

EQUITY SECURITIES

The Company’s common stock is quoted on the OTCQB electronic quotation system under the symbol

“ABKI”. These prices reflect inter-dealer prices without retail mark-up, mark-down, or commission, and

may not necessarily reflect actual transactions. The following table sets forth the high and low bid prices

for the common stock as reported for each quarterly period over the last two fiscal years.

High and Low Bid Prices

Year

Quarter Ended

High

Low

2013

May 31

$3.50

$2.52

2013

February 29

$2.85

$2.55

2012

November 30

$2.93

$1.46

2012

August 31

$2.45

$1.55

2012

May 31

$2.75

$1.00

2012

February 29

$1.25

$0.75

2011

November 30

$1.60

$0.95

2011

August 31

$1.65

$1.20

Reports to Security Holders

We are a reporting company pursuant to the Securities and Exchange Act of 1934. As such, we make

available our annual report which includes audited financial statements, and our quarterly reports which

include unaudited financial statements.

Capital Stock

The following is a summary of the material terms of the Company’s capital stock. This summary is

subject to and qualified by our articles of incorporation and bylaws.

Common Stock

As of August 28, 2013, there were 903 shareholders of record holding a total of 64,284,855 shares of

fully paid and non-assessable common stock of the 2,500,000,000 shares of common stock, par value

$0.0001, authorized. The board of directors believes that the number of beneficial owners is greater than

the number of record holders because a portion of our outstanding common stock is held in broker “street

names” for the benefit of individual investors. The holders of the common stock are entitled to one vote

for each share held of record on all matters submitted to a vote of stockholders. Holders of the common

stock have no pre-emptive rights and no right to convert their common stock into any other securities.

There are no redemption or sinking fund provisions applicable to the common stock.

33



Preferred Stock

As of August 28, 2013, there were 50,000,000 shares of preferred stock, par value $0.0001 authorized of

which none were outstanding. The Company’s preferred stock may have such rights, preferences and

designations and may be issued in such series as determined by the board of directors.

Dividends

The Company has not declared any cash dividends since inception and does not anticipate paying any

dividends in the near future. The payment of dividends is within the discretion of the board of directors

and will depend on our earnings, capital requirements, financial condition, and other relevant factors.

There are no restrictions that currently limit the Company’s ability to pay dividends on its common stock

other than those generally imposed by applicable state law.

Warrants

As of August 28, 2013, there were 2,842,992 warrants outstanding to purchase shares of the Company’s

common stock.

Stock Options

As of August 28, 2013, there were 3,880,000 stock options outstanding to purchase shares of our common

stock.

Convertible Debt Securities

As of August 28, 2013 we had three debt instruments convertible into the shares of its common stock for

an aggregate total of $2,200,000, bearing an interest rate of 5% per annum. The notes are convertible at

$1.00 per conversion unit, which consists of one share of our common stock and one-half share warrant to

purchase an additional share at $1.50 per share, with an expiration date of two years following the

conversion date. The Company extended the maturity dates for all three debt instruments. The $1,500,000

debt instrument that was due to mature on March 16, 2013 has been extended to September 15, 2014. The

$200,000 debt instrument that was due to mature on June 6, 2013 and been extended to September 15,

2014.The $500,000 debt instrument that was due to mature on July 14, 2013 has been extended to July

13, 2014.

Securities Authorized for Issuance Under Equity Compensation Plans

The Company has not authorized any securities for issuance under any equity compensation plan.

Purchases of Equity Securities made by the Issuer and Affiliated Purchasers

The Company has not repurchased any shares of its common stock during the fiscal year ended May 31,

2013 or since that date through August 28, 2013.

34



Recent Sales of Unregistered Securities; Use of Proceeds from Registered Securities

On March 22, 2013, our board of directors authorized the grant of 100,000 stock options with an exercise

price of $2.80 per share that expire ten years from the date of grant with vesting in equal one-third

increments annually beginning on December 10, 2013, to Andrew C. Hall for consulting services

rendered, in reliance upon the exemptions from registration provided by Section 4(2) and Regulation D of

the Securities Act of 1933, as amended (“Securities Act”).

The  Company  complied  with  the  exemption  requirements  of  Section  4(2)  of  the  Securities  Act  based  on

the following factors: (1) the issuance was  an isolated private transactions  by the Company which did not

involve  a  public  offering;  (2)  the  offeree  had  access  to  the  kind  of  information  which  registration  would

disclose; and (3) the offeree is financially sophisticated.

The Company complied with the requirements of Regulation D of the Securities Act by: (i) foregoing any

general  solicitation  or  advertising  to  market  the  securities;  (ii)  offering  only to  an  accredited  offeree;  (iii)

having  not   violated   antifraud  prohibitions  with  the  information   provided   to  the   offeree;   (iv)  being

available to answer questions by the offeree; and (v) providing restricted stock options to the offeree.

On April 13, 2013, our board of directors authorized the issuance of 500,000 restricted common shares

and 250,000 share purchase warrants at an exercise price of $1.50 for a period of two years from the date

to LLI Trading Limited on the conversion of $500,000 due, comprised of principal and interest, in

reliance upon the exemptions from registration provided by Section 4(2) and Regulation S of the

Securities Act.

The Company complied with the exemption requirements of Section 4(2) of the Securities Act based on

the following factors: (1) the issuances was an isolated private transactions by the Company which did not

involve a public offering; (2) the offeree had access to the kind of information which registration would

disclose; and (3) the offeree is financially sophisticated.

The Company complied with the exemption requirements of Regulation S by having directed no offering

efforts in the United States, by offering common shares only to an offeree who was outside the United

States at the time of the offering, and ensuring that the offeree to whom the common shares and warrants

were offered was a non-U.S. offeree with an address in a foreign country.

On April 17, 2013, our board of directors authorized the issuance of 145,000 shares of its common stock

and 145,000 warrants to purchase 72,500 shares of our common stock at an exercise price of $2.70 until

April 17, 2015 to the following entities and individuals for $2.30 each, or an aggregate of $333,500, and

the issuance of 50,000 shares pursuant to the exercise of warrants in reliance upon the exemptions from

registration provided by Section 4(2), Regulation D and Regulation S of the Securities Act:

Name

Consideration

Basis

Shares

Warrants

Exemption

Donald Shepard

$23,000

Subscription

10,000

10,000

Reg D/Sec 4(2)

Stratton SA

$310,500

Subscription

135,000

135,000

Reg. S/Sec 4(2)

Thomas Shea

$75,000

Warrant Exercise

50,000

Reg D/Sec. 4(2)

35



The Company complied with the exemption requirements of Section 4(2) of the Securities Act based on

the following factors: (1) the issuances and grants were isolated private transactions by the Company

which did not involve a public offering; (2) the offerees have access to the kind of information which

registration would disclose; and (3) the offerees are financially sophisticated.

The Company complied with the requirements of Rule 506 of Regulation D of the Securities Act by: (i)

foregoing any general solicitation or advertising to market the securities; (ii) selling only to accredited

offerees; (iii) having not violated antifraud prohibitions with the information provided to the offerees; (iv)

being available to answer questions by the offerees;  and (v) issuing restricted securities to the offerees.

The Company complied with the exemption requirements of Regulation S by having directed no offering

efforts in the United States, by offering common shares only to offerees who were outside the United

States at the time of the offering, and ensuring that the offerees to whom the common shares and warrants

were offered and authorized were non-U.S. offerees with addresses in foreign countries.

On May 29, 2013 our board of directors authorized the issuance of 271,324 shares of its common stock

and 135,662 warrants to purchase 135,662 shares of our common stock at an exercise price of $3.00 until

May 29, 2015 to the following entities and individuals for $2.60 each, or an aggregate of $705,440, and

the issuance of 205,233 shares pursuant to the exercise of warrants in reliance upon the exemptions from

registration provided by Section 4(2), Regulation D and Regulation S of the Securities Act:

Name

Consideration

Basis

Shares      Warrants

Exemption

The   Nielsen   Associates,   aka

$11,600

Services

4,462

2,231

Reg S

The Nielsen Group

Richard A. Beck

$10,400

Subscription

4,000

2,000     Sec. 4(2)/Reg D

Douglas D’Ewart

$26,000

Subscription

10,000

5,000     Sec. 4(2)/Reg D

Steve Ferris

$31,200

Subscription

12,000

6,000     Sec. 4(2)/Reg D

Financial Insights

$26,000

Subscription

10,000

5,000     Sec. 4(2)/Reg D

Ronald Tracy

$26,000

Subscription

10,000

5,000     Sec. 4(2)/Reg D

RedChip Companies, Inc

$22,000

Subscription

8,462

4,231     Sec. 4(2)/Reg D

Maria Eugenia Barroso Rivera

$202,800

Subscription

78,000

39,000     Sec. 4(2)/Reg S

Maria Eugenia Ribot Barroso

$35,100

Subscription

13,500

6,750     Sec. 4(2)/Reg S

Jose Maria Ribot Rodriguez

$101,400

Subscription

39,000

19,500     Sec. 4(2)/Reg S

Jose Maria Ribot Barroso

$202,800

Subscription

78,000

39,000     Sec. 4(2)/Reg S

Eduard Camelo Rosique

$10,140

Subscription

3,900

1,950     Sec. 4(2)/Reg S

Orsa & Company

$11,250     Warrant Exercise

7,500

Sec. 4(2)/Reg D

Mark Sullivan

$86,250     Warrant Exercise      57,500

Sec. 4(2)/Reg D

Stratton SA

$49,099     Warrant Exercise      32,733

Sec. 4(2)/Reg S

Green Chip SA

$37,500     Warrant Exercise      25,000

Sec. 4(2)/Reg S

Kossen Ventures

$123,750     Warrant Exercise      82,500

Sec. 4(2)/Reg S

The Company complied with the exemption requirements of Section 4(2) of the Securities Act based on

the following factors: (1) the issuances were isolated private transactions by the Company which did not

involve a public offering; (2) the offerees had access to the kind of information which registration would

disclose; and (3) the offerees are financially sophisticated.

The Company complied with the requirements of Regulation D of the Securities Act by: (i) foregoing any

general solicitation or advertising to market the securities; (ii) offering only to accredited offerees; (iii)

having not violated antifraud prohibitions with the information provided to the offerees; (iv) being

36



available to answer questions by the offerees; and (v) providing restricted common shares and warrants to

the offeree.

The Company complied with the exemption requirements of Regulation S by having directed no offering

efforts in the United States, by offering common shares only to offerees who was outside the United

States at the time of the offering, and ensuring that the offerees to whom the restricted common shares

and warrants were offered and authorized were non-U.S. offerees with addresses in a foreign country.

On June 14, 2013, our board of directors authorized the grant of 80,000 stock options with an exercise

price of $2.94 per share that expire ten years from the date of grant with vesting in equal one-third

increments annually beginning on June 14, 2014, to Richard Burns for services rendered as an employee,

in reliance upon the exemptions from registration provided by Section 4(2) and Regulation D of the

Securities Act of 1933.

The Company complied with the exemption requirements of Section 4(2) of the Securities Act based on

the following factors: (1) the issuance was an isolated private transactions by the Company which did not

involve a public offering; (2) the offeree had access to the kind of information which registration would

disclose; and (3) the offeree is financially sophisticated.

The Company complied with the requirements of Regulation D of the Securities Act by: (i) foregoing any

general solicitation or advertising to market the securities; (ii) offering only to an accredited offeree; (iii)

having not violated antifraud prohibitions with the information provided to the offeree; (iv) being

available to answer questions by the offeree; and (v) providing restricted stock options to the offeree.

Trading Information

The Company’s common stock is currently approved for quotation under the symbol “ABKI”. The

information for our transfer agent is as follows:

Island Stock Transfer

100 Second Avenue South, Suite 300

St. Petersburg, Florida  33701

Tel: (727) 289-0010.

37



ITEM 6.

SELECTED FINANCIAL DATA

The selected consolidated financial data presented below should be read in conjunction with

“Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our

consolidated financial statements and the related notes included elsewhere in this Annual Report on Form

10-K. The selected consolidated statements of operation data, balance sheet data and statements of cash

flow data as of and for each of the five years in the period ended May 31, 2013, have been derived from

the audited consolidated financial statements. The results presented below are not necessarily indicative

of financial results to be achieved in future periods.

For the Years Ended May 31,

2013

2012

2011

2010

2009

Statement of Operations Data:

Net revenues

$    1,846,862     $    2,939,428     $

---     $

---     $

---

(Loss) income from operations

(7,223,423   )      (1,119,249   )      (3,184,984   )      (1,606,698  )     (354,363   )

(Loss) income from continuing operations

(7,223,423  )

(1,119,249)

(3,184,984)

(1,606,698 )      (354,363)

Net (loss) earnings per share from continuing operations:

Basic

(0.12)

(0.02)

(0.06)

(0.03)

**

Diluted

(0.12)

(0.02

(0.06)

(0.03)

**

** = less than $(0.01) per share

For the Years Ended May 31,

2013

2012

2011

2010

2009

Selected Consolidated Balance Sheet Data:

Cash and cash equivalents

$

233,040     $

859,566     $

---     $

40,564     $

15

Working capital (1)

(2,222,670  )

(2,438,854  )

(510,867  )

(205,399  )

(344,019  )

Total assets

16,640,284

15,192,030

4,906,889

1,302,759

15,862

Current and long-term debt

5,484,526

3,909,723

1,513,046

81,536

255,037

Total liabilities

7,003,713

4,727,361

1,933,966

293,767

344,104

Total shareholders’ equity

9,636,571

10,464,669

2,972,923

1,008,992

(328,242  )

(1)     Working capital is defined as current assets less current liabilities.

38



For the Years Ended May 31,

2013

2012

2011

2010

2009

Selected Consolidated Statements of Cash Flow Data:

Net cash (used by) development  stage activities

$  (2,940,182)   $      (1,319,285) $

(912,198) $

(609,229) $

(67,964)

Net cash (used in) investing activities

(2,719,490)

(391,509)

(3,804,394)

(1,400,030)

(182,645)

Net cash provided by financing activities

5,033,146

2,570,360

4,676,028

2,049,808

249,758

Net increase (decrease) in cash and cash equivalents

(626,526)

859,566

(40,564)

40,549

(671)

ITEM 7.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATION

This Management’s Discussion and Analysis of Financial Condition and Results of Operations and other

parts of this current report contain forward-looking statements that involve risks and uncertainties.

Forward-looking statements can also be identified by words such as “anticipates,” “expects,” “believes,”

“plans,” “predicts,” and similar terms. Forward-looking statements are not guarantees of future

performance and our actual results may differ significantly from the results discussed in the forward-

looking statements. Factors that might cause such differences include but are not limited to those

discussed in the subsection entitled Forward-Looking Statements and Factors That May Affect Future

Results and Financial Condition below. The following discussion should be read in conjunction with our

financial statements and notes thereto included in this current report. Our fiscal year end is May 31.

The Company’s plan of operation for the coming year is to focus on realizing the commercialization

efforts aimed at expanded market entry for PComP and CermaClad products while continuing

research and development efforts to ensure the continuity of our product pipeline. To achieve this success

the Company and its subsidiaries during the twelve month period ended May 31, 2013:

  §

The Company completed debt and equity financings in the amount of $7,692,378.

  §

The Company filed an application to quote its common stock on the NASDAQ Capital Market.

  §

The Company added two independent directors to its board of directors, appointed a chief

financial officer and principal accounting officer and adopted corporate governance charters.

  §

MesoCoat focused its efforts on the continued development of its products.

  §

MesoCoat continued negotiations with prospective joint venture partners in parts of the world in

which it does not intend to operate independently, such as the Middle East, Germany, Russia and

South Korea.

  §

MesoCoat continued negotiations with prospective joint venture partners in respect to the

development of technological applications that it does not intend to develop on our own, such as

development of laser cladding systems for cladding very smaller diameter tubulars and complex

shapes.

  §

MesoCoat filled several key employee positions, including those for engineers and a chief

operating officer.

39



  §

MesoCoat engaged industry experts as consultants or advisors and collaborated with some of the

leading research and development entities in its field, such as the Edison Welding Institute.

  §

MesoCoat obtained ISO 9001:2008 and AS9100C certifications for its facilities to ensure the

highest standards in quality management.

  §

MesoCoat secured a $1 million low interest loan from the State of Ohio to partially fund

equipment for the new 11,000 sq. ft CermaClad clad piping manufacturing plant in Euclid,

Ohio which opened for testing, research and development in April.

  §

MesoCoat expanded marketing efforts that focused on targeted sales of PComP.

  §

MesoCoat secured a $150,000 loan as part of an overall capital budget to increase its PComP

powder production to meet demand.

  §

MesoCoat entered into a memorandum of understanding with Cone S.A. to construct a

manufacturing facility in Brazil for lease on a “build to suit” basis.

  §

MesoCoat won highly prestigious trade and industry awards such as the ‘Technology Innovation

Award’ from the Wall Street Journal, the ‘Subsea Pipeline Technology of the Year’ from the

Pipelines Industry Guild, the ‘Steel Excellence Award’ from the American Metal Market, and the

‘R&D 100’ award from the R&D Magazine.

  §

Powdermet was awarded three grants from Department of Energy, U.S. Army and U.S. Navy for

developing advanced nano-dielectric materials for capacitors, advanced composites for airframe

bearings, and advanced nanocomposite membranes for batteries.

Subsequent to the twelve month period ended May 31, 2013:

  §

MesoCoat incorporated a subsidiary in Indonesia and hired a local country manager, legal

counsel and a tax advisory firm.

  §

MesoCoat entered into negotiations with PT Kabil Citranusa to lease, with the option to

purchase, a parcel of land on Batam for the purpose of constructing a manufacturing facility on a

“build to suit basis”.

  §

MesoCoat executed a deposit agreement with Cone S.A. in connection with the construction of a

manufacturing facility in Brazil in respect to a lease agreement for a “build to suit” facility.

  §

Powdermet formed Terves Inc., to develop and commercialize proprietary reactive materials

technology for the shale gas and oil industry.

Results of Operations

Revenues

For the period from June 27, 2006 (inception) until May 31, 2013, the Company realized revenues of

$4,787,886. Revenues for the year ended May 31, 2013 were $1,846,862 as compared to $2,939,428 for

the year ended May 31, 2012, a decrease of 63%. Revenues for the two periods can be wholly attributed

to the operations of MesoCoat.

Revenue in the current year was derived from commercial revenues of $190,362 as compared to $77,391

in the prior year, contract and grant revenues of $1,656,500 in the current year as compared to $2,098,754

in the prior year, and other income of zero as compared to $763,283 in the prior year. Commercial

revenue increased by 246% as MesoCoat continues implementation of its commercial products.  The

majority of the increase in commercialized revenue was the result of activity in the last six months. The

21% decrease in contract and grant revenue in the current year over the prior year is due to the reduction

in grant applications as MesoCoat focused on developing and commercializing its products. The largest

decrease in revenue in the current period when compared to the prior period is in other revenue which was

40



comprised mostly of amounts paid by Petrobras under the terms and conditions of the cooperation

agreement.

We expect grant revenue to decrease over the next twelve months as MesoCoat’s government sponsored

contracts that commenced late last year are completed. However, we do expect a significant increase in

commercial revenue over the next twelve months as MesoCoat implements the PComP expansion plan.

Meanwhile, we continue to focus on the development of both current and new products while continuing

to commercialize existing products lines.

Gross Profit

For the period from June 27, 2006 (inception) until May 31, 2013, the Company realized a gross profit of

$2,999,615.  Gross profit for the twelve month period ended May 31, 2013 was $1,107,789 compared to

$1,890,230 for the twelve month period ended May 31, 2012, a decrease of 41%. Gross profits in both

annual periods can be wholly attributed to the operations of MesoCoat.  Gross profit decreased in the

current year over the comparative year as the result of the decrease in other revenue generated under the

terms and conditions of the cooperation agreement with Petrobras.

We expect gross profit to decrease over the next twelve months as result of the reduction in grant

applications.  This reduction is expected to be offset at an increase margin throughout the year as the

Company expands its PComP product line.

Net Losses

For the period from June 27, 2006 (inception) until May 31, 2013, the Company incurred net losses of

$13,545,788.  Net losses for the year ended May 31, 2013 were $7,223,423 compared to a net loss of

$1,119,249 for the year ended May 31, 2012, an increase of 545%.

Net losses in the current year as compared to net losses in the prior year can be attributed to the decrease

in revenues which resulted in a $782,441 decrease in gross profit.  In addition, operating expenses

increased by $2,494,833 in order to continue the development and implementation of commercial

applications.  Other income (expense) changed by $3,982,642 resulting in an additional reduction to net

income when compared to the prior year.  Over the prior year other income included among other

categories unrealized gain on the MesoCoat acquisition of $1,764,345 and equity gain in Powdermet

income of $988,533 versus a loss in the current year of $260,877.  Powdermet’s prior year equity gain

was higher since it included a valuation gain in the prior year from the Company acquisition.  The

allocation of a non-controlling interest in MesoCoat from the current year to the prior year has increased

by $1,155,742 which resulted in an increase in income.

We do not expect to realize net income in the near term as anticipated operational expenses associated

most significantly with research and development, consulting, payroll expenses and the depreciation and

amortization of existing assets. The increase in expenses are expected to be the direct result of continued

research and development costs associated with the CermClad product line in addition to costs

anticipated for the building of the planned manufacturing plant in Batam, Indonesia.

Despite management’s focus on ensuring operating efficiencies, we expect to continue to operate at a loss

through fiscal 2014.

41



Expenses

For the period from June 27, 2006 (inception) until May 31, 2013, the Company incurred operating

expenses of $17,809,674.  Operating expenses for the year ended May 31, 2013 was $7,907,865

compared to $5,413,032 the year ended May 31, 2012, an increase of 45%. The increase in operating

expenses over the prior year can be attributed to increases in administrative costs, professional fees,

consulting fees, consulting fees to related parties, payroll, depreciation and amortization, and research and

development as the Company continues to develop its product for commercial applications.  Research &

development and consulting fees increased by $1,198,579 as the Company continue to focus on

development and commercialization of its products.  Stock option expense increased by $516,464 during

the current year as the Company continues to expand it management team, directors and advisor.  General

& administrative expense, payroll and professional fees increased by $579,773 as the Company continues

the development and commercialization its products including the initially opening of its research and

testing manufacturing facility in Euclid, Ohio.

We expect that operating expenses will continue to increase as our aggressive growth strategy over the

next five years will require significant increases in personnel and facilities along with significant research

and development to ensure that products nearing commercialization are brought to market as quickly and

as effectively as possible.

Other Expense/Income

For the period from June 27, 2006 (inception) until May 31, 2013, the Company realized other income of

$192,149. Other expense for the year ended May 31, 2013 was $1,537,279 as compared to other income

of $2,445,363 for the year ended May 31, 2012.   The transition to other expense in the current year over

other income in the prior year can be primarily attributed to unrecognized gain on the acquisition of

MesoCoat of $1,764,345 in the prior comparative year versus none in the current year.  The Company

also recorded an equity gain in Powdermet income of $988,533 in the prior year versus a loss in the

current year of $260,877.  Powdermet’s prior year equity gain was higher since they included a valuation

gain in the prior year from the Company’s acquisition of MesoCoat.

We expect to continue to incur other expense in future periods due to the interest accruing on convertible

debt and the anticipated increase in interest on new debentures that are required for future growth.

Income Tax Expense (Benefit)

The Company may have a prospective income tax benefit resulting from a net operating loss carry-

forward and start up costs that will offset any future operating profit.

Capital Expenditures

The Company has spent significant amounts of capital expenditures for the period from June 27, 2006

(inception) to May 31, 2013 which amounted to $8,524,885.   A large portion of these expenditures are

related to plant, property and equipment in the construction of the manufacturing facility in Euclid, Ohio,

minority interest in Powdermet.

42



Liquidity and Capital Resources

The Company has been in the development stage since inception, and has experienced significant changes

in liquidity, capital resources, and stockholders’ equity.

As of May 31, 2013, the Company had current assets of $475,890 consisting of cash and cash equivalents

of $233,040, accounts receivable of $105,523, a note receivable from a related party of $4,500, prepaid

expenses of $117,028 and net prepaid deferred finance fees of $15,799.  The Company had total assets of

$16,640,284 consisting of current assets, property, plant and equipment of $5,595,007, patents and

licenses of $7,545,163, an assignment agreement of $210,528, an investment in Powdermet of

$2,449,312, and goodwill of $364,384.

As of May 31, 2013, the Company had current liabilities of $2,698,560, consisting of accounts payable of

$890,791, accounts payable to related parties of $251,004, capital leases of $28,006, loans payable of

$965,555, accrued interest of $153,825, loan payable to related parties of $30,000, accrued interest to

related party of $1,987 and accrued liabilities of $377,392.  The Company had total liabilities of

$7,003,713 consisting of current liabilities of $2,695,955 and long-term liabilities of $4,307,758. Long-

term liabilities consist of loans payable of $4,241,278 and capital leases of $63,875.

The Company had stockholders’ equity of $9,636,571 and a working capital deficit of $2,222,670 at May

31, 2013.

For the period from June 27, 2006 (inception) to May 31, 2013, the Company’s net cash used in

development stage activities was $5,899,317.  Net cash used in development stage activities for the year

ended May 31, 2013 was $2,940,182 as compared to $1,319,285 for the year ended May 31, 2012. Net

cash used in development stage activities is the result of the current year income plus a number of items

that are book expense items which do not affect the total amount relative to actual cash used including

depreciation, amortization of discount on debt, stock issued for services and stock option expense offset

by equity in investee profit.  Balance sheet accounts that actually affect cash but are not income statement

related items and thus are added or deducted to arrive at cash used include accrued liabilities, accounts

payable, accrued interest on loans payable, and prepaid expenses offset by changes in accounts

receivable.

We expect to continue to generate negative cash flow in operating activities until such time as net losses

transition to net income.

For the period from June 27, 2006 (inception) until May 31, 2013, the Company’s net cash used in

investing activities was $8,524,885. Net cash used in investing activities for the year ended May 31, 2013,

was $2,719,490 as compared to net cash used in investing activities of $391,509 for the year ended May

31, 2012. Net cash used in investing activities in the current period can be primarily attributed to the

purchase of property, plant and equipment, and capitalized patents and licenses.

We expect to continue to generate negative cash flow in investing activities as the Company increases its

investment in property, plant and equipment through MesoCoat.

For the period from June 27, 2006 (inception) until May 31, 2013, the Company’s net cash provided by

financing activities was $14,657,242. Net cash provided by financing activities for the year ended May

31, 2013 was $5,033,146 as compared to $2,570,360 the year ended May 31, 2012. Net cash provided by

financing activities in the current period is attributable to proceeds from the sale of common stock and

43



loans payable, including related party loans, offset by payments on loans payable, including those to

related parties, and repayments on capital leases.

We expect to continue to generate positive cash flow from financing activities as the Company seeks new

rounds of financing to build its business.

Our current assets are insufficient to meet our current obligations or to satisfy our cash needs over the

next twelve months and as such the Company will require additional debt or equity financing.

Management to this end initiated private equity placements prior to period end pursuant to which the

Company had raised $5,518,885 during the twelve month period ended May 31, 2013. Nevertheless,

additional capital will be required to meet obligations and needs over the next twelve months. Except for

the private equity placements noted, we had no other commitments or arrangements for financing at May

31, 2013, though we continue to pursue a number of prospective sources that include industry or strategic

partners, sale of additional equity, the sale of additional equity, the procurement of long term debt,

shareholder loans or the settlement of additional debt for equity. We face certain financial obstacles to

attracting new financing due to our historical record of net losses and working capital deficits. Therefore,

despite our efforts we can provide no assurance that the Company will be able to obtain the financing

required to meet its stated objectives or even to continue as a going concern.

The Company does not expect to pay cash dividends in the foreseeable future.

The Company has a defined stock option plan titled “The Abakan Inc., 2009 Stock Option Plan” and

contractual commitments with all of its officers and directors.

The Company has plans for the purchase of plant or equipment in connection with expansion of the

PComP powder production commercial line.   MesoCoat has obtained verbal commitments for future

capital expenditures from the Company to fund any shortfalls (including plant and equipment) in the

expansion of the PComP powder equipment required for expansion should it not be able to raise funds

in the normal course of business.

The Company intends to increase the number of employees engaged by MesoCoat on completion on the

PComP product line expansion and upon completion of development and commercialization of the

Cermaclad product in the new Euclid, Ohio manufacturing facility.

Off Balance Sheet Arrangements

As of May 31, 2013, the Company had no off-balance sheet arrangements that have or are reasonably

likely to have a current or future effect on our financial condition, changes in financial condition,

revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is

material to stockholders.

Going Concern

The Company’s auditors have expressed an opinion that refers to our ability to continue as a going

concern as a result of net losses of $13,545,788 and a working capital deficit of $2,222,670 as of May 31,

2013. Our ability to continue as a going concern is dependent on realizing net income from operations,

gains on investment, obtaining funding from outside sources or realizing some combination of these

objectives. Management’s plan to address the Company’s ability to continue as a going concern includes:

44



(i) obtaining funding from the private placement of debt or equity; (ii) revenue from operations; (iii)

converting debt to equity; and (iv) obtaining loans and grants from financial or government institutions.

Management believes that it will be able to obtain funding to allow the Company to remain a going

concern through the methods discussed above, though there can be no assurances that such methods will

prove successful.

The statements contained in the section titled Results of Operations and Description of Business, with the

exception of historical facts, are forward looking statements. We are ineligible to rely on the safe-harbor

provision of the Private Litigation Reform Act of 1995 for forward looking statements made in this

current report. Forward looking statements reflect our current expectations and beliefs regarding our

future results of operations, performance, and achievements. These statements are subject to risks and

uncertainties and are based upon assumptions and beliefs that may or may not materialize. These

statements include, but are not limited to, statements concerning:

 §     our anticipated financial performance;

 §     uncertainties related to the commercialization of proprietary technologies held by entities in which

we have an investment interest;

 §     our ability to generate revenue from operations or gains on investments;

 §     our ability to raise additional capital to fund cash requirements for operations;

 §     the volatility of the stock market; and

 §     general economic conditions.

We wish to caution readers that our operating results are subject to various risks and uncertainties that

could cause our actual results to differ materially from those discussed or anticipated including the factors

set forth in the section entitled Risk Factors included elsewhere in this report. We also wish to advise

readers not to place any undue reliance on the forward looking statements contained in this report, which

reflect our beliefs and expectations only as of the date of this report. We assume no obligation to update

or revise these forward looking statements to reflect new events or circumstances or any changes in our

beliefs or expectations, other that is required by law.

Critical Accounting Policies

The notes to the audited financial statements for the Company for the years ended May 31, 2013 and

2012, included in this Form 10-K, discusses those accounting policies that are considered to be significant

in determining the results of operations and financial position. Our management believes that their

accounting principles conform to accounting principles generally (GAAP) accepted in the United States

of America.

The preparation of financial statements in conformity with GAAP requires management to make

estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of

contingent assets and liabilities at the date of the financial statements and the reported amounts of

revenues and expenses during the year. The more significant areas requiring the use of estimates include

asset impairment, stock-based compensation, beneficial conversion features on debt instruments, and

future income tax amounts. Management bases its estimates on historical experience and on other

assumptions considered to be reasonable under the circumstances. Actual results may differ from the

estimates.

45



Stock-Based Compensation

We have adopted Accounting Standards Codification Topic (“ASC”) 718, which addresses the accounting

for stock-based payment transactions in which an enterprise receives employee services in exchange for

(a) equity instruments of the enterprise or (b) liabilities that are based on the fair value of the enterprise’s

equity instruments or that may be settled by the issuance of such equity instruments. We have adopted

Accounting Standards Codification Topic (“ASC”) 718, Share-Based Payment, which addresses the

accounting for stock-based payment transactions in which an enterprise receives employee services in

exchange for (a) equity instruments of the enterprise or (b) liabilities that are based on the fair value of the

enterprise’s equity instruments or that may be settled by the issuance of such equity instruments.

We account for equity instruments issued in exchange for the receipt of goods or services from other than

employees in accordance with ASC 505. Costs are measured at the estimated fair market value of the

consideration received or the estimated fair value of the equity instruments issued, whichever is more

reliably measurable. The value of equity instruments issued for consideration other than employee

services is determined on the earliest of a performance commitment or completion of performance by the

provider of goods or services.

Recent Accounting Pronouncements

We have examined all recent accounting pronouncements and believe that none of them will have a

material impact on the financial statements of the Company.

ITEM 7A.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET

RISK

Interest Rate Risk

We had cash and cash equivalents totaling $233,040, $859,566 and zero as of May 31, 2013, 2012, and

2011, respectively. Our exposure to interest rate risk primarily relates to the interest income generated by

excess cash deposited in interest bearing accounts. The cash and cash equivalents are held for working

capital purposes. We have not used derivative financial instruments in our investment portfolio. We have

not been exposed nor do we anticipate being exposed to material risks due to changes in market interest

rates. Declines in interest rates, however, will reduce future investment income, at our current balance

levels the change in our interest income will not be material, assuming consistent balance levels.

Interest rate risk also refers to our exposure to movements in interest rates associated with our interest

bearing liabilities. The interest bearing liabilities are denominated in U.S. dollars and the interest expense

is based on the market rates of interest. If the credit markets in the United States changed significantly it

could cause a material change in our interest expense and our costs of borrowing.

Foreign Currency Risk

We currently operate primarily in the United States.  As we expand our business outside the United States

through foreign subsidiaries, business is largely transacted in non-U.S. dollar currency. Accordingly, we

will be subject to exposure from adverse movements in the exchange rates of the local currency.

Consequently, changes in the exchange rates of the currencies may impact the translation of the foreign

46



subsidiaries’ statements of operations into U.S. dollars, which may in turn affect our consolidated

statement of operations.

We have not entered into any financial derivative instruments that expose us to material market risk,

including any instruments designed to hedge the impact of foreign currency exposures. We may,

however, hedge such exposure to foreign currency exchange rate fluctuations in the future.

Credit Risk

Credit risk refers to our exposures to financial institutions, suppliers and customers that have in the past

and may in the future experience financial difficulty, particularly in light of recent conditions in the credit

markets and the global economy. As of May 31, 2013, our cash and cash equivalents were held in

deposits with maturities of three months or less with banks and other financial institutions having credit

ratings of  BBB  or above. We generally monitor the financial performance of our suppliers and

customers, as well as other factors that may affect their access to capital and liquidity. Presently, we

believe that we will not incur material losses due to our exposures to such credit risk.

ITEM  8.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Our audited financial statements for the years ended May 31, 2013 and 2012 are attached hereto as F-1

through F-66.

47



Abakan Inc.

(A Development Stage Company)

Index to Financial Statements

Report of Independent Registered Public Accounting Firm

F-2

Consolidated Balance Sheets for the years ended May 31, 2013 and 2012

F-4

Consolidated Statements of Operations for the years ended May 31, 2013 and 2012, and cumulative

amounts from development stage activities (June 27, 2006 (Inception) through May 31, 2013)

F-5

Consolidated Statements of Stockholders' Equity (Deficit) for the period from inception on

June 27, 2006 through May 31, 2013

F-6

Consolidated Statements of Cash Flows for the years ended May 31, 2013 and 2012, and cumulative

amounts from development stage activities (June 27, 2006 (Inception) through May 31, 2013)

F-16

Notes to the Consolidated Financial Statements

F-18

F-1



SKODA MINOTTI

CPAs, BUSINESS & FINANCIAL ADVISORS

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Shareholders of

Abakan Inc. (a development stage company)

We   have   audited   the   accompanying   consolidated   balance   sheets   of   Abakan,   Inc.   and   Subsidiaries

(together  the  “Company”)  as  of  May  31,  2013  and  2012,  and  the  related  consolidated  statements  of

operations,  stockholders’  equity  (deficit)  and  cash  flows  for  each  of  the  three  years  in  the  period  ended

May 31,  2013  and  for  the  period  from  June  27,  2006  (date  of  inception)  through  May 31,  2013.   We  also

have  audited  the  Company’s  internal  control  over  financial  reporting  as  of  May  31,  2013,  based  on

criteria  established   in  Internal  Control—Integrated  Framework  (1992)   issued  by  the  Committee   of

Sponsoring  Organizations  of  the  Treadway  Commission  (COSO  1992).  The  Company’s  management  is

responsible   for   these   financial   statements,   for   maintaining   effective   internal   control   over   financial

reporting,  and  for  its  assessment  of  the  effectiveness  of  internal  control  over  financial  reporting,  included

in   the   accompanying   Management’s   Report   on   Internal   Control   over   Financial   Reporting.   Our

responsibility  is  to  express  an  opinion  on  these  financial  statements  and  an  opinion  on  the  Company's

internal control over financial reporting based on our audits.  We did not audit the financial statements for

the  period  June  27,  2006  (date  of  inception)  through  May  31,  2010.   Those  statements  were  audited  by

other  auditors  whose  report  has  been  furnished  to  us,  and  our  opinion  on  the  statements  of  operations,

stockholders’  equity  (deficit),  and  cash  flows  for  the  period  June  27,  2006  (date  of  inception)  through

May 31,  2013,  insofar as it relates  to the amounts  for  prior  periods  through May 31,  2010, is based solely

on the report of the other auditors.

We  conducted  our  audits  in  accordance  with  the  standards  of  the  Public  Company Accounting  Oversight

Board  (United  States).  Those  standards  require  that  we  plan  and  perform  the  audits  to  obtain  reasonable

assurance  about  whether  the  financial  statements  are  free  of  material  misstatement  and  whether  effective

internal  control  over  financial  reporting  was  maintained  in  all  material  respects.  Our  audits  of  the

financial statements included examining,  on a test basis, evidence supporting the amounts and disclosures

in  the  financial  statements,  assessing  the  accounting  principles  used  and  significant  estimates  made  by

management,  and  evaluating  the  overall  financial  statement  presentation.  Our  audit  of  internal  control

over  financial  reporting  included  obtaining  an  understanding  of  internal  control  over  financial  reporting,

assessing  the  risk  that  a  material  weakness  exists,  and  testing  and  evaluating  the  design  and  operating

effectiveness  of  internal  control  based  on  the  assessed  risk.  Our  audits  also  included  performing  such

other  procedures  as  we  considered  necessary  in  the  circumstances.  We  believe  that  our  audits  provide  a

reasonable basis for our opinions.

Cleveland / 6685 Beta Drive, Mayfield Village, Ohio 44143 / ph 440 449 6800 / fx 440 646 1615

Akron / 3875 Embassy Parkway, Suite 200, Fairlawn, Ohio 44333 / ph 330 668 1100 / fx 440 646 1615

Tampa /4301 Anchor Plaza Parkway, Suite 140, Tampa, Florida 33634 /ph 813 288 8826 /fx 813 288 8826

Skoda Minotti / Certified Public Accountants / www.skodaminotti.com

F-2



A   company's   internal   control   over   financial   reporting   is   a   process   designed   to   provide   reasonable

assurance  regarding  the  reliability  of  financial  reporting  and  the  preparation  of  financial  statements  for

external  purposes  in  accordance  with  generally  accepted  accounting  principles.  A  company's  internal

control over  financial reporting  includes  those policies and procedures that  (1) pertain to the maintenance

of  records  that,  in  reasonable  detail,  accurately  and  fairly  reflect  the  transactions  and  dispositions  of  the

assets  of  the  company;  (2)  provide  reasonable  assurance  that  transactions  are  recorded  as  necessary  to

permit  preparation  of  financial  statements  in  accordance  with  generally  accepted  accounting  principles,

and that receipts and expenditures  of the company are being made only in  accordance with authorizations

of management  and  directors  of  the  company;  and  (3)  provide  reasonable  assurance  regarding  prevention

or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have

a material effect on the financial statements.

Because  of  its  inherent  limitations,  internal  control  over  financial  reporting  may  not  prevent  or  detect

misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk

that  controls  may become  inadequate  because  of  changes  in  conditions,  or  that  the  degree  of  compliance

with the policies or procedures may deteriorate.

In  our  opinion,  the  consolidated  financial  statements  referred  to  above  present  fairly,  in  all  material

respects,  the  consolidated  financial  position  of  Abakan,  Inc.  and  Subsidiaries  at  May  31,  2013  and  the

results of the consolidated results of their operations and their cash flows for each of the three years in the

period  ended  May  31,  2013,  in  conformity  with  U.S.  generally  accepted  accounting  principles.   Also  in

our  opinion,  Abakan,  Inc.  and  Subsidiaries  maintained,  in  all  material  respects,  effective  internal  control

over financial reporting as of May 31, 2013, based on criteria established in  Internal Control – Integrated

Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

The accompanying financial statements have been prepared assuming that the Company will continue as a

going  concern.   As  discussed  in  Note  3  to  the  financial  statements,  the  Company  has  incurred  net  losses

since   inception   in   the   amount   of   $13,545,788   and   a   working   capital   deficiency   of   $2,222,670.

Management’s  plans  concerning these  matters  are  also described  in  Note  3.   The  accompanying  financial

statements do not include any adjustments that might result from the outcome of this uncertainty.

Skoda Minotti

Cleveland, Ohio

/s/ Skoda Minotti

Skoda Minotti

Cleveland, Ohio

August 29, 2013

Cleveland / 6685 Beta Drive, Mayfield Village, Ohio 44143 / ph 440 449 6800 / fx 440 646 1615

Akron / 3875 Embassy Parkway, Suite 200, Fairlawn, Ohio 44333 / ph 330 668 1100 / fx 440 646 1615

Tampa /4301 Anchor Plaza Parkway, Suite 140, Tampa, Florida 33634 /ph 813 288 8826 /fx 813 288 8826

Skoda Minotti / Certified Public Accountants / www.skodaminotti.com

F-3



ABAKAN INC.

(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED BALANCE SHEETS

May 31,

May 31,

2013

2012

ASSETS

Current assets

Cash and cash equivalents

$

233,040     $

859,566

Accounts receivable

105,523

22,854

Note receivable - related parties

4,500

4,500

Prepaid expenses

117,028

183,134

Deferred finance fees, net

15,799

-

Total current assets

475,890

1,070,054

Noncurrent assets

Property, plant and equipment, net (Note 4)

5,595,007

3,021,088

Patents and licenses, net (Note 5)

7,545,163

7,776,315

Assignment agreement - MesoCoat (Note 6)

210,528

250,000

Investment - Powdermet (Note 7)

2,449,312

2,710,189

Goodwill

364,384

364,384

Total Assets

$

16,640,284     $

15,192,030

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities

Accounts payable

$

890,791     $

425,868

Accounts payable - related parties (Note 11)

251,004

80,773

Capital leases - current portion

28,006

42,999

Loans payable, net of discounts of $171,615 and $456,164 (Note 8)

965,555

2,465,165

Accrued interest - loans payable (Note 8)

153,825

183,106

Loan payable- related parties (Note 11)

30,000

-

Accrued interest - related parties (Note 11)

1,987

-

Accrued liabilities

377,392

310,997

Total current liabilities

2,698,560

3,508,908

Non-current liabilities

Loans payable, net of discounts of $444,881and $601,940 (Note 8)

4,241,278

1,146,277

Capital leases - non-current portion

63,875

72,176

Total liabilities

7,003,713

4,727,361

Commitments and contingencies (Note 13)

Stockholders' equity (Note 9)

Preferred stock, $0.0001 par value, 50,000,000 shares

authorized, none issued and outstanding

-

-

Common stock, par value $0.0001, 2,500,000,000 shares

authorized, 64,284,855 issued and outstanding - May 31, 2013,

61,465,445 issued and outstanding - May 31, 2012

6,430

6,147

Paid-in capital

20,833,426

13,321,527

Subscription receivable

(76,244)

-

Subscription payable

-

-

Contributed capital

5,050

5,050

Accumulated deficit during the development stage

(13,545,788)

(6,322,365)

7,222,874

7,010,359

Non-controlling interest

2,413,697

3,454,310

Total stockholders' equity

9,636,571

10,464,669

Total liabilities and stockholders' equity

$

16,640,284     $

15,192,030

See accompanying notes to the consolidated financial statements.

F-4



ABAKAN INC.

(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED  STATEMENTS OF OPERATIONS

Cumulative amounts

from development

stage activities June

For the years ended

27, 2006 (inception)

May 31,

to

2013

2012

2011

May 31, 2013

Revenues

Commercial

$

190,362      $

77,391      $

-      $

267,753

Contract and grants

1,656,500

2,098,754

-

3,755,254

Other income

-

763,283

-

764,879

1,846,862

2,939,428

-

4,787,886

Cost of revenues

739,073

1,049,198

-

1,788,271

Gross profit

1,107,789

1,890,230

-

2,999,615

Expenses

General and administrative

General and administrative

831,387

625,301

163,562

1,726,654

Professional fees

513,068

246,743

172,504

1,082,869

Professional fees - related parties

60,000

60,000

60,000

225,000

Consulting

1,382,484

928,449

533,876

3,086,779

Consulting - related parties

441,250

306,580

393,900

1,681,230

Payroll and benefits expense

848,798

741,436

190,608

1,847,103

Depreciation and amortization

417,072

302,858

5,790

749,156

Research and development

1,347,190

737,316

-

2,084,506

Impairment of asset

-

-

-

180,000

Stock expense on note conversion

239,120

153,317

195,290

730,097

Stock options expense

1,827,496

1,311,032

964,439

4,416,280

Total expenses

7,907,865

5,413,032

2,679,969

17,809,674

Loss from operations

(6,800,076)

(3,522,802)

2,679,969

(14,810,059)

Other (expense) income

Interest expense:

Interest - loans

(222,134)

(273,117)

(36,000)

(547,879)

Interest - related parties

(773)

(1,118)

(811)

(7,333)

Liquidated damages

-

-

(250,000)

(250,000)

Amortization of discount on debt

(838,289)

(475,374)

(137,490)

(1,451,153)

Total interest expense

(1,061,196)

(749,609)

(424,301)

(2,256,365)

Interest income

3,794

242

2,125

8,165

Loss on debt settlement

-

-

(5,257)

(5,257)

Creditor fee

(235,794)

-

-

(241,051)

Gain on debt settlement

17,715

56,543

200,709

274,967

Gain/ (loss) on sale of assets

(921)

429,717

-

428,796

Unrealized gain on MesoCoat acquisition

-

1,764,345

-

1,764,345

Equity in Powdermet income/ (loss)

(260,877)

988,533

71,656

799,312

Equity in MesoCoat loss

-

(44,408)

(349,947)

(586,020)

Total Other (expense) income

(1,537,279)

2,445,363

(505,015)

192,149

Net (loss) before noncontrolling interest

(8,337,355)

(1,077,439)

(3,184,984)

(14,617,910)

Non-controlling interest in MesoCoat loss

1,113,932

(41,810)

-

1,072,122

Net (loss) attributable to Abakan Inc.

(7,223,423)

(1,119,249)

(3,184,984)

(13,545,788)

Provision for income taxes

-

-

-

-

Net (loss)

$

(7,223,423)      $

(1,119,249)      $

(3,184,984

(13,545,788)

Net (loss) per share - basic

$

(0.12)      $

(0.02)      $

(0.06)

Net (loss) per share - diluted

$

(0.12)      $

(0.02)      $

(0.06)

Weighted average number of common

shares outstanding - basic

62,443,108

59,752,413

57,058,470

Weighted average number of common

shares outstanding - diluted

62,443,108

59,752,413

57,058,470

See accompanying notes to the consolidated financial statements.

F-5



ABAKAN INC.

(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFECIT)

Accumulated

Deficit

Non-

During

Total

Contributed

Subscription

Subscription

controlling

Development

Stockholders’

Shares

Amount

Capital

Capital

Receivable

Payable

Interest

Stage

Equity

Inception, June 27, 2006

-      $

-      $

-

$

-

$

-      $

-      $

-      $

-      $

-

Common Shares issued to director

for cash June 27, 2006

2,500,000

250

(150)

-

-

-

-

-

100

Common Shares issued to director

for cash June 27, 2006

125,300,000

12,530

(7,518)

-

-

-

-

-

5,012

Common Shares issued to director

for cash October 31, 2006

62,500,000

6,250

(3,750)

-

-

-

-

-

2,500

Private placement closed April

30, 2007

35,265,000

3,527

67,003

-

-

-

-

-

70,530

Net (loss) for the period

-

(28,079)

(28,079)

Balance, May 31, 2007

225,565,000      $

22,557      $

55,585

$

-

$

-

-      $

-      $

(28,079)      $

50,063

Net (loss) for the year

(28,993)

(28,993)

Balance, May 31, 2008

(Restated)

225,565,000      $

22,557      $

55,585

$

-

$

-

-      $

-      $

(57,072)      $

21,070

Common Shares cancelled to

directors September 2, 2008

(175,300,000)

(17,531)

17,531

-

-

-

-

-

Contributed Capital

-

-

-

5,050

-

-

-

-

5,050

Net (loss) for the year

(354,363)

(354,363)

Balance, May 31, 2009

50,265,000      $

5,026      $

73,116

$

5,050

$

-

-      $

-      $

(411,434)      $

(328,242)

Private placement, closed

December 16, 2009 for $0.50

per share

4,200,000

420

2,099,580

-

-

-

-

-

2,100,000

Debt Converted into stock

December 16, 2009 for $0.60

per share, including costs of

$102,370

400,000

40

342,330

-

-

-

-

-

342,370

Subscription receivable from

above private placement

-

-

-

-

(1,750)

-

-

-

(1,750)

Common shares issued services

on April 26, 2010

150,000

15

89,985

-

-

-

-

-

90,000

Common shares issued services

on April 30, 2010

100,000

10

99,990

-

-

-

-

-

100,000

Stock options expense

-

-

313,313

-

-

-

-

-

313,313

Net (loss) for the year

(1,606,698)

(1,606,698)

Balance, May 31, 2010

55,115,000      $

5,511      $

3,018,313

$

5,050

$

(1,750)      $

-      $

-      $

(2,018,132)      $

1,008,992

See accompanying notes to the consolidated financial statements.

F-6



ABAKAN INC.

(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFECIT) - CONTINUED

Accumulated

Deficit

Non-

During

Total

Contributed

Subscription

Subscription

controlling

Development

Stockholders’

Shares

Amount

Capital

Capital

Receivable

Payable

Interest

Stage

Equity

Balance forwarded, May 31,

$

2010

55,115,000      $

5,511      $

3,018,313

$

5,050      $

(1,750)      $

-      $      -

(2,018,132)      $

1,008,992

Private placement for cash,

closed October 21, 2010 for

-

$0.75 per share

566,667

57

424,943

-

-

-

-

425,000

Debt Converted into stock

October 21, 2010 for $0.82 per

share, including costs of

$37,333

533,333

53

437,280

-

-

-

-

-

437,333

Private placement for cash,

closed October 22, 2010 for

-

$0.75 per share

1,660,000

166

1,244,834

-

-

-

-

1,245,000

Common shares issued for

services on November 16,

-

2010

60,000

6

60,594

-

-

-

-

60,600

Debt Converted into stock

December 10, 2010 for $0.75

per share, including costs of

$23,400

90,000

9

90,891

-

-

-

-

-

90,900

Common shares issued for

services on December 10, 2010

150,000

15

152,985

-

-

-

-

-

153,000

Private placement for cash,

closed January 27, 2011 for

-

$1.00 per share

160,000

16

159,984

-

-

-

-

160,000

Common shares issued for

assignment agreement on

March 15, 2011

150,000

15

149,985

-

-

-

-

-

150,000

Debt Converted into stock March

25, 2011 for $1.00 per share,

including costs of $4,557

56,960

6

61,511

-

-

-

-

-

61,517

Common shares issued for

services on May 2, 2011

50,000

5

49,995

-

-

-

-

-

50,000

Common shares issued for

services on May 11, 2011

60,000

6

49,194

-

-

-

-

-

49,200

Private placement for cash,

closed May 17, 2011 for $1.00

-

per share

115,000

11

114,989

-

-

-

-

115,000

Common shares issued for

services on May 20, 2011

15,000      $

1      $

18,599

$

-      $

-      $

-      $

-    $

-     $

18,600

May 31, 2011 continued on

following page

See accompanying notes to the consolidated financial statements.

F-7



ABAKAN INC.

(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFECIT) – CONTINUED

Accumulated

Deficit

Non-

During

Total

Common Stock

Paid-in

Contributed

Subscription

Subscription

controlling

Development

Stockholders’

Shares

Amount

Capital

Capital

Receivable

Payable

Interest

Stage

Equity

May 31, 2011 continued from

previous page

Private placement for cash, closed

May 25, 2011 for $1.00 per

share

65,465      $

7      $

65,458     $

-   -  $

-

$

-

$

-      $

-      $

65,465

Subscription receivable from

above private placement

-

-

-

-

(65,465)

-

-

(65,465)

Private placement for cash, closed

-

May 26, 2011 for $1.00 per

share

50,000

5

49,995

-

-

-

-

50,000

Debt Converted into stock May

-

29, 2011 for $1.00 per share,

including costs of $15,600

30,000

3

45,597

-

-

-

-

45,600

Private placement for cash, closed

-

May 29, 2011 for $1.00 per

share

100,000

10

99,990

-

-

-

-

100,000

Subscription receivable from

-

above private placement

-

-

-

-

(100,000)

-

-

(100,000)

Debt Converted into stock May

-

31, 2011 for $1.00 per share,

including costs of $114,400

220,000

22

334,378

-

-

-

-

334,400

Subscription receivable write off

-

from December 16, 2009

-

-

-

1,750

-

-

1,750

Beneficial conversion warrant

-

valuation for convertible debts

-

-

736,576

-

-

-

-

736,576

Stock options expense

-

-

964,439

-

-

-

-

-

964,439

Net (loss) for the year

(3,184,984)

(3,184,984)

Balance, May 31, 2011

59,247,425      $

5,924      $      8,330,530

$

5,050      $

(165,465)      $

-

-     $

(5,203,116)      $

2,972,923

Private placement for cash closed

June 6, 2011 for $1.00 per share

20,000

2

19,998

-

-

-

-

-

20,000

Private placement for cash closed

June 10, 2011 for $1.00 per

share

20,000

2

19,998

-

-

-

-

-

20,000

Debt converted into stock June 10,

2011 for $1.00 per share,

including costs of $5,500

10,000

1

15,499

-

-

-

-

-

15,500

May 31, 2012 continued on

following page

See accompanying notes to the consolidated financial statements.

F-8



ABAKAN INC.

(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFECIT) – CONTINUED

Accumulated

Deficit

During

Total

Common Stock

Paid-in

Contributed

Subscription

Subscription

Non-controlling

Development

Stockholders’

Shares

Amount

Capital

Capital

Receivable

Payable

Interest

Stage

Equity

May 31, 2012 continued from

previous page

Common shares issued for

services on June29, 2011

50,000      $

5

$

75,995

$

-     $

-      $

-      $

-      $

-

$

76,000

Private placement for cash,

closed July 6, 2011 for $1.00

per share

30,000

3

29,997

-

-

-

-

-

30,000

Common shares issued for

services on December 2, 2011

20,000

2

23,598

-

-

-

-

-

23,600

Private placement for cash,

closed February 20, 2012 for

$1.00 per share

300,000

30

299,970

-

-

-

-

-

300,000

Debt converted into stock

February 20, 2012 for $1.00

per share, including costs of

$12,648

421,595

42

434,201

-

-

-

-

-

434,243

Common shares issued for

services on February 20, 2012

20,000

2

20,598

-

-

-

-

-

20,600

Private placement for cash,

closed March 16, 2012 for

$1.00 per share

382,000

38

381,962

-

-

-

-

-

382,000

Debt converted into stock

March 16, 2012 for $1.00 per

share, including costs of

$76,300

218,000

22

294,278

-

-

-

-

-

294,300

Common shares issued for

services on March 20, 2012

27,500

3

39,047

-

-

-

-

-

39,050

Private placement for cash,

closed April 20, 2012 for

$1.60 per share

18,438

2

29,498

-

-

-

-

-

29,500

Debt converted into stock April

20, 2012 for $1.60 per share,

including costs of $29,219

26,562

3

71,716

-

-

-

-

-

71,719

Private placement for cash,

closed April 23, 2012 for

$1.60 per share

200,000

20

319,980

-

-

-

-

-

320,000

Private placement for cash,

closed April 24, 2012 for

$1.60 per share

74,550

7

119,193

-

-

-

-

-

119,200

Debt converted into stock April

24, 2012, including costs of

$5,650

5,000

1

13,649

-

-

-

-

-

13,650

May 31, 2012 continued on

following page

See accompanying notes to the consolidated financial statements.

F-9



ABAKAN INC.

(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFECIT) – CONTINUED

Accumulated

Deficit

Common Stock

Paid-in

During

Total

Contributed

Subscription

Subscription

Non-controlling

Development

Stockholders’

Shares

Amount

Capital

Capital

Receivable

Payable

Interest

Stage

Equity

May 31, 2012 continued from

previous page

Private placement for cash, closed

April 25, 2012 for $1.60 per

share

15,625     $

2

$

24,998      $

-

$

-      $

-      $

-

$

-   $

25,000

Private placement for cash, closed

May 29, 2012 for $1.60

50,000

5

79,995

-

-

-

-

-

80,000

Private placement for cash, closed

May 30, 2012 for $1.60 per share

268,750

27

429,973

-

-

-

-

-

430,000

Debt converted into stock May 30,

2012 for $1.60 per share,

including costs of $24,000

40,000

4

87,996

-

-

-

-

-

88,000

Subscription receivables received

from May 25 and 29, 2011

-

-

-

-

165,465

-

-

-

165,465

Purchase of controlling interest

from non-controlling interest on

July 13, 2011

-

-

-

-

-

-

3,412,500

-

3,412,500

Beneficial conversion warrant

valuation for convertible debts

-

-

846,133

-

-

-

-

-

846,133

Stock options expense

-

-

1,312,725

-

-

-

-

-

1,312,725

Net loss for the year

-

-

-

-

-

-

41,810

(1,119,249)

(1,077,439)

Balance May 31, 2012

61,465,445

6,147

13,321,527

5,050

-

-

3,454,310

(6,322,365)

10,464,669

Common shares issued for services

on July 9, 2012 at $2.00 per share

10,000

1

19,999

-

-

-

-

-

20,000

Private placement for cash, closed

July 30, 2012 for $1.75 per share

300,000

30

524,970

-

-

-

-

-

525,000

Common shares issued for services

on June 1, 2012 for services on

May 1, 2012 at $2.61 per share

12,500

1

32,624

-

-

-

-

-

32,625

Common shares issued for services

on June 1, 2012 at $2.22 per

share

12,500

1

23,124

-

-

-

-

-

23,125

Common shares issued for services

on July 1, 2012 at $2.00 per share

12,500

1

24,999

-

-

-

-

25,000

Common shares issued for services

on August 7, 2012 at $1.90 per

share

10,000

1

18,999

-

-

-

-

19,000

May 31, 2013 continued on

following page

See accompanying notes to the consolidated financial statements.

F-10



ABAKAN INC.

(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFECIT) – CONTINUED

Accumulated

Deficit

During

Total

Common Stock

Paid-in

Contributed

Subscription

Subscription

Non-controlling

Development

Stockholders’

Shares

Amount

Capital

Capital

Receivable

Payable

Interest

Stage

Equity

May 31, 2013 continued from

previous page

Common shares issued for services on

September 18, 2012 for $1.75 per

share

25,000     $

3

$

42,747      $

-

$

-      $

-

$

-

$

-   $

42,750

Private placement for cash, closed

September 28 , 2012 for $1.75

150,000

15

262,485

-

-

-

-

-

262,500

Private placement for cash, closed

October 18, 2012 for $2.30 per

share

100,000

10

229,990

-

-

-

-

-

230,000

Private placement for cash, closed

November 26, 2012 for $2.30

7,000

1

16,099

-

-

-

-

-

16,100

Common shares issued for services on

November 29, 2012 at $1.70 per

share, including costs of $21,000

20,000

2

54,998

-

-

-

-

-

55,000

Debt converted into stock November

30, 2012 for $2.30 per share,

including costs of $28,000

70,000

7

188,993

-

-

-

-

-

189,000

Accounts payable debt converted into

stock November 30, 2012 for $2.30

per share, including costs of $8,000

20,000

2

53,998

-

-

-

-

-

54,000

Private placement for cash, closed

November 30, 2012 for $2.30 per

-

-

62,718

share including costs of $5,217

25,000

3

62,715

-

-

-

Subscription receivable from above

private placement

-

-

-

-

(27,500)

-

-

(27,500)

Subscription payable deposit against

stock subscription

-

-

-

-

-

12,000

-

-

12,000

Note payable debt converted into stock

November 30, 2012 for $2.30 per

share including costs of $1,223

3,038

1

8,255

-

-

-

-

8,256

Private placement for cash, closed

December 3, 2012 for $2.30 per

share

121,500

12

278,988

-

-

-

-

279,000

Private placement for cash, closed

December 3, 2012 for $2.30

22,000

2

50,598

-

-

(12,000)

-

-

38,600

May 31, 2013 continued on following

page

See accompanying notes to the consolidated financial statements.

F-11



ABAKAN INC.

(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFECIT) – CONTINUED

Accumulated

Deficit

During

Total

Common Stock

Paid-in

Contributed

Subscription

Subscription

Non-controlling

Development

Stockholders’

Shares

Amount

Capital

Capital

Receivable

Payable

Interest

Stage

Equity

May 31, 2013 continued from

previous page

Private placement for cash,

closed December 19, 2012 for

$2.30 per share

70,000     $

7

$

160,993      $

-      $

-      $

-

$

-

$

-   $

161,000

Private placement for cash,

closed December 19, 2012 for

$2.30 per share

45,000

5

103,495

-

-

-

-

103,500

Private placement for cash,

closed December 20, 2012 for

$2.30

76,522

8

175,992

-

-

-

-

-

176,000

Subscription receivable from

above private placement

-

-

-

-

(84,000)

-

-

-

(84,000)

Private placement for cash,

closed December 30, 2012 for

$2.30 per share

100,000

10

229,990

-

-

-

-

-

230,000

Common shares issued for

services on January 8, 2013 at

$2.80 per share

21,429

2

59,998

-

-

-

-

-

60,000

Common shares issued for

services on February 21, 2013

at $2.70 per share

20,000

2

53,998

-

-

-

-

-

54,000

Common shares issued for

services on February 21, 2013

at $2.70 per share

10,000

1

26,999

-

-

-

-

-

27,000

Subscription receivables received

from November 30, 2012

-

-

-

-

27,500

-

-

-

27,500

Subscription payable deposit

against stock subscription

-

-

-

-

-

101,200

-

-

101,200

Common shares issued for

services on March 18, 2013 at

$2.80 per share

15,000

2

41,999

-

-

-

-

-

42,000

Common shares issued for raffle

prize on March 18, 2013 at

$2.54 per share

100

0

270

-

-

-

-

-

270

Common shares issued for

services to be rendered on

March 18, 2013 at $2.54 per

share

26,622

2

59,998

-

-

-

-

-

60,000

May 31, 2013 continued on

following page

See accompanying notes to the consolidated financial statements.

F-12



ABAKAN INC.

(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFECIT) – CONTINUED

Accumulated

Deficit

During

Total

Common Stock

Paid-in

Contributed

Subscription

Subscription

Non-controlling

Development

Stockholders’

Shares

Amount

Capital

Capital

Receivable

Payable

Interest

Stage

Equity

May 31, 2013 continued from

previous page

Common shares issued for services

to be rendered on March 18,

2013 at $2.52 per share

10,000     $

1

$

25,199      $

-      $

-      $

-

$

-

$

-   $

25,200

Private placement for cash, closed

March 18, 2013 for $2.30 per

share

44,000

4

101,196

-

-

(101,200)

-

-

(0)

Note payable debt converted into

stock March 18, 2013 for $2.30

per share, including costs of

$81,200

232,000

23

614,777

-

-

-

-

-

614,800

Accounts payable debt of $25,000

converted into stock and $96,000

prepaid expenses March 18,

-

2013 for $2.30 per share,

55,000

6

138,595

-

-

-

including costs of $12,100

-

138,600

Accounts payable debt converted

into stock March 25, 2013

including costs of $5,783

16,522

2

43,782

-

-

-

-

-

43,783

Cash exercise of warrants on April

1, 2013 at $1.50 per share

15,000

2

22,499

-

-

-

-

-

22,500

Common shares issued for services

on April 2, 2013 at $2.70 per

share

23,600

2

63,718

-

-

-

-

-

63,720

Private placement for cash, closed

April 10, 2013 at $1.00 per share

10,000

1

22,999

-

-

-

-

-

23,000

Common shares issued for

conversion of convertible debt

on April 13, 2013 at $1.00 per

share

500,000

50

499,950

-

-

-

-

-

500,000

Note payable debt converted into

stock April 15, 2013 for $2.30

per share, including costs of

$47,250

135,000

14

357,737

-

-

-

-

-

357,750

Cash exercise of warrants on April

18, 2013 at $1.50 per share

50,000

5

74,995

-

-

-

-

-

75,000

May 31, 2013 continued on

following page

See accompanying notes to the consolidated financial statements.

F-13



ABAKAN INC.

(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFECIT) – CONTINUED

Accumulated

Deficit

During

Total

Common Stock

Paid-in

Contributed

Subscription

Subscription

Non-controlling

Development

Stockholders’

Shares

Amount

Capital

Capital

Receivable

Payable

Interest

Stage

Equity

May 31, 2013 continued from

previous page

Private placement for cash,

closed April 22, 2013 for $2.60

per share

39,000     $

4

$

101,396      $

-      $

-      $

-

$

-

$

-    $

101,400

Private placement for cash,

closed April 23, 2013 for $2.60

per share

78,000

8

202,792

-

-

-

-

-

202,800

Private placement for cash,

closed April 29, 2013 for $2.60

per share

78,000

8

202,792

-

-

-

-

-

202,800

Private placement for cash,

closed April 30, 2013 for $2.60

per share

13,500

1

35,099

-

-

-

-

-

35,100

Cash exercise of warrants on May

7, 2013 at $1.50 per share

7,500

1

11,249

-

-

-

-

-

11,250

Note payable debt converted into

stock May 7, 2013 for $2.60

per share including costs of

$6,800

10,000

1

32,799

-

-

-

-

-

32,800

Private placement for cash,

closed May 9, 2013 for $2.60

per share

12,000

1

31,199

-

-

-

-

-

31,200

Note payable debt converted into

stock May 15, 2013 for $2.60

per share including costs of

$6,000

10,000

1

31,999

-

-

-

-

-

32,000

Cash exercise of warrants on May

17, 2013 at $1.50 per share

32,733

3

49,096

-

-

-

-

-

49,099

Cash exercise of warrants on May

21, 2013 at $1.50 per share

82,500

8

123,742

-

-

-

-

-

123,750

Private placement for cash,

closed May 21, 2013 for $2.60

per share

3,900

0

10,140

-

-

-

-

-

10,140

Cash exercise of warrants on May

29, 2013 at $1.50 per share

82,500

8

123,742

-

-

-

-

-

123,750

Subscription receivable from

above exercise of warrants

-

-

-

-

(67,244)

-

-

-

(67,244)

May 31, 2013 continued on

following page

See accompanying notes to the consolidated financial statements.

F-14



ABAKAN INC.

(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFECIT) – CONTINUED

Accumulated

Deficit

During

Total

Common Stock

Paid-in

Contributed

Subscription

Subscription

Non-controlling

Development

Stockholders’

Shares

Amount

Capital

Capital

Receivable

Payable

Interest

Stage

Equity

May 31, 2013 continued from

previous page

Accounts payable debt converted

into stock May 31, 2013 for

$2.60 per share including costs

of $16,547

26,924     $

3

$

86,546      $

-      $

-      $

-

$

-

$

-     $

86,549

Shares returned and cancelled per

settlement agreement dated

May 8, 2013, at $1.13 per

share

(31,000)

(3)

(35,027)

-

-

-

-

-

(35,030)

Shares returned and cancelled per

settlement agreement dated

May 8, 2013, at $1.18 per

share

(20,000)

(2)

(23,598)

-

-

-

-

-

(23,600)

Subscription receivables received

from December 20, 2012

-

-

-

-

75,000

-

-

-

75,000

Stock options expense

-

-

1,827,496

-

-

-

-

-

1,827,496

MesoCoat stock option expense

allocated to non-controlling

interest

-

-

(73,318)

-

-

-

73,318

-

-

Net loss for the year

-

-

-

-

-

-

(1,113,932)

(7,223,423)

(8,337,355)

Balance, May 31, 2013

64,284,855      $

6,430      $

20,833,426      $

5,050      $

(76,244)      $

-

$

2,413,697     $

(13,545,788)   $

9,636,571

See accompanying notes to the consolidated financial statements.

F-15



ABAKAN INC

(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENTS OF CASH FLOW

Cumulative

Amounts from

Development stage

For the years

Activities

ended

June 27, 2006

May 31,

(inception) to

2013

2012

2011

May 31, 2013

CASH FLOWS FROM DEVELOPMENT STAGE

ACTIVITIES

Net profit/ (loss) before non-controlling interest

$

(8,337,355)      $

(1,077,439)      $

(3,184,384)      $

(14,617,910)

Adjustments to reconcile net (loss) to net

cash provided by (used in) development stage activities:

Depreciation and amortization

417,072

302,858

5,790

749,156

Amortization of discount on debt

838,289

475,374

137,490

1,451,153

Imputed interest on debt

59,343

-

-

59,343

Stock options expense

1,827,496

1,311,032

964,439

4,416,280

Stock expense from  note conversion

239,120

153,317

195,290

730,097

Stock issued for services

415,791

159,250

331,401

1,096,442

Equity in investee (profit)/ loss

260,878

(944,125)

278,292

(213,289)

Unrealized gain on MesoCoat acquisition

-

(1,764,345)

-

(1,764,345)

Gain/ (loss) on sale of capital asset

-

(429,717)

-

(429,717)

Changes in operating assets and liabilities:

Accounts receivable

(82,669)

148,603

-

65,934

Notes receivable - related parties

-

-

4,000

(4,500)

Prepaid expenses

66,106

(166,934)

8,951

(131,181)

Prepaid expenses - related parties

(16,676)

1,485

12,667

(2,524)

Accounts payable

1,150,049

299,070

129,118

1,789,606

Accounts payable - related parties

170,231

1,562

97,073

333,735

Accrued interest - related parties

-

-

-

2,664

Accrued interest - loans payable

(14,251)

104,961

35,847

145,153

66,395

105,763

72,428

244,586

Accrued liabilities

Waste to Energy Group Inc.

-

-

-

180,000

Total adjustments

$

5,397,173

(241,846)      $

2,272,786      $

8,718,593

NET CASH (USED IN) DEVELOPMENT STAGE

ACTIVITIES

(2,940,182)

(1,319,285)

(912,198)

(5,899,317)

CASH FLOWS FROM INVESTING ACTIVITIES

Purchase of property, plant, equipment and website

(2,675,328)

(1,073,018)

(4,394)

(3,782,202)

Proceeds from sale of capital assets

921

470,000

-

470,921

MesoCoat - minority interest, net of cash assumed in

business combination

-

1 ,059,764

(2,050,000)

(2,390,266)

Investment in MesoCoat

-

(750,070)

-

(750,070)

Powdermet - minority interest

-

-

(1,650,000)

(1,650,000)

Assignment agreement - MesoCoat

-

-

(100,000)

(100,000)

Capitalized patents and licenses

(45,083)

(98,185)

-

(143,268)

Waste to Energy Group Inc.

-

-

(180,000)

(180,000)

NET CASH PROVIDED BY/ (USED) IN INVESTING

ACTIVITIES

(2,719,490)

(391,509)

(3,804,394)

(8,524,885)

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from sale of common stock

3,126,964

1,755,700

1,997,999

9,058,805

Proceeds from loans payable

2,107,292

1,079,485

2,625,769

5,958,579

Payments on loans payable

(207,816)

(375,651)

-

(583,467)

Proceeds from loans payable - related parties

66,200

-

79,680

145,880

Payments on loans payable - related parties

(36,200)

-

(27,420)

(15,137)

Repayments of capital leases

(23,294)

(54,639)

-

(77,933)

Stock issuable

-

-

-

165,465

Proceeds from capital contributed

-

-

-

5,050

NET CASH PROVIDED BY FINANCING

ACTIVITIES

5,033,146

2,570,360

4,676,028

14,657,242

NET INCREASE (DECREASE)  IN CASH AND CASH

EQUIVALENTS

(626,526)

859,566

(40,564)

233,040

CASH AND CASH EQUIVALENTS, BEGINNING OF

-

PERIOD

859,566

-

40,564

-

CASH AND CASH EQUIVALENTS, END OF PERIOD

$

233,040      $

859,566      $

-      $

233,040

See accompanying notes to the consolidated financial statements.

F-16



ABAKAN INC.

 

(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENTS OF CASH FLOWS – CONTINUED

Supplemental Disclosures:

Cash paid for income taxes

$

-      $

-      $

-      $

-

Cash paid for interest

$

-      $

964      $

-      $

964

Supplemental Non-cash Disclosures:

Notes and accounts payable converted to stock

Accounts payable - related parties

$

(279,255)      $

(188,460)      $

(141,960)      $

(485,226)

Loans payable

(1,607,595)

(567,895)

(625,169)

(2,257,764)

Accrued interest

(13,044)

(7,737)

(4,331)

(17,375)

Notes payable - related parties

-

-

-

(99,515)

Accrued interest - related parties

-

-

-

(9,724)

Common stock

1,976,138

764,092

774,460

2,874,354

Subscription payable

-

-

(3,000)

(3,000)

-

(1,750)

(1,750)

Subscription receivable

(76,244)

$

-      $

-

$

-      $

-

Stock issued for assignment agreement - MesoCoat

Assignment agreement - MesoCoat

$

-      $

-      $

(150,000)      $

(150,000)

Common stock

-

-

(150,000)

150,000

$

-      $

-      $

-      $

-

Capital lease equipment acquired

Property, plant and equipment

$

-      $

126,907      $

-      $

126,907

Capital lease payable

-

(126,907)

126,907

(126,907)

$

-      $

-      $

-      $

-

Non-cash write off of balances

Accounts payable - related parties

$

-      $

-      $

52,030      $

52,030

Loans payable

-

-

(156)

(156)

Accrued interest

-

-

(553)

(553)

Notes payable - related parties

-

-

(52,260)

(52,260)

Accrued interest - related parties

-

-

(811)

(811)

Subscription receivable

-

-

1,750

1,750

$

-      $

-      $

-      $

-

Accounts payable converted to Notes Payable

Accounts payable

155,161

-

-

155,161

Notes payable

(155,161)

-

-

(155,161)

-

-

-

-

Beneficial conversion valuation

Additional paid-in capital

$

-      $

815,669      $

736,576      $

1,241,449

Discount on convertible debts

-

(815,669)

(736,576)

(1,241,449)

$

-      $

-      $

-      $

-

Controlling interest purchase - Mesocoat

Accounts receivable

$

-      $

171,457      $

-      $

171,457

Property and equipment, net

-

1,899,598

-

1,899,598

Patents and licenses, net

-

7,938,206

-

7,938,206

Total assets

-

10,009,261

-

10,009,261

Accounts payable

-

(268,398)

-

(268,398

Capital leases

-

(42,907)

-

(42,907)

Loans Payable and accrued interest

-

(2,233,474)

-

(2,233,474)

Other accrued liabilities

-

(65,545)

-

(65,545)

Total liabilities

-

(2,610,324)

-

(2,610,324)

Net assets

-

7,398,937

-

7,398,937

Noncontrolling interest equity

-

(3,412,500)

-

(3,412,500)

Goodwill

-

364,384

-

364,384

Investment in Mesocoat

-

(1,849,665)

-

(1,849,665)

MesoCoat net assets received

$

-      $

2,501,156      $

-

2,501,156

See accompanying notes to the consolidated financial statements.

F-17



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

Note 1 – BUSINESS

Your Digital Memories, Inc. was incorporated in the state of Nevada on June 27, 2006.

Waste to Energy Group Inc., a wholly-owned subsidiary of Your Digital Memories Inc., was

incorporated in the state of Nevada on August 13, 2008. Waste to Energy Group Inc. and Your Digital

Memories Inc. entered into an Agreement and Plan of Merger on August 14, 2008. The board of

directors of Waste to Energy Group Inc. and Your Digital Memories Inc. deemed it advisable and in the

best interest of their respective companies and shareholders that Waste to Energy be merged with and

into Your Digital Memories Inc. with Your Digital Memories Inc. remaining as the surviving

corporation under the name Waste to Energy Group Inc.

Abakan Inc., a wholly-owned subsidiary of Waste to Energy Group Inc., was incorporated in the state of

Nevada on November 6, 2009. Abakan Inc. and Waste to Energy Group Inc. entered into an Agreement

and Plan of Merger on November 6, 2009. The board of directors of Abakan Inc. and Waste to Energy

Group Inc. deemed it advisable and in the best interest of their respective companies and shareholders

that Abakan Inc. be merged with and into Waste to Energy Group Inc. with Waste to Energy Group Inc.

remaining as the surviving corporation under the name “Abakan Inc.”

Unless the context indicates otherwise, all references herein to the “Company”, “we,” “us,” and “our”

refer to Abakan Inc. and its consolidated subsidiaries. The Company is in the development stage as

defined under FASB ASC 915-10, "Development Stage Entities."

On December 10, 2009 the Company purchased a thirty-four percent (34%) interest in MesoCoat, Inc.

("MesoCoat"), and on July 13, 2011 purchased an additional eighteen and one-half percent (18.50%),

for an aggregate total of fifty two and one-half percent (52.50%) of the outstanding stock of MesoCoat.

MesoCoat (formerly “Powdermet Coating Technologies, Inc.”) was incorporated in Nevada as a wholly

owned subsidiary of Powdermet, Inc. (“Powdermet”) on May 18, 2007. Operations began in 2008 and

effective March 31, 2008 it was renamed as MesoCoat Inc. Future success of operations is subject to

several technical hurdles and risk factors, including satisfactory product development, regulatory

approval and market acceptance of MesoCoat’s products and its continued ability to obtain future

funding. MesoCoat is currently in the development stage, as operations consist primarily of research and

development expenditures, and revenues from planned principal operations that have not yet been

realized. MesoCoat has invested heavily in intellectual property, machinery and equipment to initiate

the research and development of its core technology. Currently, MesoCoat’s revenue consists of

government grants, cooperative reimbursement agreements and commercial contracts.

On March 21, 2011, the Company purchased 596,813 shares of Powdermet from Kennametal, Inc., an

unrelated party, equal to a fully diluted 41% interest in Powdermet.

Powdermet was formed in 1996 as a Delaware corporation and has since developed a product platform

of advanced materials solutions derived from nano-engineered particle agglomerate technology and

derived hierarchically structured materials. Powdermet also owns 47.50% of MesoCoat.

F-18



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 1 – BUSINESS - continued

On June 8, 2011, the Company formed a wholly owned subsidiary company named, AMP Distributors,

Ltd. (“AMP Distributors”), a Grand Cayman corporation. In April 2013, AMP SEZC filed for a Trade

Certificate which was approved in full in May 2013 to begin operations as a Special Economic Zone

Company, accordingly we change name from AMP Distributors to AMP SEZC. Fully staffed offices

have been established by AMP SEZC in the Cayman Enterprise City. The primary purpose of these

entities is to negotiate, execute and administer the set up of overseas operations as well as handling

some international sales of MesoCoat's products.

On July 27, 2012, the Company formed a wholly owned subsidiary company named, AMP Distributors,

Inc. (“AMP FL”), a Florida corporation. AMP Distributors was formed to distribute MesoCoat products

to consumer markets.

Abakan’s plan of operations is to develop and commercialize their products in advanced coatings and

metal formulations markets as a result of its investment in MesoCoat, Inc. (“MesoCoat”) and

Powdermet, Inc. (“Powdermet”).  Abakan is actively involved in supporting their R&D, market

development, and commercialization efforts.  Since the Company is in the pre-commercialization phase

for the majority of its products, it is anticipated that the Company will need successive rounds of

financing to fund research & development, lengthy qualification periods, sales and marketing efforts.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Accounting Basis

These financial statements are prepared on the accrual basis of accounting in conformity with

accounting principles generally accepted in the United States of America (GAAP).

We follow accounting standards set by the Financial Accounting Standards Board, commonly referred

to as the FASB.  The FASB sets GAAP that we follow to ensure we consistently report our financial

condition, results of operations, and cash flows.  References to GAAP issued by the FASB in these

footnotes are to the FASB Accounting Standards Codification, sometimes referred to as the Codification

or ASC.

Cash and Cash Equivalents

For the purposes of the statements of cash flows, cash equivalents include all highly liquid investments

with a maturity of three months or less.

Concentration in Sales to Few Customers

In the years ended May 31, 2013 and 2012, our government contracts accounted for 90% and 71% of our

revenues, respectively. There was no revenue for the year ended May 31, 2011.

F-19



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – continued

Cash in Excess of FDIC Insured Limits

We maintain our cash in bank deposit accounts which, at times, may exceed federally insured limits.

Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $250,000. At May

31, 2013 and 2012, we had approximately none and $207,239, respectively, in excess of FDIC insured

limits. We have not experienced any losses in such accounts.

Consolidation Policy

The accompanying May 31, 2013 financial statements include the Company’s accounts and the accounts of

its subsidiaries. All significant intercompany transactions and balances have been eliminated in

consolidation. The Company’s ownership of its subsidiaries as of May 31, 2013 is as follows:

Name of Subsidiary

Percentage of Ownership

AMP SEZC (Cayman)

100.00%

AMP Distributors (Florida)

100.00%

MesoCoat, Inc.

52.50%

Fair Value of Financial Instruments

In January 2008, the Company adopted FASB ASC 820, Fair Value Measurements and Disclosures

(“ASC 820”) (Formerly referenced as SFAS No. 157, Fair Value Measurements), to value its financial

assets and liabilities. The adoption of ASC 820 did not have a significant impact on the Company’s

results of operations, financial position or cash flows.  ASC 820 defines fair value, establishes a

framework for measuring fair value under GAAP and expands disclosures about fair value

measurements.  ASC 820 defines fair value as the exchange price that would be paid by an external party

for an asset or liability (exit price).

ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of

observable inputs and minimize the use of unobservable inputs when measuring fair value.  Three levels

of inputs may be used to measure fair value:

·

Level 1 – Active market provides unadjusted quoted prices for identical assets or liabilities that the

company has the ability to access;

·

Level 2 – Quoted prices for similar assets or liabilities in active markets or quoted prices for identical

or similar assets or liabilities in inactive markets. Level 2 inputs include those other than quoted

prices that are observable for the asset or liability and that are derived principally from, or

corroborated by, observable market data by correlation of other means. If the asset or liability has a

specified term the Level 2 input must be observable for substantially the full term of the asset or

liability; and

·

Level 3 – Inputs to the valuation methodology are unobservable and significant to the fair value

measurement.

F-20



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued

Fair value estimates discussed herein are based upon certain market assumptions and pertinent

information available to management as of May 31, 2013.  The Company uses the market approach to

measure fair value for its Level 1 financial assets and liabilities.  The market approach uses prices and

other relevant information generated by market transactions involving identical or comparable assets or

liabilities.

Fair Value of Financial Instruments - continued

The respective carrying value of certain on-balance-sheet financial instruments approximated their fair

values.  These financial instruments which include cash, accounts receivable, accounts payable, and notes

payable are valued using Level 1 inputs and are immediately available without market risk to

principal.  Fair values were assumed to approximate carrying values for these financial instruments since

they are short term in nature and their carrying amounts approximate fair values or they are receivable or

payable on demand.  The carrying value of note payable to stockholder approximates its fair value

because the interest rates associated with the instrument approximates current interest rates charged on

similar current borrowings.  The Company does not have other financial assets that would be

characterized as Level 2, but we do feel that our investment in Powdermet would be characterized as

Level 3 assets.

Non-Controlling Interest

Non-controlling interest represents the minority members’ proportionate share of the equity of MesoCoat,

Inc.  The Company’s controlling interest in MesoCoat requires that its operations be included in the

consolidated financial statements.  The equity interest of MesoCoat that is not owned by the Company is

shown as non-controlling interest in the consolidated financial statements.

Equity Method

Investee companies that are not consolidated, but over which the Company exercises significant

influence, are accounted for under the equity method of accounting, in accordance with ASC 323.

Whether or not the Company exercises significant influence with respect to an Investee depends on an

evaluation of several factors including, among others, representation on the investee company’s board of

directors and ownership level, which is generally a 20% to 50% interest in the voting securities of the

investee company. Under the equity method of accounting, an investee company’s accounts are not

reflected within the Company’s Balance Sheets and Statements of Operations; however, the Company’s

share of the earnings or losses of the investee company is reflected in the caption “Equity in (Investee)

income (loss)” in the Statements of Operations. The Company’s carrying value in an equity method

investee company is reflected in the caption “Investment – (Investee)” in the Company’s Balance Sheets.

Occasionally, we may make payments towards our investment in investee companies. As we make those

deposits on our total investment, we account for those payments on our balance sheet as “Investment

deposits in (investee).” When we complete the total investment amount, these amounts are moved into the

individual investment accounts discussed above.

F-21



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued

Earnings (Loss) Per Common Share

The Company computes net loss per share in accordance with FASB ASC 260-10, "Earnings per Share".

FASB ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of

the statement of operations. Basic  EPS  is  computed   by  dividing  net  loss  available to common

stockholders  (numerator)  by  the   weighted  average  number  of  shares outstanding (denominator)

during the period.  Diluted EPS gives effect to all potentially dilutive common shares outstanding during

the period. Diluted EPS excludes all potentially dilutive shares if their effect is anti-dilutive. The only

potentially dilutive common shares outstanding are stock options and warrants from inception (Note 10).

Development Stage Enterprise

At May 31, 2013, the Company’s business operations had not fully developed and the Company is highly

dependent upon funding and therefore is considered a development stage enterprise.

Accounts Receivable

Accounts receivable are stated at face value, less an allowance for doubtful accounts. The Company

provides an allowance for doubtful accounts based on management's periodic review of accounts,

including the delinquency of account balances. Accounts are considered delinquent when payments have

not been received within the agreed upon terms, and are written off when management determines that

collection is not probable. As of May 31, 2013 and 2012 management has determined that no allowance

for doubtful accounts is required.

Notes Receivable

Notes receivable are stated at face value, plus any accrued interest earned. The Company analyzes each

note receivable each period for probability of collectability. Notes are considered in default when

payments have not been received within the agreed upon terms, and are written off when management

determines that collection is not probable. As of May 31, 2013 and 2012, management has determined

that no occurrence of default exists.

Property, Plant and Equipment

Property, plant and equipment are stated at cost less accumulated depreciation and amortization.

Maintenance and repairs are charged to operations as incurred. Depreciation and amortization are based

on the straight-line method over the estimated useful lives of the related assets. When assets are retired or

otherwise disposed of, the cost and accumulated depreciation and amortization are removed from the

accounts, and any resulting gain or loss is reflected in operations in the period realized.

F-22



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued

Asset Construction In Progress

Construction in progress assets, represent assets that are in process of construction and rehabilitation in

order to bring them to operational status. All costs are captured in a separate Construction in Progress

account, and are included in the “Property, plant and equipment – net” amounts, and when the asset is

ready to enter service, the total costs are capitalized and depreciation commences per the schedule below.

Depreciation

Depreciation is computed on the straight-line method net of salvage value with useful lives as follows:

Computer equipment and software

3 - 5 years

Office furniture and equipment

5 - 7 years

Machinery and equipment

7 - 10 years

Leasehold improvements

balance of lease term

Patent and Technology Licenses

Patent costs are recorded at the cost to obtain the patent and are amortized on a straight-line basis over their estimated

useful lives up to 20 years, beginning when the patent is secured by the Company. License costs are recorded at

the cost to obtain the license and are amortized on a straight-line basis over effective term of the license, up to 15

years.

Indefinite-lived Intangible Assets

In accordance with GAAP, Intellectual Property Research and Development in the amount of $6,120,200

related to the acquisition of MesoCoat, will not be amortized, and was  reviewed for impairment  starting fiscal

year ending May 31, 2013, due to its indefinite life. Indefinite-lived intangible assets are tested for impairment

using qualitative analysis and, if necessary, fair value measurement techniques. As of the years ended May 31,

2013 and 2012, no impairment charges were necessary.

Goodwill

In accordance with GAAP, goodwill in the amount of $364,384 related to the acquisition of MesoCoat was

evaluated for impairment on an annual basis starting fiscal year ending May 31, 2013.

Dividends

The Company has not adopted any policy regarding payment of dividends.  No dividends have been

paid during the periods shown.

F-23



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued

Income Taxes

Income taxes are provided for using the liability method of accounting. A deferred tax asset or liability

is recorded for all temporary differences between financial and tax reporting. Deferred tax expense

(benefit) results from the net change during the year in deferred tax assets and liabilities.  Valuation

allowances are established when necessary to reduce deferred tax assets to the amount expected to more

likely than not be realized in future tax returns. Tax law and rate changes are reflected in income in the

period such changes are enacted.

Revenue Recognition

The Company recognizes revenue when there is persuasive evidence of an arrangement, delivery has

occurred or services have been rendered, the sales price is fixed or determinable, and collectability is

reasonably assured.

Grant Revenue

Revenue from grants is generally recorded when earned as defined under the terms of the agreements. Each

grant document sets the timing of amounts that are allowed to be billed and how to bill those amounts. We generally

look at a two week time period to bill from and work on the incurred costs for the same time period and bill according

to preset amounts that are allowed to be billed for per the grant documents. This is then billed through a government

billing system, reviewed by the government department, and then payment is sent to us.

Research and Development Costs

Research and development costs are charged to expense as incurred and are included in operating expenses. Total

research and development costs were $1,347,190, $737,316 and none for the years ended May 31, 2013, 2012

and 2011, respectively.

Advertising Expenses

Advertising costs are expensed as incurred. Advertising expenses are included in general and

administrative expense in the accompanying statements of operations. Total advertising expenses were

$6,875, $14,376 and $950 for the years ended May 31, 2013, 2012 and 2011, respectively.

Shipping and Handling Costs

The Company’s shipping and handling costs are included in cost of revenues for all periods presented.

F-24



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued

Stock-Based Compensation

The Company follows FASB ASC 718-10 and values our employee stock based awards based on the

grant-date fair value estimated in accordance with the provisions of FASB ASC 718-10.  The Company

accounts for equity instruments issued in exchange for the receipt of goods or services from other than

employees in accordance with FASB ASC 718-10 and the conclusions reached in FASB ASC 505-10.

Costs are measured at the estimated fair market value of the consideration received or the estimated fair

value of the equity instruments issued, whichever is more reliably measurable.  The value of equity

instruments issued for consideration other than employee services is determined on the earliest of a

performance commitment or completion of performance by the provider of goods or services as defined

by FASB ASC 505-10.

Derivatives

The Company occasionally issues financial instruments that contain an embedded instrument. At

inception, the Company assesses whether the economic characteristics of the embedded derivative

instrument are clearly and closely related to the economic characteristics of the financial instrument (host

contract), whether the financial instrument that embodies both the embedded derivative instrument and

the host contract is currently measured at fair value with changes in fair value reported in earnings, and

whether a separate instrument with the same terms as the embedded instrument would meet the definition

of a derivative instrument.

If the embedded derivative instrument is determined not to be clearly and closely related to the host

contract, is not currently measured at fair value with changes in fair value reported in earnings, and the

embedded derivative instrument would qualify as a derivative instrument, the embedded derivative

instrument is recorded apart from the host contract and carried at fair value with changes recorded in

current-period earnings.

The Company determined that all embedded items associated with financial instruments at this time do

not qualify for derivative treatment, nor should those be separated from the host.

Impairment of Long Lived Assets

We evaluate whether events and circumstances have occurred which indicate the remaining estimated

useful life of long lived assets, including other intangible assets, may warrant revision or the remaining

balance of an asset may not be recoverable. The measurement of possible impairment is based on a

comparison of the fair value of the related assets to the carrying value using discount rates that reflect the

inherent risk of the underlying business. Impairment losses, if any, would be recorded to the extent the

carrying value of the assets exceeds the implied fair value resulting from this calculation.  As of May 31,

2013 and 2012, the Company has not recognized any impairment associated with long lived assets.

F-25



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued

General Accounting Policy for Contingencies

Certain conditions may exist which may result in a loss to the Company, but which will only be resolved

when one or more future events occur or fail to occur. The Company’s management and its legal counsel

assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In

assessing loss contingencies related to legal proceedings that are pending against the Company, or

unasserted claims that may result in such proceedings, the Company’s legal counsel evaluates the

perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the

amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and

the amount of the liability can be estimated, the estimated liability would be accrued in the Company’s

financial statements. If the assessment indicates that a potentially material loss contingency is not

probable but is reasonably possible, or is probable but cannot be estimated, the nature of the contingent

liability, together with an estimate of the range of possible loss if determinable and material, would be

disclosed.

Loss contingencies considered remote are generally not disclosed unless they arise from guarantees, in

which case the guarantees would be disclosed.

As of May 31, 2013 and 2012, the Company’s management believes that there are no outstanding legal

proceedings which would have a material adverse effect on the financial position of the Company.

Use of Estimates in the Preparation of Financial Statements

The preparation of financial statements in conformity with GAAP requires management to make

estimates and assumptions that affect the reported amounts of assets, the disclosure of contingent assets

and liabilities at the date of the financial statements and the reported amounts of revenues and expenses

during the reporting periods. The more significant areas requiring the use of estimates include asset

impairment, stock-based compensation, beneficial conversion features on debt instruments, and future

income tax amounts. Management bases its estimates on historical experience and on other assumptions

considered to be reasonable under the circumstances. Actual results may differ from the estimates.

Subsequent Events

In accordance with ASC 855-10 “Subsequent Events”, the Company has evaluated subsequent events and

transactions for potential recognition or disclosure in the financial statements through the date the

financial statements were issued (Note 17).

F-26



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 3 – GOING CONCERN

The accompanying financial statements have been prepared assuming that the Company will continue as

a going concern.  The Company has net losses for the period of June 27, 2006 (inception) to the year

ended May 31, 2013, of $13,545,788, and a working capital deficit of $2,222,670.  These conditions

raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s

continuation as a going concern is dependent on its ability to develop additional sources of capital,

and/or achieve profitable operations and positive cash flows. Management’s plan is to aggressively

pursue its present business plan. Since inception we have funded our operations through the issuance of

common stock, debt financing, and related party loans and advances, and we will seek additional debt or

equity financing as required. The accompanying financial statements do not include any adjustments

that might result from the outcome of this uncertainty.

NOTE 4 – PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consisted of the following:

May 31, 2013

May 31, 2012

Machinery and equipment

$

4,227,464

$

427,641

Construction in progress

692,655

2,617,196

Computer equipment and office furniture

47,032

35,369

Leasehold improvements

840,953

53,818

5,808,104

3,134,024

Less accumulated depreciation and amortization

(213,097)

(112,936)

$

5,595,007

$

3,021,088

Depreciation and amortization expense was $100,488, $42,782 and $2,290 for the years ended May 31,

2013, 2012 and 2011, respectively.  The Company recognized a loss of $921 for equipment sold the year

ended May 31, 2013.

F-27



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE  5    PATENTS  AND  LICENSES

Patents and licenses consist of the following:

May 31, 2013

May 31, 2012

Patents

$

118,074     $

72,991

Website

21,000

21,000

Intellectual Property Research and Development

6,120,200

6,120,200

Licenses

1,843,200

1,843,200

8,102,474

8,057,391

Less accumulated amortization

(557,311)

(281,076)

$

7,545,163     $

7,776,315

Amortization expense was $276,235, $260,076 and $3,500 for the years ended May 31, 2013, 2012 and

2011, respectively. In the years ended May 31, 2013 and 2012, we have capitalized an additional $45,083

and $98,185, respectively, on patents and licenses, and have begun amortizing those according to our policy.

Future amortization patents and licenses are presented in the table below:

For the years ended May 31,

2014

$

291,152

2015

291,152

2016

291,152

2017

291,152

2018 and beyond

260,355

$

1,424,963

Patent license agreement

The Company has an exclusive commercial patent license agreement with a third party which requires the

Company to invest in the research and development of technology and the market for products by

committing to a certain level of personnel hours and $350,000 of expenditures.

The patent license agreement required a total of $50,000 in execution fees which are included in

intangible assets. The patent license agreement requires royalty payments equal to 2.5% of net sales of the

product sold by the Company beginning after the first commercial sale. For the first calendar year after

the achievement of a certain milestone and the following two calendar years during the term of the

agreement, the Company will pay a minimum annual royalty payment of $10,000, $15,000 and $20,000

respectively. During the year ended May 31, 2013, $19,742 of royalty payments were made.

F-28



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 6 – ASSIGNMENT AGREEMENT – MESOCOAT

On March 25, 2011, the Company entered into an assignment agreement (the Agreement) whereby it

would assume the exclusive rights to distribute MesoCoat’s products intended for applications specific to

the oil and gas pipeline industry in consideration of $250,000.  The Agreement was entered into with a

company who entered into an exclusive distribution agreement with MesoCoat dated October 10, 2008

which was in effect for 10 years following the original date of the exclusive distribution agreement.  On

May 31, 2011, the Company completed the transfer of consideration and assumed all rights to the

agreement.  We commenced amortization on June 1, 2012, over the remaining term of 76 months, and

have recorded $39,472, none and none in amortization expense as of the year ended May 31, 2013, 2012

and 2011, respectively.

NOTE 7 – INVESTMENT IN NON-CONTROLLING INTEREST

Powdermet, Inc.

The Company purchased a forty one percent (41%) interest in Powdermet, Inc. (“Powdermet”), on June

28, 2010 from Kennametal in exchange for one million six hundred fifty thousand dollars ($1,650,000).

Powdermet was formerly the parent company of MesoCoat, owning 66% of MesoCoat at May 31, 2011.

Andy Sherman serves as the chief executive officer of both Powdermet and MesoCoat in addition to his

duties as a member of the Company’s board of directors. Through the Company’s purchase of 41% of

Powdermet, it also gained indirect ownership of the additional shares of MesoCoat that Powdermet owns.

We have analyzed our investment in accordance of “Investments – Equity Method and Joint Ventures”

(ASC 323), and concluded that when the stock purchase agreement was completed our 41% minority

interest investment gave us significant influence over Powdermet’s business actions, board of directors,

and its management, and therefore we account for our investment using the Equity Method. The table

below reconciles our investment amount and equity method amounts to the amount on the accompanying

balance sheet.

March 21, 2011, initial investment

$

1,650,000

Equity in profit for period of March 21

through May 31, 2011

71,656

Investment balance, May 31, 2011

$

1,721,656

Equity in profit for year ended May 31, 2012

988,533

Investment balance, May 31, 2012

$

2,710,189

Equity in loss for the year ended May 31, 2013

(260,877)

Investment balance, May 31, 2013

$

2,449,312

Powdermet’s ownership in MesoCoat was diluted when the Company exercised its initial option to

purchase 86,156 shares of common stock from MesoCoat. Powdermet’s ownership in MesoCoat as of

May 31, 2013 and 2012 is 47.50%.

F-29



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 7 – INVESTMENT IN NON-CONTROLLING INTEREST - CONTINUED

Powdermet, Inc.- continued

Below is a table with summary financial results of operations and financial position of Powdermet:

Powdermet Inc.

For the year ended

For the year ended

May 31, 2013

May 31, 2012

Equity Percentage

41%

41%

Condensed income statement information:

Total revenues

$

2,178,117     $     $

2,053,959

Total cost of revenues

1,188,988

941,441

Gross margin

1,042,264

1,112,518

Total expenses

(946,873)

(1,055,386)

Other income/ (expense)

(1,057,278)

3,515,113

Provision (for) benefit from income taxes

378,737

(1,161,190)

Net profit (loss)

$

(636,285)     $     $

2,411,055

Company’s equity in net profit

$

(260,877)      $    $

988,533

Condensed balance sheet information:

May 31, 2013

May 31, 2012

Total current assets

$

533,168    $     $

578,725

Total non-current assets

3,080,248

4,234,600

Total assets

$

3,613,416    $     $

4,813,325

Total current liabilities

$

260,897    $     $

395,614

Total non-current liabilities

1,676,463

2,105,370

Total equity

1,676,056

2,312,341

Total liabilities and equity

$

3,613,416    $     $

4,813,325

F-30



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 8 – LOANS PAYABLE

As of May 31, 2013 and 2012, the loans payable balance was comprised of:

Description

May 31, 2013

May 31, 2012

Convertible demand note to an unrelated  entity bearing 5% interest per annum which matures

$

-     $

400,231

on April 13, 2013. The note is shown net of a discount of $-0- and $99,769, respectively,

attributable to the beneficial conversion feature, and an effective interest rate of 30.19%.

Convertible demand note to an unrelated  entity bearing 5% interest per annum which matures

1,500,000

1,214,917

on September 15, 2015. The note is shown net of a discount of $-0- and $285,083,

respectively, attributable to the beneficial conversion feature, and an effective interest rate of

31.19%.

Convertible demand note to an unrelated  entity bearing 5% interest per annum which matures

175,163

38,531

on September 15, 2015. The note is shown net of a discount of $24,837 and $161,469,

respectively,  attributable to the beneficial conversion feature, and an effective interest rate of

175.84%.

Convertible demand note to an unrelated  entity bearing 5% interest per annum which matures

387,473

70,671

on July 14, 2013. The note is shown net of a discount of $112,527 and $429,329, respectively,

attributable to the beneficial conversion feature, and an effective interest rate of 142.77%.

Uncollateralized demand note to an unrelated entity bearing 8% interest per annum

70,000

70,000

Uncollateralized demand note to an unrelated entity bearing 8% interest per annum

3,850

3,850

Uncollateralized demand note to an unrelated entity bearing 8% interest per annum

-

303

Uncollateralized demand note to an unrelated entity bearing 8% interest per annum

19,350

19,350

Uncollateralized demand note to an unrelated entity bearing 8% interest per annum

20,000

20,000

Collateralized note to an unrelated entity bearing 1% interest for the first year and then 7%

1,000,000

-

per annum for years two – seven.

Uncollateralized demand note to a related entity bearing 8% interest per annum

30,000

-

Convertible demand note to an unrelated  entity bearing 7.5% imputed interest per annum

48,228

56,043

which matures on July 10, 2018.

Uncollateralized notes to an unrelated entity bearing 8% interest per annum, matures on

405,877

-

September 15, 2014

Capital leases payable to various vendors expiring in various years through September 2016;

91,881

115,175

collateralized by certain equipment with a cost of $205,157.

Uncollateralized demand note to an unrelated entity for royalties shown net of discount of

1,576,892

1,717,546

$23,108 and $82,454, respectively

5,328,714     $

3,726,617

Less current liabilities

1,023,561

2,508,164

Total long term liabilities

$

4,305,153     $

1,218,453

We also owed $155,812 and $183,106 in accrued interest for the above notes as of May 31, 2013 and

2012, respectively. We also amortized $838,289, $475,374 and $137,490 in discount on debt as of May

31, 2013, 2012 and 2011, respectively.

As of May 31, 2013 and 2012, we had no restrictive covenants attached to any of the above referenced

notes except for the $1,000,000 Development Loan which requires MesoCoat to create or maintain 46

jobs by the 3rd anniversary date of the completion of the project in Euclid, Ohio. If the 46 jobs are not

created or maintained by such date, the interest rate will increase from 7% to 10% per annum.

F-31



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 8 – LOANS PAYABLE – CONTINUED

Future maturity of our notes payable is presented in the table below:

For the years ended May 31,

2014

$      1,023,561

2015

3,056,282

2016

588,010

2017

193,126

2018 and beyond

467,735

$   5,328,714

Development Loan - MesoCoat

On October 2, 2012 we began drawing against a development loan from the State of Ohio with a

maximum amount of $1,000,000, and bearing an interest rate of one percent the first year after the

disbursement date, and then for years two through seven, the interest rate is seven percent. On October 2,

2012, we received our first payout from this loan of $584,066.  We received three additional draws on

October 5, 2012, February 7, 2013, and April 30, 2013 of $316,477, $69,441, and $30,016, respectively,

for a total of $1,000,000. The loan is to be repaid over seven years, and is collateralized by the project

equipment, one CermaClad system and automated pipe blasting equipment, and all inventory, equipment,

all fixtures, all intangibles and accounts receivables owned by MesoCoat.

Convertible Debentures - 2011

On March 17 and April 13, 2011 we signed two convertible debentures for a total of $2,000,000, due

March 17 and April 13, 2013, respectively. As of May 31, 2011, we received all of the proceeds from

these debentures. The notes bear an interest rate of 5% per annum, if any amounts are not paid when due

the interest rate will adjust and will be 10% per annum until paid.

On April 13, 2013, we converted $500,000 of the above debentures into shares of our common stock as

part of the private placements completed in the year ended May 31, 2013 (Note 9).  The $1,500,000

convertible debenture was extended to September 15, 2014.

The notes have a provision for conversion of the outstanding amounts owed  into conversion units for

$1.00 per unit; units consists of one share of our common stock and one-half share common stock

warrant to purchase shares of stock for $1.50 per share, with an expiration date of two years from the

conversion date. We have analyzed these detachable warrants in accordance with FASB ASC 470-20-

25-4, Debt with conversion options, and have determined that they have a beneficial conversion feature.

Accordingly we have valued these using the Black-Scholes method and have arrived at an aggregate

total $736,576, of relative fair value and was recorded as additional paid-in capital and has been

recorded as a discount on debt against the corresponding convertible note payable. In our valuation of

the warrant value we used the following terms:

F-32



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 8 – LOANS PAYABLE – CONTINUED

Convertible Debentures – 2011 - continued

March 17 and April 13, 2011

Expected volatility (based on historical

178.10%

volatility)

Expected dividends

0.00

Expected term in years

2.0

Risk-free rate

0.95%

In accordance with FASB ASC 470-20-55-32, we are amortizing this amount using the effective interest

method over the life of the notes payable of 24 months. For the years ended May 31, 2013, 2012 and

2011, we have recorded $384,852, $214,234 and $137,490, respectively, in amortization of discount on

debt and are reflected as a component of interest expense in our statement of operations. The remaining

aggregate total of none and $384,852 for the years ended May 31, 2014 and 2013, respectively, will be

amortized over the remaining life of the notes.

Convertible Debentures - 2012

On June 7, July 14, and August 29, 2011 we signed three convertible debentures for a total of $846,665,

due June 7, July 14 and August 29, 2013, respectively. As of May 31, 2012, we received all of the

proceeds from these debentures. The notes bear an interest rate of 5% per annum, if any amounts are not

paid when due the interest rate will adjust and will be 10% per annum until paid.

On February 20, 2012, we converted $146,665 of the above debentures that was due on August 29, 2013

into shares of our common stock

as part of the private placements completed in the year ended May 31, 2012 (Note 9). As part of this

conversion the note holder also converted $3,748 of accrued interest, and expensed the remaining

amount of $110,255 from the related discount on debt.

The notes have a provision for conversion of the outstanding amounts owed  into conversion units for

$1.00 per unit; units consists of one share of our common stock and one-half share common stock

warrant to purchase shares of stock for $1.50 per share, with an expiration date of two years from the

conversion date. We have analyzed these detachable warrants in accordance with FASB ASC 470-20-

25-4, Debt with conversion options, and have determined that they have a beneficial conversion feature.

Accordingly we have valued these using the Black-Scholes method and have arrived at an aggregate

total $815,670, of relative fair value and was recorded as additional paid-in capital and has been

recorded as a discount on debt against the corresponding convertible note payable. In our valuation of

the warrant value we used the following terms:

F-33



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 8 – LOANS PAYABLE – CONTINUED

Convertible Debentures – 2012 - continued

June 7, 2011

July 14 2011

August 29, 2011

Expected volatility (based on historical

170.29%

170.29%

170.29%

volatility)

Expected dividends

0.00

0.00

0.00

Expected term in years

2.0

2.0

2.0

Risk-free rate

0.39%

0.38%

0.20%

In accordance with FASB ASC 835-30-35-2, we are amortizing discounts of debt using the effective

interest method over the life of the notes payable of 24 months. For the years ended May 31, 2013, 2012

and 2011, we have recorded $453,434, $224,872 and none, respectively, in amortization of discount on

debt and are reflected as a component of interest expense in our statement of operations. The remaining

aggregate total of $137,364 and $590,798 for the years ended May 31, 2014 and 2013, respectively, will

be amortized over the remaining life of the notes.

Convertible Debt Note Extensions

The Company extended two of the above convertible notes, $1,500,000 and $200,000, to September 15,

2014 that were due to mature on March 16, 2013 and June 7, 2013, respectively.  The accrued interest on

both notes and a creditor fee was placed into a new $405,877 note bearing interest at 8% and will mature

on September 15, 2014. In addition to the extension date, certain force conversion options were modified

on each of the original notes.

F-34



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 9 – STOCKHOLDERS' EQUITY

Common Shares – Authorized

The Company has 2,500,000,000 common shares authorized at a par value of $0.0001 per share and

50,000,000 shares of preferred stock, par value $0.0001 per share.  All common stock shares have equal

voting rights, are non-assessable and have one vote per share.  Voting rights are not cumulative and,

therefore, the holders of more than 50% of the common stock could, if they choose to do so, elect all the

directors of the Company.

Common Stock Issuances

Private placements

For the years ended May 31, 2013 and 2012, we issued the following shares:

On June 6, 2011, we closed a private placement for $20,000, or 20,000 units consisting of one share of

our restricted common stock and one-half share common stock warrant to purchase shares of our common

stock, with a purchase price of $1.50 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $20,000.

On June 10, 2011, we closed a private placement for $20,000, or 20,000 units consisting of one share of

our restricted common stock and one-half share common stock warrant to purchase shares of our common

stock, with a purchase price of $1.50 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $20,000.

On July 6, 2011, we closed a private placement for $30,000, or 30,000 units consisting of one share of our

restricted common stock and one-half share common stock warrant to purchase shares of our common

stock, with a purchase price of $1.50 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $30,000.

On February 20, 2012, we closed a private placement for $300,000, or 300,000 units consisting of one

share of our restricted common stock and one common stock warrant to purchase shares of our common

stock, with a purchase price of $1.25 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $300,000.

On March 16, 2012, we closed a private placement for $382,000, or 382,000 units consisting of one share

of our restricted common stock and one common stock warrant to purchase shares of our common stock,

with a purchase price of $2.00 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $382,000.

On April 20, 2012, we closed a private placement for $29,500, or 18,438 units consisting of one share of

our restricted common stock and one-half common stock warrant to purchase shares of our common

stock, with a purchase price of $2.00 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $29,500.

F-35



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 9 – STOCKHOLDERS' EQUITY – CONTINUED

Common Stock Issuances - continued

Private placements - continued

On April 23, 2012, we closed a private placement for $320,000, or 200,000 units consisting of one share

of our restricted common stock and one-half common stock warrant to purchase shares of our common

stock, with a purchase price of $2.00 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $320,000.

On April 24, 2012, we closed a private placement for $119,200, or 74,550 units consisting of one share of

our restricted common stock and one-half common stock warrant to purchase shares of our common

stock, with a purchase price of $2.00 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $119,200.

On April 25, 2012, we closed a private placement for $25,000, or 15,625 units consisting of one share of

our restricted common stock and one-half common stock warrant to purchase shares of our common

stock, with a purchase price of $2.00 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $25,000.

On May 29, 2012, we closed a private placement for $80,000, or 50,000 units consisting of one share of

our restricted common stock and one-half common stock warrant to purchase shares of our common

stock, with a purchase price of $2.00 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $80,000.

On May 30, 2012, we closed a private placement for $430,000, or 268,750 units consisting of one share

of our restricted common stock and one-half common stock warrant to purchase shares of our common

stock, with a purchase price of $2.00 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $430,000.

On July 30, 2012, we closed a private placement for $525,000, or 300,000 units consisting of one share of

our restricted common stock and one-half common stock warrant to purchase shares of our common

stock, with a purchase price of $2.00 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $525,000.

On September 28, 2012, we closed a private placement for $262,500, or 150,000 units consisting of one

share of our restricted common stock and one-half common stock warrant to purchase shares of our

common stock, with a purchase price of $2.00 per share and an expiration date of two  years from the

closing. In connection with this placement we had no offering costs for a net of $262,500.

On October 18, 2012, we closed a private placement for $230,000, or 100,000 units consisting of one

share of our restricted common stock and one-half common stock warrant to purchase shares of our

common stock, with a purchase price of $2.70 per share and an expiration date of two  years from the

closing. In connection with this placement we had no offering costs for a net of $230,000.

F-36



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 9 – STOCKHOLDERS' EQUITY – CONTINUED

Common Stock Issuances - continued

Private placements - continued

On November 26, 2012, we closed a private placement for $16,100, or 7,000 units consisting of one share

of our restricted common stock and one-half common stock warrant to purchase shares of our common

stock, with a purchase price of $2.70 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $16,100.

On November 30, 2012, we closed a private placement for $62,715, or 25,000 units consisting of one

share of our restricted common stock and one-half common stock warrant to purchase shares of our

common stock, with a purchase price of $2.70 per share and an expiration date of two  years from the

closing. In connection with this placement we had no offering costs for a net of $5,217.

On December 3, 2012, we closed two private placements for a total of $279,000, or 121,500 units

consisting of one share of our restricted common stock and one-half common stock warrant to purchase

shares of our common stock, with a purchase price of $2.70 per share and an expiration date of two years

from the closing. In connection with this placement we had no offering costs for a net of $279,000.

On December 8, 2012, we closed a private placement for a total of $50,600, or 22,000 units consisting of

one share of our restricted common stock and one-half common stock warrant to purchase shares of our

common stock, with a purchase price of $2.70 per share and an expiration date of two  years from the

closing. In connection with this placement we had no offering costs for a net of $50,600.

On December 18, 2012, we closed two private placements for a total of $161,000, or 70,000 units

consisting of one share of our restricted common stock and one-half common stock warrant to purchase

shares of our common stock, with a purchase price of $2.70 per share and an expiration date of two years

from the closing. In connection with this placement we had no offering costs for a net of $161,000.

On December 19, 2012, we closed a private placement for $103,500, or 45,000 units consisting of one

share of our restricted common stock and one-half common stock warrant to purchase shares of our

common stock, with a purchase price of $2.70 per share and an expiration date of two  years from the

closing. In connection with this placement we had no offering costs for a net of $103,500.

On December 20, 2012, we closed a private placement for $176,000, or 76,522 units consisting of one

share of our restricted common stock and one-half common stock warrant to purchase shares of our

common stock, with a purchase price of $2.70 per share and an expiration date of two  years from the

closing. In connection with this placement we had no offering costs for a net of $176,500.

On December 30, 2012, we closed a private placement for $230,000, or 100,000 units consisting of one

share of our restricted common stock and one-half common stock warrant to purchase shares of our

common stock, with a purchase price of $2.70 per share and an expiration date of two  years from the

closing. In connection with this placement we had no offering costs for a net of $230,000.

F-37



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 9 – STOCKHOLDERS' EQUITY – CONTINUED

Common Stock Issuances - continued

Private placements - continued

On March 18, 2013, we closed a private placement for $101,200, or 44,000 units consisting of one share

of our restricted common stock and one-half common stock warrant to purchase shares of our common

stock, with a purchase price of $2.70 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $101,200.

On April 1, 2013, we issued 15,000 shares of our common stock for $1.50 per share, to a warrant holder

exercising previously issued warrants for a total of $22,500.

On April 10, 2013, we closed a private placement for $23,000 or 10,000 units consisting of one share of

our restricted common stock and one-half common stock warrant to purchase shares of our common

stock, with a purchase price of $2.70 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $23,000.

On April 18, 2013, we issued 50,000 shares of our common stock for $1.50 per share, to a warrant holder

exercising previously issued warrants for a total of $75,000.

On April 22, 2013, we closed a private placement for $101,400 or 39,000 units consisting of one share of

our restricted common stock and one-half common stock warrant to purchase shares of our common

stock, with a purchase price of $3.00 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $101,400.

On April 23, 2013, we closed a private placement for $202,800 or 78,000 units consisting of one share of

our restricted common stock and one-half common stock warrant to purchase shares of our common

stock, with a purchase price of $3.00 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $202,800.

On April 29, 2013, we closed a private placement for $202,800 or 78,000 units consisting of one share of

our restricted common stock and one-half common stock warrant to purchase shares of our common

stock, with a purchase price of $3.00 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $202,800.

On April 30, 2013, we closed a private placement for $35,100 or 13,500 units consisting of one share of

our restricted common stock and one-half common stock warrant to purchase shares of our common

stock, with a purchase price of $3.00 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $35,100.

On May 7, 2013, we issued 7,500 shares of our common stock for $1.50 per share, to a warrant holder

exercising previously issued warrants for a total of $11,250.

F-38



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 9 – STOCKHOLDERS' EQUITY – CONTINUED

Common Stock Issuances - continued

Private placements - continued

On May 9, 2013, we closed a private placement for $31,200 or 12,000 units consisting of one share of our

restricted common stock and one-half common stock warrant to purchase shares of our common stock,

with a purchase price of $3.00 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $31,200.

On May 17, 2013, we issued 32,733 shares of our common stock for $1.50 per share, to a warrant holder

exercising previously issued warrants for a total of $49,099.

On May 21, 2013, we issued 82,500 shares of our common stock for $1.50 per share, to a warrant holder

exercising previously issued warrants for a total of $123,750.

On May 21, 2013, we closed a private placement for $10,140 or 3,900 units consisting of one share of our

restricted common stock and one-half common stock warrant to purchase shares of our common stock,

with a purchase price of $3.00 per share and an expiration date of two years from the closing. In

connection with this placement we had no offering costs for a net of $10,140.

On May 29, 2013, we issued 82,500 shares of our common stock for $1.50 per share, to a warrant holder

exercising previously issued warrants for a total of $123,750.

Conversion of debt to shares

On June 10, 2011, we closed a private placement for $10,000, or 10,000 units consisting of one share of

our restricted common stock and one-half share common stock warrant to purchase shares of our common

stock, with a purchase price of $1.50 per share and an expiration date of two years from the closing. In

connection with this placement we incurred stock expense on conversion of $5,500.

On February 20, 2012, we converted several debt obligations for $418,793, or 406,595 units consisting of

one share of our restricted common stock and one common stock warrant to purchase shares of our

common stock, with a purchase price of $1.25 per share and an expiration date of two  years from the

closing. In connection with this placement we incurred stock expense on conversion of $12,198.

On February 20, 2012, we also converted accounts payable for $15,450, or 15,000 shares of our restricted

common stock. In connection with this placement we incurred stock expense on conversion of $450.

On March 16, 2012, we converted several debt obligations for $294,300, or 218,000 units consisting of

one share of our restricted common stock and one common stock warrant to purchase shares of our

common stock, with a purchase price of $2.00 per share and an expiration date of two  years from the

closing. In connection with this placement we incurred stock expense on conversion of $76,300.

F-39



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 9 – STOCKHOLDERS' EQUITY – CONTINUED

Common Stock Issuances - continued

Conversion of debt to shares - continued

On April 20, 2012, we converted several debt obligations for $71,719, or 26,562 units consisting of one

share of our restricted common stock and one-half common stock warrant to purchase shares of our

common stock, with a purchase price of $2.00 per share and an expiration date of two  years from the

closing. In connection with this placement we incurred stock expense on conversion of $29,219.

On April 24, 2012, we converted several debt obligations for $13,650, or 5,000 units consisting of one

share of our restricted common stock and one-half common stock warrant to purchase shares of our

common stock, with a purchase price of $2.00 per share and an expiration date of two  years from the

closing. In connection with this placement we incurred stock expense on conversion of $5,650.

On May 30, 2012, we converted several debt obligations for $88,000, or 40,000 units consisting of one

share of our restricted common stock and one-half common stock warrant to purchase shares of our

common stock, with a purchase price of $2.00 per share and an expiration date of two  years from the

closing. In connection with this placement we incurred stock expense on conversion of $24,000.

On November 30, 2012, we converted several debt obligations for $168,033, or 73,058 units consisting of

one share of our restricted common stock and one-half common stock warrant to purchase shares of our

common stock, with a purchase price of $2.70 per share and an expiration date of two  years from the

closing. In connection with this placement we incurred stock expense on conversion of $29,223.

On November 30, 2012, we converted several accounts payables for $46,000, or 20,000 units consisting

of one share of our restricted common stock and one-half common stock warrant to purchase shares of

our common stock, with a purchase price of $2.70 per share and an expiration date of two years from the

closing. In connection with this placement we incurred stock expense on conversion of $8,000.

On November 30, 2012, we converted several accounts payable for $30,000, or 13,043 units consisting of

one share of our restricted common stock and one-half common stock warrant to purchase shares of our

common stock, with a purchase price of $2.70 per share and an expiration date of two  years from the

closing. In connection with this placement we incurred stock expense on conversion of $5,217.

On February 21, 2013, we converted accounts payables due to related party for $54,000, or 20,000 units

consisting of one share of our restricted common stock. In connection with this placement we did not

incurred any stock expense.

On March 18, 2013, we converted several debt obligations for $660,100, or 287,000 units consisting of

one share of our restricted common stock and one-half common stock warrant to purchase shares of our

common stock, with a purchase price of $2.70 per share and an expiration date of two  years from the

closing. In connection with this placement we incurred stock expense on conversion of $93,300.

F-40



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 9 – STOCKHOLDERS' EQUITY – CONTINUED

Common Stock Issuances - continued

Conversion of debt to shares - continued

On March 25, 2013, we converted several accounts payables for $38,000, or 16,522 units consisting of

one share of our restricted common stock and one-half common stock warrant to purchase shares of our

common stock, with a purchase price of $2.70 per share and an expiration date of two  years from the

closing. In connection with this placement we incurred stock expense on conversion of $5,783.

On April 13, 2013, we converted one of our convertible debentures for $500,000 to 500,000 shares of our

restricted common stock with a conversion price of $1.00 per share.  As part of the original convertible

debenture agreement, the holder received one-half common stock warrant to purchase shares of our

common stock upon conversion, with a purchase price of $1.25 per share and an expiration date of two

years from the closing.

On April 15, 2013, we converted several debt obligations for $310,500, or 135,000 units consisting of one

share of our restricted common stock and one-half common stock warrant to purchase shares of our

common stock, with a purchase price of $2.70 per share and an expiration date of two  years from the

closing. In connection with this placement we incurred stock expense on conversion of $47,250.

On May 7, 2013, we converted a note payable for $26,000, or 10,000 units consisting of one share of our

restricted common stock and one-half common stock warrant to purchase shares of our common stock,

with a purchase price of $3.00 per share and an expiration date of two years from the closing. In

connection with this placement we incurred stock expense on conversion of $6,800.

On May 15, 2013, we converted a note payable for $26,000, or 10,000 units consisting of one share of our

restricted common stock and one-half common stock warrant to purchase shares of our common stock,

with a purchase price of $3.00 per share and an expiration date of two years from the closing. In

connection with this placement we incurred stock expense on conversion of $6,000.

On May 31, 2013, we converted several debt obligations for $70,002, or 26,924 units consisting of one

share of our restricted common stock and one-half common stock warrant to purchase shares of our

common stock, with a purchase price of $3.00 per share and an expiration date of two  years from the

closing. In connection with this placement we incurred stock expense on conversion of $16,547.

Share based compensation

For the years ended May 31, 2013 and 2012, we issued the following shares for compensation:

On June 29, 2011, we issued 50,000 shares of our common stock for services performed valued at

$76,000.

On December 2, 2011, we issued 20,000 shares of our common stock for services performed valued at

$23,600.

F-41



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 9 – STOCKHOLDERS' EQUITY – CONTINUED

Common Stock Issuances - continued

Share based compensation - continued

On February 20, 2012, we issued 20,000 shares of our common stock for services performed valued at

$20,600.

On March 20, 2012, we issued 27,500 shares of our common stock for services performed valued at

$39,050.

On June 1, 2012, we issued 12,500 shares of our common stock for services performed valued at $32,625.

On August 20, 2012, we issued 12,500 shares of our common stock for services performed valued at

$23,125.

On July 1, 2012, we issued 12,500 shares of our common stock for services performed valued at $25,000.

On July 9, 2012, we issued 10,000 shares of our common stock for services performed valued at $20,000.

On August 7, 2012, we issued 10,000 shares of our common stock for services performed valued at

$19,000.

On September 18, 2012, we issued 25,000 shares of our common stock for services performed valued at

$42,750.

On November 29, 2012, we issued 20,000 shares of our common stock for services performed valued at

$55,000, including costs of $21,000.

On January 8, 2013, we issued 21,429 shares of our common stock for services performed valued at

$60,000.

On February 21, 2013, we issued 10,000 shares of our common stock for future services to be performed

valued at $27,000.

On March 18, 2013, we issued 15,000 shares of our common stock for future services performed valued

at $42,000.

On March 18, 2013, we issued 100 shares of our common stock for a raffle prize valued at $270.

On March 18, 2013, we issued 33,622 shares of our common stock for future services to be performed

valued at $85,200.

On April 2, 2013, we issued 23,600 shares of our common stock for future services performed valued at

$63,720.

F-42



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 9 – STOCKHOLDERS' EQUITY – CONTINUED

Share returned and cancelled

On May 8, 2013, we received back to the Treasury 31,000 shares of our common stock that were issued

for consulting services and the services were never performed valued at $35,030. Subsequently these

shares were cancelled.

On May 8, 2013, we received back to the Treasury 20,000 shares of our common stock that were issued

for consulting services and the services were never performed valued at $23,600. Subsequently these

shares were cancelled.

Common Stock Warrants

In connection with the above private placement we valued the common stock warrants granted during

the year ended May 31, 2013, using the Black-Scholes model with the following assumptions:

July 30,

September

October

November

November

December 3,

2012

28, 2012

18, 2012

26, 2012

30, 2012

2012

Expected volatility

102.68%

89.29%

89.62%

81.57%

81.63%

81.48%

(based on historical

volatility)

Expected dividends

0.00

0.00

0.00

0.00

0.00

0.00

Expected term in years

2.00

2.00

2.00

2.00

2.00

2.00

Risk-free rate

0.23%

0.23%

0.29%

0.27%

0.25%

0.25%

December

December

February

March

April 4,

May 5,8,

7, 8, 18, 19,

30, 2012

18, 2013

18,22,25,

7, 10, 23,

9, 10,

and 20,

2013

29, 2013

15, 31,

2012

2013

Expected volatility

81.34%

81.46%

80.17%

79.48% -

79.45% -

73.16 -

(based on historical

79.53%

79.63%

79.45%

volatility)

Expected dividends

0.00

0.00

0.00

0.00

0.00

0.00

Expected term in years

2.00

2.00

2.00

2.00

2.00

2.00

Risk-free rate

0.25 –

0.25%

0.24%

0.24-

0.20 –

0.20% -

.28%

.26%

0.24%

0.30%

The expected volatility assumption was based upon historical stock price volatility measured on a daily

basis. The risk-free interest rate assumption is based upon U.S. Treasury bond interest rates appropriate

for the term of the Company’s warrants. The dividend yield assumption is based on our history and

expectation of dividend payments. All warrants are immediately exercisable upon granting.

F-43



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 9 – STOCKHOLDERS' EQUITY – CONTINUED

Common Stock Warrants - continued

A summary of the common stock warrants granted during the years ended May 31, 2013 and May 31,

2012 are presented below:

Weighted

Weighted

Average

Average

Remaining

Number of

Exercise

Contractual

Warrants

Price

Terms (In Years)

Balance at June 1, 2011

2,670,233

$

0.85

Granted

1,696,063

1.67

Exercised

-

-

Forfeited or expired

(2,300,000)

0.75

Balance at May 31, 2012

2,066,296

$

1.64

2.00 years

Exercisable at May 31, 2012

2,066,296

$

1.64

2.00 years

Weighted average fair value of

warrants granted during the year

ended May 31, 2012

$

1.64

Balance at June 1, 2012

2,066,296

$

1.64

Granted

1,186,934

2.35

Exercised

(270,233)

1.50

Forfeited or expired

(140,005)

1.50

Balance at May 31, 2013

2,842,992

$

1.80

2.00 years

Exercisable at May 31, 2013

2,842,992

$

1.80

2.00 years

Weighted average fair value of

warrants granted during the year ended

May 31, 2013

$

2.35

F-44



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 9 – STOCKHOLDERS' EQUITY – CONTINUED

Common Stock Warrants - continued

The following table summarizes information about the warrants outstanding at May 31, 2013:

Warrants Exercisable

Weighted

Weighted

Range of

Number

Weighted Average

Average

Number

Average

Exercise

Outstanding at

Remaining

Exercise

Exercisable at

Exercise

Price

May31, 2013

Contractual Life

Price

May 31, 2013

Price

$

1.25

1,306,595

2.00 Years

$

1.25

$

1,306,595     $

1.25

$

1.50

250,000

2.00 Years

$

1.50

$

250,000     $

1.50

$

2.00

574,463

2.00 Years

$

2.00

$

574,463     $

2.00

$

2.70

576,272

2.00 Years

$

2.70

$

576,272     $

2.70

$

3.00

135,662

2.00 Years

$

3.00

$

135,662     $

3.00

2,842,992

2.00 Years

$

1.80

$

2,842,992     $

1.80

F-45



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 10 – EARNINGS-PER-SHARE CALCULATION

Basic earnings per common share for the years ended May 31, 2013 and 2012 are calculated by dividing

net income by weighted-average common shares outstanding during the period. Diluted earnings per

common share for the years ended May 31, 2013 and 2012 are calculated by dividing net income by

weighted-average common shares outstanding during the period plus dilutive potential common shares,

which are determined as follows:

For the year ended

For the year ended

May 31, 2013

May 31, 2012

Net earnings from operations

$

(7,223,423)

$

(1,119,249)

Weighted-average common shares

62,443,108

59,752,413

Effect of dilutive securities:

Warrants

-

-

Options to purchase common stock

-

-

Dilutive potential common shares

62,443,108

59,752,413

Net earnings per share from operations:

Basic

$

(0.12)

$

(0.02)

Diluted

$

(0.12)

$

(0.02)

Dilutive potential common shares are calculated in accordance with the treasury stock method, which

assumes that proceeds from the exercise of all warrants and options are used to repurchase common stock

at market value. The amount of shares remaining after the proceeds are exhausted represents the

potentially dilutive effect of the securities. The increasing number of warrants used in the calculation is a

result of the increasing market value of the Company’s common stock.

In periods where losses are reported the weighted-average number of common shares outstanding

excludes common stock equivalents because their inclusion would be anti-dilutive.

These securities below were excluded from the calculations above because to include them would be anti-

dilutive:

For the year ended May

For the year ended May 31,

31, 2013

2012

Common Stock Equivalents:

Warrants

2,842,992

2,066,296

Options to purchase common stock

3,800,000

5,160,000

Total of Common Stock Equivalents:

6,642,992

7,226,296

F-46



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 11 – RELATED PARTY TRANSACTIONS

Due to the common control between the Company and its related parties, the Company is exposed to the

potential that ownership risks and rewards could be transferred among the parties.

In addition to related party transactions mentioned elsewhere, we have the below agreements and

transactions:

Board of Advisors

On June 1, 2012, we appointed a new member to our Board of Advisors and granted him 100,000 stock

options for his service. The stock options have an exercise price of $2.30 per share of common stock, and

expire ten years from the date of grant. These options vest in equal one-third parts beginning on June 1,

2013, and every grant date anniversary for the next two years. The term of the Board of Advisors

Agreement will be in force until June 1, 2013, and shall renew automatically on an annual basis unless

terminated in writing. We also agreed to reimburse the advisor for all reasonable business expenses.

On June 20, 2012, we appointed a new member to our Board of Advisors and agreed to pay him $5,000

per month for his services beginning July 1, 2012. We also granted him 50,000 stock options for his

service. The stock options have an exercise price of $2.05 per share of common stock, and expire ten

years from the date of grant. These options vest in equal one-third parts beginning on June 20, 2013, and

every grant date anniversary for the next two years. The term of the Board of Advisors Agreement will be

in force until May 31, 2013, and shall renew automatically on an annual basis unless terminated in

writing.  This agreement has subsequently been terminated.

On August 1, 2012, we appointed a new member to our Board of Advisors and agreed to pay him $3,000

per month for his services beginning August 1, 2012. We also granted him 75,000 stock options for his

service. The stock options have an exercise price of $1.95 per share of common stock, and expire ten

years from the date of grant. These options vest in equal one-third parts beginning on August 1, 2013, and

every grant date anniversary for the next two years. The term of the Board of Advisors Agreement will be

in force until August 1, 2013, and shall renew automatically on an annual basis unless terminated in

writing. We also agreed to reimburse the advisor for all reasonable business expenses.

On February 21, 2013, we appointed a new member to our Board of Advisors and agreed to pay up to

$5,000 and 10,000 restricted shares for services rendered through April 30, 2013.    Thereafter we agreed

to pay him $3,000 per month for his services through February 28, 2015.  We also granted him 15,000

stock options for his services.  The stock options have an exercise price of $2.70 per share of common

stock, and expire ten years from the date of grant. These options vest in equal one-third parts beginning

on March 1, 2013, and every year for the next two years. The term of the Board of Advisors Agreement

will be in force until February 28, 2015.  We also agreed to reimburse the advisor for all reasonable

business expenses. As of May 31, 2013, we owed this advisor $3,000.

F-47



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 11 – RELATED PARTY TRANSACTIONS – CONTINUED

Board of Advisors-continued

On March 22, 2013, we appointed a new member to our Board of Advisors and agreed to grant him

100,000 stock options for his services.  The stock options have an exercise price of $2.80 per share of

common stock, and expire ten years from the date of grant. These options vest in equal one-third parts

beginning on December 10, 2013, and every year for the next two years. The term of the Board of

Advisors Agreement will be in force until March 22, 2015.  We also agreed to reimburse the advisor for

all reasonable business expenses. As of May 31, 2013, we owed this advisor $20,250.

Board of Directors

On June 15, 2012, we appointed a new member to our Board of Directors. We agreed to pay him $15,000

per annum, payable in four equal payments. We also agreed to issue him 10,000 restricted shares of our

common stock and granted him 150,000 stock options for his service. The stock options have an exercise

price of $2.30 per share of common stock, and expire ten years from the date of grant. These options vest

in equal one-third parts beginning on September 15, 2012, and every September 15 after that. We also

agreed to pay for continuing education classes and related travel expenses, for a maximum of $4,500.

This agreement will be in force until May 31, 2015, unless terminated with a sixty day notice. We also

agreed to reimburse the new director for all reasonable business expenses. The director resigned on

December 5, 2012 and accepted the chief financial officer position of the Company.

On August 7, 2012, we appointed a new member to our Board of Directors. We agreed to issue him

10,000 restricted shares of our common stock and granted him 150,000 stock options for his service. The

stock options have an exercise price of $1.90 per share of common stock, and expire ten years from the

date of grant. These options vest in equal one-third parts beginning on August 7, 2013 and every August 7

after that. This agreement will be in force until August 7, 2015, unless terminated with a sixty day notice.

We also agreed to reimburse the new director for all reasonable business expenses. As of May 31, 2013,

we owed this advisor $3,000.

On December 5, 2012, we appointed a new member to our Board of Directors. We agreed to grant him

175,000 stock options for his service. The stock options have an exercise price of $2.61 per share of

common stock, and expire ten years from the date of grant. These options vest as follows; 25,000 upon

the date of this agreement and then in equal parts of 50,000 options beginning on December 5, 2013 and

every December 5 after that. This agreement will be in force until December 5, 2015, unless terminated

with a sixty day notice. We also agreed to reimburse the new member of the Board for all reasonable

business expenses.

On February 1, 2013, the Board of Directors approved the proposal of the Compensation Committee that

all independent members of the Board of Directors and all members of the respective Compensation,

Governance and Nominating Committee be compensated for attending Board or Committee meetings in

the amount of $750.  It was also agreed that the Company shall compensate the director which is the Head

of the Compensation, Compliance and Nominating Committees $5,000 per annum and issue 20,000

restricted shares which were issued on February 21, 2013.

F-48



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 11 – RELATED PARTY TRANSACTIONS – CONTINUED

Employment agreement

On December 5, 2012, we entered into an employment agreement commencing December 10, 2012

with a related individual to perform duties as our Chief Financial Officer.  The individual was a prior

director and resigned the effective date of this agreement.  The employee retained previously issued

stock options. The terms of the employment agreement are $16,000 per month salary of which a portion

is deferred. The employment agreement will end on December 31, 2015 at which time it can be renewed

for 2 one year periods.  In the event that this agreement is terminated, the employee may be eligible for

severance pay based upon the length of employment. The employee was granted 125,000 stock options

with an exercise price of $2.61 per share; they will vest equally over 3 years beginning December 9,

2013. The employee was also given a retention award to be paid $20,000 in common shares the month

following the anniversary date of his employment. For the year ended May 31, 2013 we expensed

$19,000 in connection with these contracts and are included in professional fees – related party, and

$86,308 in Payroll and benefits expense. As of May 31, 2013 we owed $11,064 included in accounts

payable - related party.

Consulting Agreements

On December 1, 2009 we entered into an agreement with a related individual to provide bookkeeping

services. The terms of the consulting agreement are $2,500 per month payable in consulting fees and

reimbursement to the consultant for all reasonable business expenses incurred by her in the performance

of her duties, and was in effect until December 1, 2010. The consultant was also granted 100,000 stock

options with an exercise price of $0.60 per share; they will vest equally over 2 years and the first third

was vested upon signing. On April 1, 2010, we entered into an amended agreement with the same

related individual to provide bookkeeping services. The terms of the amended consulting

agreement are $5,000 per month payable in consulting fees and reimbursement for all reasonable

business expenses incurred in the performance of her duties effective until April 1, 2011. The agreement

also had a provision to automatically renew for subsequent annual terms unless terminated in writing by

either party. For the years ended May 31, 2013 and 2012, we expensed $60,000 and $60,000,

respectively, in connection with these contracts and are included in professional fees – related party. As

of May 31, 2013 and 2012, we owed $5,000 and $4,751, respectively, included in accounts payable -

related party.

F-49



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 11 – RELATED PARTY TRANSACTIONS – CONTINUED

Consulting Agreements - continued

On April 26, 2010, we entered into an employment agreement with a related individual to perform the

duties of Vice President – Pipeline Coating Sales. The terms of the employment agreement were $6,000

per month payable in consulting fees, with increases payable with the attaining of certain milestones of

performance, and reimbursement to the employee for all reasonable business expenses incurred by him

in the performance of his duties, and which was in effect until March 31, 2013. The employee was also

granted 400,000 stock options with an exercise price of $0.60 per share; they will vest equally over 3

years, beginning April 26, 2011 and continuing on the anniversary date of signing (see Note 12). For the

year ended May 31, 2013 and 2012, we expensed none and $90,000, respectively, in connection with

this contract and are included in payroll and benefits expense.  On March 23, 2012, his employment agreement was terminated.

As of May 31, 2013 and 2012, we have recorded an accrued liability of $107,400 and $85,633,

respectively.

On August 20, 2010, we entered into a consulting agreement commencing August 1, 2010 with a related

individual to perform duties as our Chief Financial Officer. On May 11, 2011, this individual resigned

his position as Chief Financial Officer. Effective May 10, 2011, this agreement was amended to change

the consultant’s role from Chief Financial Officer to general consultant, and all other provisions remain

the same.  The terms of the consulting agreement are $8,000 per month payable in consulting fees and

reimbursement to the consultant for all reasonable business expenses incurred by him in the

performance of his duties, and which was in effect until July 31, 2012. The consultant was also granted

200,000 stock options with an exercise price of $0.65 per share; they will vest equally over 3 years (see

Note 12). For the years ended May 31, 2013 and 2012, we expensed $96,000 and $96,000, respectively,

in connection with this contract and are included in consulting – related party. As of May 31, 2013 and

2012, we owed $63,310 and $7,292, respectively, and is included in accounts payable - related party.

On May 1, 2011, we entered into a consulting agreement with a related individual to perform the duties

of Vice President – Business Development and a Director of the Company. The terms of the consulting

agreement are $5,000 per month payable in consulting fees, and reimbursement to the consultant for all

reasonable business expenses incurred by him in the performance of his duties, and which was in effect

until April 30, 2013, and was not renewed. For the years ended May 31, 2013 and 2012, we expensed

$55,000 and $60,000, respectively, in connection with this contract and are included in consulting –

related party. As of May 31, 2013 and 2012, we have recorded a liability of $107,400 and $56,243,

respectively and is included in accounts payable - related party.

F-50



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 11 – RELATED PARTY TRANSACTIONS – CONTINUED

Consulting Agreements - continued

On June 1, 2010, we entered into a consulting agreement with a company controlled by the spouse of

our Chief Executive Officer. The terms of the consulting agreement are $2,500 per month payable in

consulting fees and reimbursement to the consultant for all reasonable business expenses incurred by it

in the performance of its duties, and rental of office space for $1,200 per month, and will be in effect

until June 1, 2011. On December 1, 2010, we entered into a revised consulting agreement to supersede

the above agreement, with the same company as above. The terms of the consulting agreement are

$2,500 per month payable in consulting fees and reimbursement to the consultant for all reasonable

business expenses incurred by it in the performance of its duties, and rental of office space for $2,213

per month, and will be in effect until December 1, 2011 and continues in force. For the years ended May

31, 2013 and 2012, we expensed $30,000 and $30,000, respectively, in connection with this contract

and are included in consulting – related party. As of May 31, 2013 and 2012, we owed $5,623 and none,

respectively, and is included in accounts payable - related party.

On May 5, 2011, we entered into an employment agreement commencing May 1, 2011 with a related

individual to perform duties as our Chief Financial Officer. The terms of the employment agreement are

$10,000 per month salary, a car reimbursement of $500 per month and reimbursement to the employee

for all reasonable business expenses incurred by him in the performance of his duties, and will be in

effect until April 30, 2013. The employee was also granted 400,000 stock options with an exercise price

of $1.00 per share; they will vest equally over 3 years (see Note 12). The employee was also granted a

stock signing bonus of 60,000 shares of our common stock (Note 9) valued at $49,200 and is reflected

in consulting- related party. For the years ended May 31, 2013 and 2012, we expensed none and

$56,262, in connection with this contract and is included in payroll and benefits expense. As of May 31,

2013 and 2012 we owed $0 to this employee. On October 24, 2011, this individual resigned his position

as Chief Financial Officer, this agreement was discontinued, and he forfeited the 400,000 stock options

granted to him and received in settlement 100,000 vested stock options as part of this agreement.

On June 1, 2011, we entered into a consulting agreement commencing June 1, 2011, with a related

individual to provide services as our Chief Executive Officer. The terms of the consulting agreement are

the consultant will be paid $10,000 per month. We also agreed to reimburse the consultant for all

reasonable business expenses incurred by him in the performance of his duties, and will be in effect

until June 1, 2012. For the year ended May 31, 2013 and 2012, we expensed $120,000 and $120,000,

respectively, in connection with this contract, which amount is included in consulting – related party. As

of May 31, 2013 and 2012, we owed $53,673 and $12,487, respectively, which amount is included in

accounts payable - related party.

Note receivable – Related Party

On April 29, 2010, we entered in to a non-collateralized note receivable with a related company to ours

with some common ownership on an interest free basis, payable on demand. On July 15, 2010, we were

repaid $4,000 cash on this note and as of May 31, 2013 and 2012 we are owed a balance remaining of

$4,500.

F-51



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 11 – RELATED PARTY TRANSACTIONS – CONTINUED

Notes Payable – Related Party

For the year ended May 31, 2012, we entered into two uncollateralized demand notes to a Company

controlled by our Chief Executive Officer’s spouse, Prosper Financial, bearing 8% interest per annum

for an aggregate total of $9,000. On May 31, 2012, we repaid the principal amount of $9,000 plus

accrued interest of $499. As of May 31, 2012 we owed no balance.

On February 2, 2012, we entered into an uncollateralized demand note to a related individual, bearing

8% interest per annum for an aggregate total of $10,500. We also owed $63 in accrued interest for the

above note as of February 29, 2012. On March 16, this debt and accrued interest was converted into

share of our common stock as discussed in Note 9, and has a zero balance.

For the year ended May 31, 2013, we entered into two uncollateralized demand notes to a Company

controlled by our Chief Executive Officer’s spouse, Prosper Financial, bearing 8% interest per annum

for an aggregate total of $66,200. On August 31, 2012, we applied $6,200 of principal in addition to

$59.24 of accrued interest to advances owed to us by the same company. On September 25, 2012, we

also made a cash principal payment of $30,000. As of May 31, 2013 we owed $30,000, and $1,987 of

accrued interest.

License agreement – Related Party

The Company has a license agreement with Powdermet, Inc., a related party, which grants the

Company an exclusive license to the use of technical information, proprietary know-how, data and patent

rights assigned to and/or owned by Powdermet, Inc. The agreement will end upon the last to expire valid

claim of licensed patents, unless terminated within the terms of the agreement.

As part of the agreement, the Company has a commitment to purchase consumable powders from

Powdermet, Inc. through July 1, 2014. Also, as part of the agreement the Company will receive

technology transition and development service to support its research and development activities on a cost

reimbursement basis. Total expense related to the cost reimbursement was $369,184 and $275,365 for the

years ended May 31, 2013 and 2012, respectively.

F-52



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 12 – STOCK – BASED COMPENSATION

2009 Stock Option Plan – The Company

Our board of directors adopted and approved our 2009 Stock option Plan (“Plan”) on December 14, 2009,

which provides for the granting and issuance of up to 10 million shares of our common stock.

On August 15, 2011, we granted 25,000 stock options to a consultant at an exercise price of $1.25 per

share, and these options will expire ten years from the grant date, and will vest in equal one third parts on

the anniversary of the option grant date.

On October 24, 2011, we granted 100,000 stock options to our former Chief Financial Officer in

connection with his Separation Agreement at an exercise price of $1.20 per share, and these options will

expire five years from the grant date, and will vest immediately.

On January 2, 2012, we granted 100,000 stock options to a consultant at an exercise price of $1.00 per

share, and these options will expire ten years from the grant date, and will vest in equal one third parts on

the anniversary of the option grant date.

On January 5, 2012, we granted 150,000 stock options to a consultant at an exercise price of $1.00 per

share, and these options will expire ten years from the grant date, and will vest in equal one third parts on

the anniversary of the option grant date.

On February 1, 2012, we granted 70,000 stock options to a consultant at an exercise price of $1.07 per

share, and these options will expire ten years from the grant date, and will vest in equal one half parts on

the six month anniversary of the option grant date, and another one half part on the twelve month

anniversary of the option grant date.

On February 6, 2012, we granted 25,000 stock options to a consultant at an exercise price of $1.07 per

share, and these options will expire ten years from the grant date, and will vest in equal one half parts on

the date of grant, and another one half part on the six month anniversary of the option grant date.

On February 15, 2012, we granted 50,000 stock options to a consultant at an exercise price of $1.03 per

share, and these options will expire four years from the grant date, and will vest in equal one third parts

on the anniversary of the option grant date.

During the year ended May 31, 2012, we had 780,000 options that were expired or forfeited for

termination and resignation from service. After these grants there will be 4,840,000 available for future

grant.

F-53



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 12 – STOCK – BASED COMPENSATION - CONTINUED

2009 Stock Option Plan – The Company - continued

For the year ended May 31, 2013, the Company granted the following stock options:

For the year ended May 31, 2013

Options

Exercise

Expiration

To Whom

Grant Date

Granted

Price

term in  years

Granted

Vesting Terms

June 12,

Granted to a

Will vest in equal one third parts on the

2012

100,000

$

2.30

10.00

consultant

anniversary date of the option grant date

Will vest in one third on grant date and

June 12,

Granted to a

remaining equally over two years on

2012

75,000

$

2.30

10.00

employee

anniversary of the option grant date

Will vest in equal one third parts

beginning on September 15, 2012 and

June 15,

Granted to a new

then every September 15th for the next

2012

150,000

$

2.30

10.00

Director

two years

June 20,

Granted to a

Will vest in equal one third parts on the

2012

50,000

$

2.05

10.00

consultant

anniversary date of the option grant date

July 27,

Granted to a

Will vest in equal one third parts on the

2012

75,000

$

1.95

10.00

consultant

anniversary date of the option grant date

August 7,

Granted to a new

Will vest in equal one third parts on the

2012

150,000

$

1.90

10.00

Director

anniversary date of the option grant date

Will vest 25,000 options on Grant date,

remaining 150,000 options in equal one

December

Granted to a new

third parts on the anniversary date of the

5, 2012

175,000

$

2.61

10.00

Director

option grant date

Granted to our

December

new Chief

Will vest in equal one third parts on the

5, 2012

125,000

$

2.61

10.00

Financial Officer

anniversary date of the option grant date

February 1,

Granted to a

Will vest in equal one half parts on

2013

70,000

$

2.70

10.00

consultant

January 31, 2014 and 2015

February

Granted to a

Will vest in equal one third parts

21, 2013

15,000

$

2.70

10.00

consultant

beginning on March 1, 2013

December

Granted to a

Will vest in equal one third parts

17, 2012

50,000

$

2.80

10.00

employee

beginning on December 17, 2013

March 22,

Granted to  a

Will vest in equal one third parts

2013

100,000

2.80

10.00

consultant

beginning on December 10, 2013

Total

Granted

1,135,000

On December 4, 2012, we rescinded 1,500,000 stock options by mutual agreement between the Company

and the respective holders. From June 1, 2012 to May 31, 2013, 945,000 stock options expired without

exercise according to the option agreement.

F-54



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 12 – STOCK – BASED COMPENSATION - CONTINUED

2009 Stock Option Plan – The Company - continued

After these grants and expirations there are 6,200,000 stock options available for future grant.

Our board of directors administers our Plan, however, they may delegate this authority to a committee

formed to perform the administration function of the Plan. The board of directors or a committee of the

board has the authority to construe and interpret provisions of the Plan as well as to determine the terms

of an award.  Our board of directors may amend or modify the Plan at any time.  However, no

amendment or modification shall adversely affect the rights and obligations with respect to outstanding

awards unless the holder consents to that amendment or modification.

The Plan permits us to grant Non-Statutory stock options to our employees, directors and consultants.

The options issued under this Plan are intended to be Non-Statutory Stock Options exempt from Code

Section 409A.

The duration of a stock option granted under our Plan cannot exceed ten years.  The exercise price of an

incentive stock option cannot be less than 100% of the fair market value of the common stock on the

date of grant.

The Plan administrator determines the term of stock options granted under our Plan, up to a maximum

of ten years, except in the case of certain events, as described below.  Unless the terms of an optionee's

stock option agreement provide otherwise, if an optionee's relationship with us ceases for any reason

other than disability or death, the optionee may exercise any vested options for a period of ninety days

following the cessation of service.  If an optionee's service relationship with us ceases due to disability

or death the optionee or a beneficiary may exercise any vested options for a period of 12 months in the

event of disability or death.

Unless the Plan administrator provides otherwise, options generally are not transferable except by will,

the laws of descent and distribution, or pursuant to a domestic relations order.  An optionee may

designate a beneficiary, however, who may exercise the option following the optionee's death.

The value of employee and non-employee stock options granted during the year ended May 31, 2013

was estimated using the Black-Scholes model with the following assumptions:

June 12, 2012

June 15, 2012

June 20, 2012

July 27, 2012

August 7,

2012

Expected volatility (based on

154.39%

154.39%

154.39%

154.39%

154.39%

historical volatility)

Expected dividends

0.00

0.00

0.00

0.00

0.00

Expected term in years

10

10

10

10

10

Risk-free rate

1.67%

1.60%

1.65%

1.58%

1.66%

F-55



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 12 – STOCK – BASED COMPENSATION - CONTINUED

2009 Stock Option Plan – The Company - continued

December 5,

February 1,

February 21,

December 17,

March 22,

2012

2012

2012

2012

2013

Expected volatility (based on

147.16%

147.16%

147.16%

142.93%

142.93%

historical volatility)

Expected dividends

0.00

0.00

0.00

0.00

0.00

Expected term in  years

10

10

10

10

10

Risk-free rate

1.60%

2.04%

1.99%

1.78%

1.93%

The expected volatility assumption was based upon historical stock price volatility measured on a daily

basis. The risk-free interest rate assumption is based upon U.S. Treasury bond interest rates appropriate

for the term of the Company’s employee stock options. The dividend yield assumption is based on our

history and expectation of dividend payments.

A summary of the options granted to employees and non-employees under the plan and changes during

the years ended May 31, 2013 and 2012 is presented below:

Weighted

Average

Weighted

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Terms

Intrinsic

Options

Price

(In Years)

Value

Balance at June 1, 2011

5,420,000

$

0.75

Granted

520,000

1.06

Exercised

-

-

Forfeited or expired

(780,000)

-

Balance at May 31, 2012

5,160,000

$

0.77

9.00 years

$

185,000

Exercisable at May 31, 2012

2,980,829

$

0.71

9.00 years

$

--

Weighted average fair value of

options granted during the year ended

May 31, 2012

$

1.06

Balance at June 1, 2012

5,160,000

$

0.77

Granted

1,135,000

2.39

Exercised

-

-

Forfeited or expired

(2,495,000)

$

0.69

Balance at May 31, 2013

3,800,000

$

1.26

7.78 years

$

108,750

Exercisable at May 31, 2013

2,396,662

$

0.86

7.78 years

$

--

Weighted average fair value of

options granted during the year ended

May 31, 2013

$

2.39

F-56



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 12 – STOCK – BASED COMPENSATION - CONTINUED

2009 Stock Option Plan – The Company - continued

The following table summarizes information about employee stock options under the 2009 Plan

outstanding at May 31, 2013:

Options Outstanding

Options Exercisable

Weighted

Range

Number

Average

Weighted

Number

Weighted

of

Outstanding

Remaining

Average

Exercisable

Average

Aggregate

Exercis

at May 31,

Contractual

Exercise

Intrinsic

at May 31,

Exercise

Intrinsic

e Price

2013

Life

Price

Value

2013

Price

Value

$

0.60

1,100,000

7.0 Years

$

0.60

$

--

1,100,000     $

0.60

$

--

$

0.65

475,000

7.0 Years

$

0.65

$

27,500

316,665     $

0.65

$

23,974

$

0.75

200,000

7.0 Years

$

0.75

$

30,000

200,000     $

0.75

$

30,000

$

1.00

250,000

9.0 Years

$

1.00

$

1,000

83,333     $

1.00

$

472

$

1.02

50,000

8.0 Years

$

1.02

$

10,000

33,333     $

1.02

$

6,827

$

1.03

50,000

9.0 Years

$

1.03

$

3,000

16,666     $

1.03

$

1,333

$

1.05

120,000

8.0 Years

$

1.05

$

--

79,999     $

1.05

$

--

$

1.07

95,000

9.0 Years

$

1.07

$

--

95,000     $

1.07

$

--

$

1.20

100,000

4.0 Years

$

1.20

$

--

100,000     $

1.20

$

--

$

1.25

25,000

8.0 Years

$

1.25

$

1,250

16,666     $

1.25

$

1,015

$

1.30

250,000

7.0 Years

$

1.30

$

--

250,000     $

1.30

$

--

$

1.90

150,000

9.0 Years

$

1.90

$

--

--     $

0.00

$

--

$

1.95

75,000

9.0 Years

$

1.95

$

9,000

--     $

0.00

$

2,532

$

2.30

325,000

9.0 Years

$

2.30

$

--

75,000     $

2.30

$

--

$

2.61

300,000

10.0 Years

$

2.61

$

27,000

25,000     $

2.61

$

6,325

$

2.70

85,000

10.0 Years

$

2,70

$

--

5,000     $

2.70

$

--

$

2.80

150,000

10.0 Years

$

2.80

$

--

--     $

0.00

$

--

3,800,000

7.78 Years

$

1.26

$      108,750

2,396,662     $

0.86

$

72,429

The total value of employee and non-employee stock options granted during the years ended May 31,

2013 and 2012, was $2,730,968 and $541,490, respectively. During years ended May 31, 2013, 2012

and 2011 the Company recorded $1,752,087, $1,311,032 and $964,439, respectively, in stock-based

compensation expense relating to stock option grants.

F-57



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 12 – STOCK – BASED COMPENSATION - CONTINUED

2009 Stock Option Plan – The Company - continued

At May 31, 2013 and 2012 there was $2,015,966 and $1,331,281, respectively, of total unrecognized

compensation cost related to stock options granted under the plan.  That cost is expected to be

recognized pro-rata through December 15, 2015. The following table represents the stock options

expense for the each of the next three fiscal years ended May 31:

For years ended May 31,

Expense

2014

$

1,040,976

2015

746,211

2016

228,779

$

2,015,966

Stock Option Plan - MesoCoat

MesoCoat accounts for equity awards using the grant-date fair value.

The Company’s stock option plan (the Stock Option Plan) is intended to advance the interest of the

Company and its shareholders. Options granted under the Stock Option Plan can be either incentive stock

options or non-qualified stock options. The Stock Option Plan authorized the issuance of a maximum of

9,000 shares of the Company’s common stock. These options have a term of up to seven years and will

expire through 2019.

A summary of the Company’s stock option plan as of May 31, 2013 and 2012, and the changes during the

years then ended is presented in the table below:

Options Outstanding

Number of

Weighted

Shares

Average Exercise

Price

Outstanding at May 31, 2011

4,200    $

1.95

Granted

250

18.11

Exercised

-

Forfeited

-

Outstanding at May 31, 2012

4,450    $

2.68

Options exercisable at May 31, 2012

3,150    $

1.95

F-58



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 12 – STOCK – BASED COMPENSATION - CONTINUED

2009 Stock Option Plan – The Company - continued

Number of

Weighted

Shares

Average Exercise

Price

Outstanding at May 31, 2012

4,450    $

2.68

Granted

5,270

25.09

Exercised

-

Forfeited

(4,200)

(1.95)

Outstanding at May 31, 2013

5,520    $

24.78

Options exercisable at May 31, 2013

2,043    $

18.11

The total value of employee and non-employee stock options granted during the years ended May 31,

2013 and 2012, was $286,647 and none, respectively. During years ended May 31, 2013 and 2012 the

Company recorded $75,408 and $2,089, respectively, in stock-based compensation expense relating to

stock option grants.

At May 31, 2013, 2012 and 2011 there was $211,239, $2,089 and none, respectively, of total

unrecognized compensation cost related to stock options granted under the plan.  That cost is expected

to be recognized pro-rata through November 1, 2016. The following table represents the stock options

expense for the each of the next three fiscal years ended May 31:

For years ended May 31,

Expense

2014

$

66,862

2015

62,232

2016

54,876

2017

27,269

$

211,239

NOTE 13 COMMITMENTS

Consulting Agreements

On March 1, 2012, we entered into a consulting agreement commencing March 1, 2012, with an

unrelated individual to provide investor relations consulting. The terms of the consulting agreement are

that the consultant is paid $6,000 per month in addition the consultant was issued 50,000 shares of our

restricted common stock for the six month period. The shares will be issued in 12,500 share increments

each month on the signing date, May 1, July 1, and August 31. We also agreed to reimburse the

F-59



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

consultant for all reasonable business expenses incurred by him in the performance of his duties, with a

term expiring September 1, 2012.

Consulting Agreements-continued

On March 1, 2012, we entered into a consulting agreement commencing March 1, 2012, with an

unrelated individual to provide capital investment consulting. The terms of the consulting agreement are

that the consultant is paid $102,000 for the twelve month term; at the start of each subsequent quarter,

the consultant and the Company will review the work performed and the projected work for the

following quarter to ensure the retainer balance is sufficient to pay for the requested services. We also

agreed to reimburse the consultant for all reasonable business expenses incurred by him in the

performance of his duties with a term expiring March 1, 2013.

On March 26, 2012, we entered into a consulting agreement commencing March 26, 2012, with an

unrelated individual to provide capital investment consulting. The terms of the consulting agreement are

that the consultant is paid $5,000 per month; in addition the consultant was issued 15,000 shares of our

restricted common stock for the initial three month period. Then commencing July 1, 2012 and each

quarter after the Company will issue 15,000 shares. We also agreed to reimburse the consultant for all

reasonable business expenses incurred by him in the performance of his duties, with a term expiring

September 26, 2012, at which time the agreement became a month to month agreement.

On September 1, 2012, we entered into a consulting agreement commencing September 1, 2012, with an

unrelated individual to provide investor relations. The terms of the consulting agreement are that the

consultant is paid $5,000 per month for the six month term. In addition, we will grant 30,000 shares of

our restricted common stock to them as follows, upon signing – 10,000 shares, 5,000 shares on

November 1, 2012, December 1, 2012, January 1, 2013 and February 1, 2013. We also agreed to

reimburse the consultant for all reasonable business expenses incurred by him in the performance of his

duties with a term expiring March 1, 2013.

On March 1, 2013, we entered into a consulting agreement commencing March 8, 2013, with an

unrelated individual to provide website consulting. The terms of the consulting agreement are that the

consultant is paid 1,200 shares of our common stock for the six month term. We agreed to issue the first

three months in advance and then monthly after that until the six month term is reached. We also agreed

to reimburse the consultant for all reasonable business expenses incurred by him in the performance of

his duties with a term expiring March 1, 2013.

F-60



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 13 COMMITMENTS - CONTINUED

Leases

In August 2011, the Company entered into a non-cash leasing arrangement where services are provided in

exchange for an asset. The Company has an obligation to provide 600 hours of services at a fair value of

$120,000 as consideration during the period from August 2011 to August 2017. The Company has

recorded this capital lease at its fair value. During the years ended May 31, 2013 and 2012, the Company

completed 51 and 143 hours of service, respectively, with a fair value of $10,200 and $28,600,

respectively. This amount is included in revenue.

The Company leases its office space in Miami on a month to month basis at a cost of $2,213 a month paid

to Prosper Financial, Inc., a related party. The Company was also committed to a non-cancellable operating

lease for a vehicle that expired in March 2012.

MesoCoat subleases its research and development and laboratory space, in Ohio, from Powdermet, a related

party. The cost of the sub-lease to MesoCoat is $6,700 per month that expires on May 31, 2020.  Mesocoat

leases a research and testing facility in Euclid, Ohio from a non-related party.  The cost of the lease to MesoCoat

is $3,750 per month and expires on February 28, 2014.

MesoCoat also leases machinery and equipment under various capital lease arrangements, which expires

through September 2016. These leases are included in long-term and short-term debt and the related assets have

been capitalized.

Total expense related to the operating leases was $156,116, $148,854 and $20,670 for the years ended

May 31, 2013, 2012 and 2011, respectively. Interest expense for the capitalized leases for the years ended

May 31, 2013, 2012 and 2011 was $5,357, $2,593 and none respectively.

Minimum annual rental commitments are as follows at May 31, 2013:

For the years ended May 31,

Capital Leases

Operating Leases

2014

$

28,006      $

114,150

2015

28,006

80,400

2016

28,006

80,400

2017

22,227

80,400

2018

-

80,400

2019 and thereafter

167,500

Total minimum lease payments

$

106,246      $

603,250

Less amount representing interest

14,365

Present value of net minimum capital lease payments

91,881

Less current maturities

(28,006)

Long-term obligations under capital leases

$

63,875

F-61



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 14 – INCOME TAXES

The following is an analysis of deferred tax assets as of May 31, 2013 and 2012:

Deferred

Valuation

Tax Assets

Allowance

Balance

Net deferred tax assets at May 31, 2011

$

777,195

$      (777,195)

$

-

Tax effective of rate change

984,449

(984,449)

Provision to tax return true ups

142,476

(142,476)

-

Additions for the year

378,172

(378,172)

-

Deferred tax assets at May 31, 2012

$

2,282,292

$   (2,282,292)

$

-

Provision to tax return true ups &

adjustments

(1,017,660)

1,017,660

-

Additions for the year

2,244,170

(2,244,170)

-

Deferred tax assets at May 31, 2013

$

3,508,802

$   (3,508,802)

$

-

Deferred income taxes are provided to recognize the effects of temporary differences between financial

reporting and income tax reporting. These differences arise principally from federal net operating losses,

stock compensation expense, basis differences in investments in affiliates and the use of accelerated

depreciation methods for tax purposes as opposed to the straight-line depreciation method for financial

reporting purposes and Federal net operating losses.  The adjustment to deferred taxes for the current

year is to include the fixed asset and intangibles basis differences for 52.5% of MesoCoat.

F-62



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 14 – INCOME TAXES - CONTINUED

Temporary differences between financial statement carrying amounts and tax basis of assets and

liabilities that give rise to significant deferred tax assets and liabilities are presented below at May 31:

2013

2012

Deferred tax assets:

Current:

Compensation accruals

$

30,703

$

87,096

Non-current:

Deferred tax assets:

Net operating loss carry forward

3,733,957

1,962,349

Fixed asset basis differences

-

113,236

Stock options

1,489,357

880,187

Equity loss in affiliates, net

199,247

-

Credits

114,246

-

Other

7

387

Total non-current deferred tax

5,536,814

2,956,159

assets

Deferred tax liabilities:

Equity profit in affiliates, net

(271,766)

(161,217)

Fixed asset & intangibles basis

(1,187,203)

-

differences

Book fair value adjustment of

(599,746)

(599,746)

investment in affiliate

Total non-current deferred tax

(2,058,715)

(760,963)

liabilities

Net non-current deferred tax assets

3,478,099

2,195,196

Net deferred tax assets before

3,508,802

2,282,292

valuation allowance

Valuation allowance

(3,508,802)

(2,282,292)

Net deferred tax asset

$

-

$

-

F-63



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 14 – INCOME TAXES

The following is reconciliation from the expected statutory Federal income tax rate to the Company’s

actual income tax rate for the years ended May 31:

2013

2012

Expected income tax (benefit) at

Federal statutory tax rate – 34%

$

(2,455,949)

$

(380,545)

Permanent differences

211,779

2,372

Tax effect of rate change

(-)

(984,449)

Other adjustments

1,017,660

(142,474)

Change in valuation allowance

1,226,510

1,505,096

Income tax expense

$

-

$

-

We currently have three years of tax returns that are subject to examination, including the fiscal years

ended May 31, 2012, 2011 and 2010, based on their filing dates by taxing authorities. We currently have

no uncertainty of the tax positions that we have taken and believe that we can defend them to any tax

jurisdiction.

The net operating loss carry forward as of May 31, 2013 expires as follows:

Abakan

MesoCoat at

Expiring Year

52.5%

Amount

2027

$554

$

$

554

2028

61,834

-

61,834

2029

352,219

50,787

403,006

2030

1,044,860

732,433

1,777,293

2031

1,715,508

29,753

1,745,261

2032

2,359,640

-

2,359,640

2033

3,349,048

1,285,590

4,634,638

Total

8,883,663

2,098,563

$ 10,982,226

These loss carryovers could be limited under the Internal Revenue Code should a significant change in

ownership occur.  These net operating losses include 52.5% of the losses related to MesoCoat.

F-64



Abakan Inc.

 

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 15 - EMPLOYEE BENEFIT PLANS

The Company has a 401(k) Plan (the Plan) covering substantially all of its employees who are at least age

21 and have completed three months of service. Participating employees may elect to contribute, on a tax

deferred basis, a portion of their compensation in accordance with Section 401(k) of the Internal Revenue

Code. Additional matching contributions may be made to the Plan at the discretion of the Company. For

the years ended May 31, 2013, 2012 and 2011, the Company contributed $25,196, $19,376 and none,

respectively.

NOTE 16 – RECENT ACCOUNTING PRONOUNCEMENTS

We have examined all recent accounting pronouncements and believe that none of them will have a

material impact on the financial statements of the Company.

NOTE 17– SUBSEQUENT EVENTS

Management has evaluated subsequent events after the balance sheet date, through the issuance of the

financial statements, for appropriate accounting and disclosure. The Company has determined that there

were no such events that warrant disclosure or recognition in the financial statements, except for the

below:

Stock Options Granted

On June 14, 2013, we granted 80,000 stock options to a MesoCoat officer at an exercise price of $2.94

per share, and these options will expire ten years from the grant date, and will vest in equal one third parts

on the anniversary of the option grant date, beginning on June 14, 2014.

Amendment to Convertible Promissory Note

On July 14, 2013, we amended the maturity date and forced conversion rights of a $500,000 Convertible

Promissory Note that was due to mature on July 13, 2013.  The maturity date was extended to July 14,

2014.  The Company’s forced conversion of the Convertible Promissory Note changed from permitting

the Company to force a conversion if the Company’s Shares for each of 20 consecutive trading days is

greater than $3.00 to entitlement to a force conversion in the event that the Company completes a

$5,000,000 financing in a single closing.

New Demand Promissory Notes

The Company has closed five Demand Promissory Notes from July 2, 2013 to August 23, 2013 for a total

amount of $550,000.  The Notes bear interest from 5% to 8% and are due on demand.

F-65



Abakan Inc.

(A Development Stage Enterprise)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the years ended May 31, 2013 and 2012

NOTE 17– SUBSEQUENT EVENTS - CONTINUED

Other Business

On June 17, 2013, MesoCoat executed a deposit agreement with Cone S.A. in connection with the

construction of a manufacturing facility in Brazil. Negotiations are ongoing in respect to a lease

agreement for a “build to suit” facility.

F-66



ITEM 9.

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON

ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

In connection with the preparation of this annual report, an evaluation was carried out by the Company’s

management, with the participation of the chief executive officer and the acting chief financial officer, of

the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and

15d-15(e) under the Securities Exchange Act of 1934 (“Exchange Act”)) as of May 31, 2013. Disclosure

controls and procedures are designed to ensure that information required to be disclosed in reports filed or

submitted under the Exchange Act is recorded, processed, summarized, and reported within the time

periods specified in the Commission’s rules and forms, and that such information is accumulated and

communicated to management, including the chief executive officer and the chief financial officer, to

allow timely decisions regarding required disclosures.

Based on that evaluation, the Company’s management concluded, as of the end of the period covered by

this report, that the Company’s disclosure controls and procedures was effective in recording, processing,

summarizing, and reporting information required to be disclosed, within the time periods specified in the

Commission’s rules and forms, and such information was accumulated and communicated to

management, including the chief executive officer and the chief financial officer, to allow timely

decisions regarding required disclosures.

Management’s Report on Internal Control over Financial Reporting

The Company’s management is responsible for establishing and maintaining adequate internal control

over financial reporting. The Company’s internal control over financial reporting is a process, under the

supervision of the chief executive officer and the chief financial officer, designed to provide reasonable

assurance regarding the reliability of financial reporting and the preparation of the Company’s financial

statements for external purposes in accordance with United States generally accepted accounting

principles (GAAP). Internal control over financial reporting includes those policies and procedures that:

§     Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the

transactions and dispositions of the Company’s assets.

§     Provide reasonable assurance that transactions are recorded as necessary to permit preparation of

the financial statements in accordance with generally accepted accounting principles, and that

receipts and expenditures are being made only in accordance with authorizations of management

and the board of directors.

§     Provide reasonable assurance regarding prevention or timely detection of unauthorized

acquisition, use, or disposition of the Company’s assets that could have a material effect on the

financial statements.

Due to its inherent limitations, internal control over financial reporting may not prevent or detect

misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk

that controls may become inadequate because of changes in conditions or that the degree of compliance

with the policies or procedures may deteriorate.

48



The Company’s management conducted an assessment of the effectiveness of our internal control over

financial reporting as of May 31, 2013 based on criteria established in Internal Control – Integrated

Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, this

assessment is to determine if there exist material weaknesses in internal control over financial reporting.

A material weakness is a control deficiency, or a combination of deficiencies in internal control over

financial reporting that creates a reasonable possibility that a material misstatement in annual or interim

financial statements will not be prevented or detected on a timely basis. Since the assessment of the

effectiveness of our internal control over financial reporting did not identify material weaknesses,

management considers its internal control over financial reporting to be effective.

This annual report includes an attestation report of our independent registered public accounting firm

regarding internal control over financial reporting for the year ended May 31, 2013. The attestation is

included in the accounting firm’s report on our audited financial statements.

Changes in Internal Controls over Financial Reporting

During the period ended May 31, 2013, management has implemented a variety of internal controls

procedure and financial reporting oversight.  This has enabled the company to perform an assessment of

the effectiveness of our internal control over financial reporting.  This assessment did not identify

material weaknesses, thus management considers its internal control over financial reporting to be

effective.

ITEM 9B.

OTHER INFORMATION

None.

49



PART III

ITEM 10.

DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE

Set forth below is the name, age and present principal occupation or employment, and material

occupations, positions, offices or employments for the past five years of our current directors and

executive officers:

Name

Age

Year Appointed

Position(s) and Office(s)

Robert H. Miller

60

2009

President, Chief Executive Officer,

and Director

Andrew J. Sherman

50

2010

Director

Stephen Goss

70

2012

Director

David Charbonneau

52

2012

Chief Financial Officer

Jeffrey Webb

48

2012

Director

Raymond Tellini

47

2012

Director

Business Experience

The following is a brief account of the business experience of our directors, executive officers, and other

significant employees, including their background occupations and employment over the past five years.

We also provide the responsibilities and qualifications of our executive officers and other significant

employees and the qualifications of our directors. The following includes other directorships in public

companies over the past five years of our directors. Except as otherwise noted, none of the following

referenced organizations are affiliates of the Company.

Robert H. Miller was appointed as a member of the board of directors and as the Company’s chief

executive officer on December 8, 2009.

Background:

From 2007 until the present Mr. Miller has been a director of Lifespan Biosciences Inc., a company

commercializing proprietary antibodies, providing immune histochemistry services and developing

localization databases. Since 2009 he has served as an officer and director of Sonnen Corporation, a

company involved in the research and development of a novel process for energy generation consisting of

specific materials and proprietary material combinations. (Mr. Miller is the beneficial owner of more than

ten percent of Sonnen’s common stock.) From 2002 to present, Mr. Miller has been a consultant to

Prosper Financial, Inc., a management company that provides financial and corporate consulting services

to start-up companies. Between 1998 and 2000 he was a director and financier of Zmax Corporation, a

"y2k" company. From 1997 to 2002 Mr. Miller was the president of Stamford International whose

principal subsidiary, Nanovation Technologies Inc., was a developer of nano-sized fiber-optic products

and he served as director of Nanovation between 1998 and 2001. In 1992 Mr. Miller was the founder and

president of Crystallex International Corporation and he served as the company’s Chairman between 1992

and 1996. Between 1988 and 1992 he was the principal financier and consultant to Asiamerica Equities

Inc., a NASDAQ listed merchant bank.

50



Officer and Director Responsibilities and Qualifications:

Mr. Miller is responsible for the overall management of the Company and is involved in many of the

Company’s day-to-day operations. He is the Company’s primary leader, communicator and fundraiser.

Mr. Miller has worked as officer and director of many early-stage companies for almost three decades and

has participated as the principal investor in dozens of business ventures. He has founded corporations,

listed numerous companies on the NASDAQ and the Toronto Stock Exchange, worked full-time with and

as a consultant to numerous startups.

Other Public Company Directorships in the Last Five Years:

Mr. Miller has been a director of Sonnen Corporation since 2009.

Andrew J. Sherman was appointed as a member of the board of directors on August 20, 2010.

Business Experience:

From 1996 until the present Mr. Sherman has served as CEO for Powdermet and from 2007 until the

present he has served as CEO of MesoCoat (both of which are the Company’s affiliates). Between 1986

and 1996 Mr. Sherman was Chief Metallurgist and New Business Development Manager for Ultramet,

Inc., a leading Chemical Vapor Deposition (CVD) company, in Pacoima, California, where his technical

and business developments resulted in a 10-fold growth in company revenues and the creation of three

spinouts (including a $100M plus exit). Mr. Sherman’s developments have been the basis for the

formation of eight successful companies to date.

Director Responsibilities and Qualifications:

Mr. Sherman brings his 25 years of experience in the nano-engineered coatings field (including an

intimate knowledge of both MesoCoat and Powdermet) and his entrepreneurial spirit to the board of

directors.

Additionally, Mr. Sherman was appointed to the United States Department of Energy’s Hydrogen Safety

Panel and has served on the review panel since 2006.  Panel duties include interfacing with codes and

standards, accident investigations, site reviews, H2 (hydrogen) project reviews, and H2 information and

training, education, and best practices development. He received a M.Sc. and B.Sc. in Ceramic

Engineering and a B.Sc. in Chemical Engineering from Ohio State University. He has also authored more

than 95 papers and presentations on ceramics, metallurgy and composite powder coatings and was

recognized with the 2000 R&D 100 award for his patented nano powder production and is a 2009 Ernst

and Young entrepreneur of the year finalist.

Other Public Company Directorships in the Last Five Years:

None.

Stephen Goss was appointed as a member of the board of directors on January 4, 2012. Mr. Goss further

serves on the Company’s audit committee, compensation committee, nominating & governance

committee and the Compliance & Ethics committee as an independent member of the board of directors.

51



Business Experience:

Mr. Goss has served as a director of Gemocasha, SA, a specialized consultancy group with emphasis on

giving technical, marketing and cash management advice to major firms such as Kraft, Heinz, Crystallex,

and BP from 1987 to present. He served as the chief executive officer of Crystallex de Venezuela, a

mining firm from 1992 to 1998 and Schindler Elevator from 1982 to 1987 in Venezuela, a role in which

he successfully integrated multiple acquisitions.  He also served as the Technical Maintenance and

Installation Manager for Schindler Brazil between 1979 and 1982 in which position he managed over

2,000 people and turned it from the least efficient worldwide operation to one of the three most efficient

operations worldwide.

Director Responsibilities and Qualifications:

Mr. Goss brings independent oversight and a deep scientific and entrepreneurial background to the

Corporation with over three decades of senior management and consultancy experience. He speaks five

languages fluently, has received decorations from the Order of the British Empire for services related to

enhancing international trade and is a graduate of the University of Grenoble.

Mr. Goss serves on the Company’s Audit Committee, Compensation Committee, Nominating &

Governance Committee and the Compliance & Ethics Committee as an independent member of the board

of directors.

Other Public Company Directorships in the Last Five Years:

None.

Jeffrey Webb was appointed as a member of the board of directors on August 7, 2012.

Business Experience:

Mr. Webb is the Business Development Manager and a Director of Fidelity (Cayman) Ltd., one of the

largest banks in the Cayman Islands. He joined Fidelity (Cayman) Ltd in January 1990 and has since

earned extensive experience in the international banking sector. Mr. Webb’s responsibilities have

included the development, management and direction of investment banking activities alongside

corporate finance and risk management. He has exhibited leadership in various roles and provided advice

on multiple committees within and without the banking community.

Director Responsibilities and Qualifications:

Mr. Webb brings independent management oversight and an expert leadership background with over two

decades of accounting, management and consultancy experience to the Corporation’s board of directors.

Mr. Webb serves on the Company’s Audit Committee, Compensation Committee, Nominating &

Governance Committee and the Compliance & Ethics Committee as an independent member of the board

of directors.

Other Public Company Directorships in the Last Five Years:

None.

52



Raymond Tellini was appointed as a member of the board of directors on December 5, 2012.

Business Experience:

Mr. Tellini is currently the managing member of Brennecke Partners LLC, a private investment firm

located in Connecticut that makes specialty finance and growth capital investments. He brings to the

Company’s board of directors independent management oversight with an expert accounting and

investment background garnered over two decades of accounting, management and investment

experience.

Director Responsibilities and Qualifications:

Mr. Tellini serves as the head of the Company’s Audit Committee, and as a member of the Compensation

Committee, Nominating & Governance Committee and the Compliance & Ethics Committee as an

independent member of the board of directors.   He is a Certified Public Accountant, inactive, in New

York. Mr. Tellini started his career at PricewaterhouseCoopers, LLC where he worked from 1987-1994

most recently as a manager in the corporate finance group.  Afterward, Mr. Tellini has held executive

level financial positions for Wassall Plc (1995-1999), a private equity firm, and for the hedge fund firms

Palladin Partners Group LP and its successor, Imperium Partners Group LP, where he also ran their

investment banking affiliate.   Mr. Tellini brings independent management oversight, investment

management, consultancy experience and expert leadership background to the Corporation’s board of

directors.

Mr. Tellini earned a Bachelor of Science in Accounting from Lehigh University and an MBA in Finance

from the New York University, Stern School of Business.

Other Public Company Directorships in the Last Five Years:

None.

David Charbonneau was appointed the Chief Financial Officer and Principal Accounting Officer on

December 5, 2012.

Business Experience:

Mr. Charbonneau is the founder of CFO Consultant’s Inc. in Cleveland, Ohio for which he has advised

clients since 2008 on strategic planning, budget preparation, sales and margin enhancement, overhead

cost management, accounting and corporate affairs.  He also worked as an Associate Director of SS&G

Parkland Consulting LLC in Cleveland, Ohio. His duties focused on strategic planning, performance

improvements and institutional relationships. From 1998 to 2008, Mr. Charbonneau was the President and

Chief Financial Officer of Premier Modular Buildings LC, a Florida commercial modular builder.

53



Director Responsibilities and Qualifications:

Mr. Charbonneau brings independent management oversight and an expert accounting background with

over two decades of accounting, management and consultancy experience. He is a Certified Public

Accountant in Ohio. Mr. Charbonneau started his accounting career as an auditor for Arthur Anderson &

Co. in Cleveland.  His experience includes 5 years as Chief Financial Officer for Diamond Engineered

Space Inc.  Diamond was a national commercial modular builder and a subsidiary of a UK publically

traded company.  After the company was sold, he transferred to their sister company, Waco International

Corporation, a subsidiary of an Australian public company.  He was their Chief Financial Officer and a

Director from 1993 until 1998. Waco was a scaffolding manufacturer and construction rental equipment

company with multiple US locations and over 600 employees.

Mr. Charbonneau earned a Bachelor of Science in Business Administration with a Major in Accounting

from The Ohio State University.

Other Public Company Directorships in the Last Five Years:

None.

Term of Office

Our directors are appointed for one year terms to hold office until the next annual meeting of our

shareholders or until removed from office in accordance with our bylaws. Our executive officers are

appointed by our board of directors and hold office pursuant to employment agreements or until removed

by the board.

Family Relationships

There are no family relationships between or among the directors or executive officers.

Involvement in Certain Legal Proceedings

During the past ten years there are no events that occurred related to an involvement in legal proceedings

that are material to an evaluation of the ability or integrity of any of the Company’s directors, persons

nominated to become directors or executive officers.

Compliance with Section 16(A) of the Exchange Act

Section 16(a) of the Securities Exchange Act of 1934 requires officers and directors of the Company and

persons who own more than ten percent of a registered class of the Company's equity securities to file

reports of ownership and changes in their ownership with the Commission, and forward copies of such

filings to us. Based solely upon a review of Forms 3, 4 and 5 furnished to the Company, we are not aware

of any persons who, during the annual period ended May 31, 2012, failed to file, on a timely basis, reports

required by Section 16(a) of the Securities Exchange Act of 1934.

54



Code of Ethics

The Company adopted a Code of Business Conduct & Ethics on June 13, 2012 and amended on

December 10, 2012, within the meaning of Item 406(b) of Regulation S-K of the Securities Exchange Act

of 1934, a copy of which is attached hereto as Exhibit 14 to this Form 10-K. Further, our Code of

Business Conduct & Ethics is available in print, at no charge, to any security holder who requests such

information by contacting us.  Our Code of Business Conduct and Ethics applies to directors and senior

officers, such as our principal executive officer, principal financial officer, controller, persons performing

similar functions and employees.

Board of Directors Committees

Audit Committee

The board of directors established an Audit Committee on June 25, 2012, comprised solely of

independent members to act on and report to the board of directors with respect to various auditing and

accounting matters, including the recommendations and performance of independent auditors, the scope

of the annual audits, fees to be paid to the independent auditors, and internal accounting and financial

control policies and procedures. Certain stock exchanges currently require companies to adopt a formal

written charter that establishes an audit committee that specifies the scope of an audit committee’s

responsibilities and the means by which it carries out those responsibilities.

Compensation Committee

The board of directors established a Compensation Committee on June 25, 2012, comprised solely of

independent members to help the board of directors discharge its responsibilities with respect to the

compensation of our Chief Executive Officer and other executive officers, the administration of the

Company's executive compensation and benefits programs and the production of an annual report on

executive compensation for inclusion in the Company's proxy statement.

Nominating Committee

The board of directors has established a Nominating & Corporate Governance Committee on June 25,

2012, comprised solely of independent members to assist the board of directors in connection with

nominations and corporate governance practices related to serving on the Company’s board of directors,

including candidates that may be referred by the Company’s stockholders. Stockholders who desire to

recommend candidates for evaluation may do so by contacting the Company in writing, identifying the

potential candidate and providing background information. Candidates may also come to the attention of

the board of directors through current members of the board of directors, professional search firms and

other persons. In evaluating potential candidates, the Nominating & Corporate Governance Committee

takes into account a number of factors, including among others, the following:

§     independence from management;

§     whether the candidate has relevant business experience;

§     judgment, skill, integrity and reputation;

§     existing commitments to other businesses;

§     corporate governance background;

§     financial  and  accounting  background,  to  enable  the  board  of  directors  to  determine  whether  the

candidate would be suitable for audit committee membership; and

§     the size and composition of the board.

55



Compliance

The board of directors established a Compliance and Ethics Committee on June 25, 2012, comprised

solely of independent members to assist the board of directors in connection with overseeing the

Company’s compliance program with respect to the laws and regulations applicable to the Company’s

business and compliance with Company’s Code of Business Conduct & Ethics and related policies by

employees, officers, directors and other agents or associates of the Company.

Director Compensation

Directors currently are reimbursed for out-of-pocket costs incurred in attending meetings, awarded stock

compensation, granted stock options pursuant to our 2009 Stock Option Plan and reimbursed for expenses

related to their service. The Company has entered into board of director’s compensation agreements with

each of its independent directors and employment agreements with its dependent directors which

compensation is not tied to their service to the board of directors.

The following table provides summary information for the fiscal year ended May 31, 2013 concerning

cash and non-cash compensation paid or accrued by the Company to or on behalf of our directors.

Director Compensation Table

Name

Fees

Stock

Option

Non-Equity

Nonqualified

All Other

Total

Earned

Awards

Awards

Incentive Plan

Deferred

Compensation

($)

Paid in

($)

($)

Compensation     Compensation

($)

Cash ($)

($)

Earnings

($)

Robert H.

$0

$0

$0

$0

$0

$120,000     $120,000

Miller

Andrew J.

$0

$0

$0

$0

$0

$144,000     $144,000

Sherman

Stephen Goss

$20,250

$54,000     $147,000

$0

$0

$0     $221,250

David

$19,000

$20,000      $317,991

$0

$0

$0     $356,991

Charbonneau(1)

Jeffrey Webb

$0

$19,000     $243,920

$0

$0

$0     $262,920

Herman

$0

$0     $324,519

$0

$0

$55,000     $384,519

Buschor(2)

Theodore

$0

$0     $182,304

$0

$0

$0     $182,304

Sarniak III (3)

Raymond

$0

$0     $463,937

$0

$0

$0     $463,937

Tellini

(1)  David Charbonneau was appointed on June 15, 2012 and resigned on December 5, 2012 after accepting the position of Chief

Financial Officer and Principal Accounting Officer for the Company.

(2)  Herman Buschor resigned on June 14, 2012

(3)  Theodore Sarniak III’s death was acknowledged on August 7, 2012 with the appointment of Jeffrey Webb.

56



Key Advisors

Reg Allen was most recently Chief Executive Officer of Vortek, a Canadian technology company that had

developed the world’s most powerful arc lamp. In 2004, Mr. Allen successfully sold Vortek to a public

U.S. semiconductor equipment manufacturer. Mr. Allen is considered a leading authority on applications

of the focused arc lamp system that is employed by the Company. At Vortek, Mr. Allen assembled an

international team of top-caliber staff and executed an ambitious business plan to commercialize the

application of arc lamp technology in advanced semiconductor equipment manufacturing. Mr. Allen has

over 30 years of experience working with engineering related solutions.

James Rodriguez de Castro's most recent professional background includes 14 years spent with Merrill

Lynch based in Japan and Hong Kong. His numerous senior executive roles there included Head of

Global Markets, New Initiatives and Advisory, Pacific Rim; Head of Trading, Equity Derivatives, CBs

and Index Arbitrage, Asia; and Head Trader, Japanese Equity Derivatives. His experience in the oil and

gas sector began with Bankers Trust during the 1992 Gulf War. He remains a very active investor in this

sector in Asia, and maintains active interests in mining and offshore equipment rental.

Sam Thomas is a professor of Banking and Finance at the Weatherhead School of Management of Case

Western Reserve University. He teaches in the Weatherhead MBA, MS, and Undergraduate programs.

His research and consulting activities focus on the practice of investment science, valuation, and

corporate strategy. His notable expertise is in integrating the global macro business cycle with practices in

corporate finance strategy and investments strategy. Dr. Thomas is active in the research and development

activities of corporate strategists, institutional investors, financial advisors and money managers and is

known for his ability to materially integrate academic research with product development. His recent

projects incorporate innovations in the design of corporate strategy and life-long portfolio construction in

a manner that is compatible with phases of the business cycle. Dr. Thomas recently played a very

important role at BluFin to develop India’s first comprehensive monthly Consumer Confidence Index

(CCI) to assess the pulse rate of the consumer that is expected to become the de facto standard for

measuring consumer sentiment in India.  Other projects include business cycle indicators and the design

of a comprehensive suite of stock market indices for India.

Damian Kotecki brings 43 years of welding expertise as well as his extensive technical and business

network to the Company. Dr. Kotecki’s extensive experience in welding research, pipeline failure

analyses, welding training and specifications, welding procedure development, quality assurance and

stainless/high alloy welding filler metal and product development will help assure the company’s

CermaCladtm  products incorporate the highest levels of technical excellence. In addition to co-authoring

the leading textbook on stainless steel welding, Dr. Kotecki conducted welding research projects and

pipeline failure analyses for the Battelle Memorial Institute, was the Director of Research for Teledyne

McKay (today part of Illinois Tool Works) and retired as the Technical Director for Stainless and High

Alloy Product Development for the world’s largest welding company, The Lincoln Electric Company. Dr.

Kotecki is past president of the American Welding Society (AWS), where he currently chairs the A5D

subcommittee on stainless steel welding and the International Standards Activities Committee. He is also

past chair of the International Institute of Welding Commission II Arc Welding and Filler Metals. Dr.

Kotecki holds a BS and MS in Mechanical Engineering, and a Ph.D. in Mechanical Engineering with a

minor in Metallurgical Engineering.

Andrew Hall is the founder and managing partner of Hall, Lamb and Hall, P.A. based in Miami, Florida

where he specializes in complex commercial litigation, professional negligence, securities litigation and

arbitration and international cases. From the Watergate trials and the Ohio savings and loan crisis, to the

2000 terrorist attack on the USS Cole, Hall’s trial skills have earned him national recognition, including

being named one of “The Best Lawyers in America” by Best Lawyers for the past decade.

57



Vinod Gupta is currently the chairman of the Ohio Board of Regents, where he also chairs the

Commercialization Tasks Force and serves on the Shared Services Task Force. He also serves as an

Entrepreneur-In Residence (EIR) for the Cleveland-based venture development non-profit organization,

Jumpstart Entrepreneurial Network (JEN) Advisors, where he helps to grow the northeast Ohio

technology ecosystem by using his 15 years of materials sector experience to coach entrepreneurs.

ITEM 11.

EXECUTIVE COMPENSATION

The objective of the Company’s compensation program is to provide compensation for services rendered

by our executive officers. The Company’s salaries and stock option awards are designed to retain the

services of our executive officers. Salary and stock option awards are currently the only type of

compensation used in our compensation program. We use these forms of compensation because we feel

that they are adequate to retain and motivate our executive officers. The amount we deem appropriate to

compensate our executive officers is determined in accordance with market forces as we have no specific

formula to determine compensatory amounts at this time. While we have deemed that our current

compensatory program and the decisions regarding compensation are easy to administer and are

appropriately suited for our objectives, we may expand our compensation program to additional future

employees to include other compensatory elements.

For the year ended May 31, 2013, $537,692 was paid in salary, stock option awards and separation

amounts to retain our chief executive officer and chief financial officer. For the year ended May 31, 2012,

$288,976 was paid in salary and stock option awards to retain said executive officers. We expect that the

amount paid to retain executive officers will increase over the next twelve months.

During the annual periods ended May 31, 2013 and May 31, 2012 our chief executive officer received

compensation of $10,000 per month pursuant to his existing consulting agreement with the Company.

Management believes that the executive compensation paid to our chief executive officer will increase

over the next twelve months as its business develops as in a higher salary and the grant of stock options.

On December 5, 2012 the company entered into an employment agreement with our current chief

financial officer.  During the annual period ended May 31, 2013, our chief financial officer received

compensation of $16,000 per month pursuant to an employment agreement dated December 5, 2012. Also

included was the grant of 125,000 stock options at an exercise price of $2.61 per share for a period of ten

years from the date of grant valued at $331,384, as part of his agreement.

During the annual period ended May 31, 2012, our former chief financial officer received compensation

of $10,000 per month pursuant to an employment agreement and on his resignation dated October 24,

2011, a separation amount which included the grant of 100,000 stock options to purchase shares of the

Company’s common stock for $1.20 a share for a period of five years from the date of grant valued at

$112,714, as part of his agreement to cancel the 400,000 stock options granted pursuant to his

employment agreement.

58



Summary Compensation

The following table provides summary information for the fiscal years ended May 31, 2013 and 2012

concerning cash and non-cash compensation paid or accrued by the Company to or on behalf of (i) the

chief executive officer, (ii) the two most highly compensated executive officers other than the chief

executive officer if compensated at over $100,000 and (iii) additional individuals if compensated at over

$100,000.

Executive Compensation Table

Name and

Year

Annual

Bonus

Stock

Option

Non-Equity

Nonqualified

All Other

Total

Principal

(ended

Salary

($)

Awards

Awards

Incentive Plan

Deferred

Compensation

($)

Position

May

($)

($)

($)

Compensation

Compensation

($)

31)

($)

Earnings

($)

Robert Miller:

2013

$120,000

$0

$0

$0

$0

$0

$0

$120,000

CEO, director(1)

2012

$120,000

$0

$0

$0

$0

$0

$0

$120,000

David

2013

$86,308

$0

$0     $331,384

$0

$0

$0

$417,692

Charbonneau:

CFO, PAO(4)

David

2013

$0

$0

$20,000     $317,991

$0

$0

$19,000

$356,991

Charbonneau

Director(4)

Mark W.

Sullivan: CFO,

2012

$56,262

$0

$0     $112,714

$0

$0

$0

$168,976

PAO(2)

Hermann

2013

$55,000

$0

$0

$0

$0

$0

$0

$55,000

Buschor:

2012

$60,000

$0

$0

$0

$0

$0

$6,000

$66,000

director, VP Bus.

Development

Andrew J.

2013

$144,000

$0

$0

$0

$0

$0

$0

$144,000

Sherman(3)

2012

$144,000

$0

$0

$0

$0

$0

$0

$144,000

Director

Stephen Goss:

2013

$0

$0

$54,000

$0

$0

$0

$20,250

$74,250

director

2012

$0

$0

$0     $147,044

$0

$0

$0

$147,044

Jeffrey Webb

2013

$0

$0

$19,000     $243,920

$0

$0

$0

$262,920

director

Raymond Tellini:    2013

$0

$0

$0     $463,937

$0

$0

$0

$463,937

director(5)

(1)      Mr. Miller as appointed as chief executive officer and director on December 8, 2009.

(2)     Mr. Sullivan entered into an employment agreement with the Company in connection with his appointment as chief financial

officer and principal accounting officer on May 11, 2011. Terms of the agreement included a signing bonus of 60,000

shares, options to purchase 400,000 shares, and a salary of $120,000 per annum. He resigned on October 24, 2011.

(3)     Andrew J. Sherman was appointed as a director on August 20, 2010 and also serves as the president of both MesoCoat and

Powdermet.

(4)    David Charbonneau was appointed on June 15, 2012 and resigned on December 5, 2012 after accepting the position of Chief

Financial Officer and Principal Accounting Officer for the Company.

(5)    Raymond Tellini was appointed on director on December 5, 2012

.

59



Outstanding Equity Awards

The following table provides summary information for the period ended May 31, 2013 concerning

unexercised options, stock that has not vested, and equity incentive plan awards by the Company to or on

behalf of (i) the chief executive officer and chief financial officer and (ii) the three most highly

compensated individuals whose total compensation exceeds $100,000:

Outstanding Equity Awards at Fiscal Year-End

Option awards

Stock awards

Equity

Equity

incentive

Equity

incentive plan

plan

Market    incentive plan  awards: market

awards:

Number

value of

awards:

or payout

Number of

Number of

number of

of shares

shares

number of

value of

securities

securities

securities

or units

or units

unearned

unearned

underlying

underlying

underlying

of stock

of stock     shares, units   shares, units or

unexercised

unexercised

unexercised

Option

that have

that

or other rights     other rights

options

options

unearned

exercise

Option

not

have not    that have not     that have not

(#)

(#)

options

price

expiration

vested

vested

vested

vested

Name

exercisable      unexercisable

(#)

($)

date

(#)

(#)

(#)

($)

Robert H.

Miller(1)

-

-

-

-

-

-

-

-

-

Robert H.

Miller(1)

-

-

-

-

-

-

-

-

-

Andrew J.

Sherman

1,000,000

-

-

0.60     December

11, 2019

-

-

-

-

Stephen Goss

-

150,000

-

1.00     January 4,

2022

-

-

-

-

Jeffrey Webb

150,000

-

1.20      August 7,

2022

-

-

-

-

David

Charbonneau

50,000

100,000

2.30

June 15,

2022

-

-

-

-

David

Charbonneau

125,000

2.61   December 5,

2022

Ray Tellini

25,000

155,000

2.61   December 5,

2022

(1)  Mr. Miller was the indirect, beneficial owner of 1 million and 500,000 options.  The previously granted options

dated December 11, 2009 and October 19, 2010 were cancelled per mutual agreement on December 4, 2012.

.

2009 Stock Option Plan

Our board of directors adopted and approved our 2009 Stock option Plan (“Plan”) on December 14,

2009, which provides for the granting and issuance of up to 10 million shares of our common stock. As

of August 16, 2013, 3,880,000 shares of common stock were outstanding at exercise prices of $0.60,

$0.65, $0.75, $1.00, $1.02, $1.03, $1.05, $1.07, $1.20,  $1.25, $1.30, $1,90, $1.95, $2.30, $2.61, $2.70,

$2.80 and $2.94 per share, which options vest up to three years.  The Stock Option Plan has 6,120,000

options available for future grant.

Our board of directors administers our Plan, however, they may delegate this authority to a committee

formed to perform the administration function of the Plan. The board of directors or a committee of the

board has the authority to construe and interpret provisions of the Plan as well as to determine the terms

of an award. Our board of directors may amend or modify Plan at any time. However, no amendment or

modification shall adversely affect the rights and obligations with respect to outstanding awards unless

the holder consents to that amendment or modification.

60



The Plan permits us to grant non-statutory stock options to our employees, directors and consultants.

The options issued under this Plan are intended to be non-statutory stock options exempt from Code

Section 409A. The duration of a stock option granted under our Plan cannot exceed ten years. The

exercise price of an incentive stock option cannot be less than 100% of the fair market value of the

common stock on the date of grant.

The Plan administrator determines the term of stock options granted under our Plan, up to a maximum

of ten years, except in the case of certain events, as described below. Unless the terms of an optionee's

stock option agreement provide otherwise, if an optionee's relationship with us ceases for any reason

other than disability or death, the optionee may exercise any vested options for a period of ninety days

following the cessation of service. If an optionee's service relationship with us ceases due to disability or

death the optionee or a beneficiary may exercise any vested options for a period of 12 months in the

event of disability or death.

Unless the Plan administrator provides otherwise, options generally are not transferable except by will,

the laws of descent and distribution, or pursuant to a domestic relations order. An optionee may

designate a beneficiary, however, who may exercise the option following the optionee's death.

Long Term Incentive Plan Awards.

We have no long-term incentive plans.

Termination of Employment and Change in Control Arrangements

The Company has no plans that provides for the payment of retirement benefits, or benefits that will be

paid primarily following retirement.

The Company has no agreement that provides for payment to any executive officer at, following, or in

connection with the resignation, retirement or other termination, or a change in control of Company or a

change in our executive officers’ responsibilities following a change in control except for employment

agreement with Mr. David Charbonneau, Chief Financial Officer, dated December 5, 2012.  The 3 year

employment agreement requires severance payment between $100,000 to $200,000 for early termination

without cause, change in responsibilities or upon completion of initial term if not extended by mutual

agreement.

61



ITEM 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND

MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table sets forth certain information concerning the ownership of the Company’s 64,284,855

shares of common stock issued and outstanding as of August 28, 2013 with respect to: (i) all directors; (ii)

each person known by us to be the beneficial owner of more than five percent of our common stock; and

(iii) our directors and executive officers as a group.

Title of Class

Name and Address of Beneficial

Amount and nature

Percent of Class

Ownership

of Beneficial

Ownership1

Robert H. Miller

Common Stock

4801 Alhambra Circle

24,120,0002

35.5%

Coral Gables, Florida 33146

Andrew J. Sherman

Common Stock

9181 Boyer Lane

03

0%

Kirtland Hills, Ohio  44060

Stephen Goss

Common Stock

16373 Bridle Wood Circle

20,0004

<0.01%

Delray Beach, Florida 33445

David Charbonneau

Common Stock

9085 Ledgemont Drive

10,0005

<0.01%

Cleveland, Ohio 44147

Jeffrey Webb

Common Stock

44 Oak Drive, Grand Cayman

10,0006

<0.01%

Cayman Islands KY1 1107

Ray Tellini

Common Stock

2665 South Bayshore Drive, Suite 450

07

0%

Miami, Florida 33133

Common Stock

All Executive Officers and Directors as

a Group

24,160,000

35.5%

Maria Maz

Common Stock

4801 Alhambra Circle

17,420,0008

27.1%

Coral Gables, Florida 33146

Common Stock

Thomas and Mario Miller Family

Irrevocable Trust u/a/d 12/01/2009

5,250,000

8.2%

(1)     Beneficial ownership is determined in accordance with Commission rules and generally includes voting or investment power with

respect to securities. Shares of common stock subject to options, warrants and convertible preferred stock currently exercisable or

convertible, or exercisable or convertible within sixty (60) days, would be counted as outstanding for computing the percentage of the

person holding such options or warrants but not counted as outstanding for computing the percentage of any other person.

(2)     Mr. Miller is a beneficial owner of 17,420,000 shares held by Ms. Maria Maz, to whom Mr. Miller is married, Ms Maz was the

previous chief executive officer of the Company from September 2008 until Mr. Miller assumed the position in Dec 2009 and the

beneficial owner of 5,250,000 shares held by the Thomas and Mario Miller Family Irrevocable Trust u/a/d 12/01/2009, which trust’s

beneficiaries are Mr. Miller’s children, and 1,450,000 shares held by the Tarija Foundation for which Mr. Miller serves as a director.

(3)     Mr. Sherman was granted 1,000,000 options that vest in equal increments over three years to purchase shares of common stock at

$0.60 per share on or before December 14, 2019.

(4)     Mr. Goss was granted 150,000 options that vest in equal increments beginning on January 5, 2013 over three years to purchase shares

of common stock at $1.00 per share on or before January 4, 2023.

(5)     David Charbonneau was issued 10,000 common shares and granted 150,000 options as director that vest in equal increments

beginning on September 15, 2012 over three years to purchase common stock at $2.30 per share on or before September 14, 2022. Mr.

Charbonneau was granted 125,000 options as chief financial officer that vest in equal increments beginning on December 5, 2013.

(6)     Jeffrey Webb was issued 10,000 common shares and granted 150,000 options that vest in equal increments beginning on August 7,

2013 over three years to purchase common stock at $1.90 per share on or before August 6, 2023.

(7)     Ms. Maz directly owns 17,420,000 shares, and beneficially owns 5,250,000 shares held by the Thomas and Mario Miller Family

Irrevocable Trust u/a/d 12/01/2009, which trust’s beneficiaries are Ms. Maz’s children and 1,450,000 shares held by the Tariji

Foundation for which Mr. Miller serves as a director.

(8)     Mr. Tellini was granted 175,000 options that vest in equal increments beginning on December 5, 2012 and thereafter in equal parts

over three years to purchase shares of common stock at $2.61 per share on or before December 4, 2022.

62



ITEM 13.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND

DIRECTOR INDEPENDENCE

Neither our director or executive officer, nor any proposed nominee for election as a director, nor any

person who beneficially owns, directly or indirectly, shares carrying more than 5% of the voting rights

attached to all of our outstanding shares, nor any members of the immediate family (including spouse,

parents, children, siblings, and in-laws) of any of the foregoing persons has any material interest, direct or

indirect, in any transaction in the period covered by this report or in any presently proposed transaction

which, in either case, has or will materially affect us, except as follows:

On December 5, 2012, we entered into a board of director’s compensation agreement with Raymond

Tellini, pursuant to which agreement Mr. Tellini was granted 175,000 stock options at an exercise price

of $2.61 per share for a period of ten years with 25,000 vesting on the day of the grant and the

remaining vest in equal amounts over three years from the date of grant.

On December 5, 2012, we entered into a employment agreement with David Charbonneau as Chief

Financial Officer pursuant to which agreement Mr. Charbonneau was granted 125,000 stock options at

an exercise price of $2.61 per share for a period of ten years that vest in equal amounts over three years

beginning on December 5, 2013.

On August 7, 2012, we entered into a board of director’s compensation agreement with Jeffrey Webb,

pursuant to which agreement Mr. Webb was issued 10,000 shares of common stock and granted 150,000

stock options at an exercise price of $1.90 per share for a period of ten years that vest in equal amounts

over three years from the date of grant.

On June 15, 2012, we entered into a board of director’s compensation agreement with David

Charbonneau pursuant to which agreement Mr. Charbonneau was issued 10,000 shares of common

stock, granted 150,000 stock options at an exercise price of $2.30 per share for a period of ten years that

vest in equal amounts over three years beginning on September 15, 2012, an annual fee of $15,000 paid

in four installments and up to $4,500 in 2012 for continuing education expenses in accountancy. Mr.

Charbonneau resigned on December 5, 2012 after accepting the position of Chief Financial Officer for

the Company.

On January 5, 2012, we entered into a stock option agreement with Stephen Goss in connection with his

service as a director, pursuant to which agreement Mr. Goss was granted 150,000 stock options at an

exercise price of $1.00 per share for a period of ten years that vest in equal amounts over three years

from the date of grant.

On June 1, 2011, we entered into a consulting agreement with Robert Miller to provide services as our

Chief Executive Officer. The terms of the consulting agreement included a fee of $10,000 per month for

a term to expire on June 1, 2012. We also agreed to reimburse Mr. Miller for all reasonable business

expenses incurred by him in the performance of his duties. The agreement also has a provision to

automatically renew for subsequent annual terms unless terminated in writing by either party. Mr.

Miller’s agreement was renewed for an additional annual term on June 1, 2012 and for another on June

13, 2013.

63



Director Independence

Our common stock is quoted on the OTCQB electronic quotation system, which does not have director

independence requirements. Nonetheless, for the purposes of determining director independence, we have

applied the definitions set out in NASDAQ Rule 4200(a) (15), pursuant to which rule a director is not

considered independent if he or she is also an executive officer or employee of the corporation.

Accordingly, the Company deems Mr. Goss, Mr. Webb and Mr. Tellini to be independent directors.

ITEM 14.

PRINCIPAL ACCOUNTANT FEES AND SERVICES

The  following  is  a  summary  of  the  fees  that  are  billed  to  us  by  our  auditors  for  professional  services

rendered for the past two fiscal years:

Fee Category

Fiscal 2013 Fees ($)     Fiscal 2012 Fees ($)

Audit Fees

80,500

69,000

Audit-Related Fees

7,690

15,739

Tax Fees

7,210

5,430

All Other Fees

0

0

Audit fees consist of fees billed for professional services rendered for the audit of our financial statements

and review of the interim financial statements included in quarterly reports and services that are normally

provided by Skoda Minotti & Co., Certified Public Accountants (“Skoda”), since July 19, 2011 in

connection with statutory and regulatory filings or engagements.

Audit Committee Pre-Approval

The audit committee pre-approved all services provided to us by Skoda Minotti for the year ending May

31, 2013.  The Company did not have a standing audit committee at the time of the engagement of Skoda

for the year ending May 31, 2012.  Therefore, all services provided to us by Skoda for year ending May

31, 2012, were pre-approved by our board of directors. Skoda performed all work only with their

permanent full time employees.

64



PART IV

ITEM 15.

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a) Financial Statements

The following documents are filed under Item 8. Financial Statements and Supplementary Data, pages

F-1 through F-66, and are included as part of this Form 10-K:

Financial Statements of the Company for the years ended May 31, 2013 and 2012:

Report of Independent Registered Public Accounting Firm

Balance Sheets

Statements of Operations

Statements of Stockholders’ Equity

Statements of Cash Flows

Notes to Financial Statements

(b) Exhibits

The exhibits required to be attached by Item 601 of Regulation S-K are listed in the Index to Exhibits on

page 67 of this Form 10-K, and are incorporated herein by this reference.

(c) Financial Statement Schedules

We are not filing any financial statement schedules as part of this Form 10-K because such schedules are

either not applicable or the required information is included in the financial statements or notes thereto.

65



SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant

has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Abakan Inc.

Date

/s/ Robert H. Miller

August 29, 2013

By: Robert H. Miller

Its: Chief Executive Officer and Director

/s/ David Charbonneau

August 29, 2013

By: David Charbonneau

Its: Chief Financial Officer and Principal Accounting Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by

the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Date

/s/ Robert H. Miller

August 29, 2013

Robert H. Miller

Chief Executive Officer and Director

/s/ Andrew Sherman

August 29, 2013

Andrew Sherman

Director

/s/ Stephen Goss

August 29, 2013

Stephen Goss

Director

/s/ Jeffrey Webb

August 29, 2013

Jeffrey Webb

Director

/s/ Ray Tellini

August 29, 2013

Ray Tellini

Director

66



INDEX TO EXHIBITS

Exhibit No.

Exhibit Description

3.1*

Articles of Incorporation and Certificate of Amendment, incorporated hereto by reference to

the Form SB-2, filed with the Commission on June 19, 2007.

3.2*

Bylaws, incorporated hereto by reference to the Form SB-2, filed with the Commission on

June 19, 2007.

10.1*

Lease Agreement between Powdermet and Sherman Properties, LLC dated March 7, 2007,

incorporated hereto by reference to the Form 10-K filed with the Commission on September

13, 2011.

10.2*

License agreement between MesoCoat and Powdermet dated July 22, 2008, incorporated

hereto by reference to the Form 10-K/A-2 filed with the Commission on December 27, 2011.

10.3*

Exclusive license between MesoCoat and UT-Battelle, LLC, dated September 22, 2009,

incorporated hereto by reference to the Form 10-K/A-2 filed with the Commission on

December 27, 2011.

10.4*

Articles of Merger dated November 9, 2009, incorporated hereto by reference to the Form 8-

K filed with the Commission on December 9, 2009.

10.5*

Agreement and Plan of Merger dated November 9, 2009, incorporated hereto by reference to

the Form 8-K filed with the Commission on December 9, 2009.

10.5*

Consulting agreement dated December 1, 2009, between the Company and Mr. Greenbaum,

incorporated hereto by reference to the Form 8-K filed with the Commission on May 28,

2010.

10.7*

Employment agreement dated December 1, 2009, between MesoCoat and Andrew Sherman,

incorporated hereto by reference to the Form 10-K filed with the Commission on September

13, 2011.

10.8*

Consulting agreement date December 1, 2009 between the Company and Prosper Financial

Inc., incorporated hereto by reference to the Form 10-K filed with the Commission on

September 13, 2011.

10.9*

Consulting agreement dated December 8, 2009 between the Company and Robert Miller,

incorporated hereto by reference to the Form 10-K filed with the Commission on September

13, 2011.

10.10*

Investment Agreement dated December 9, 2009, between the Company, MesoCoat and

Powdermet, incorporated hereto by reference to the Form 8-K filed with the Commission on

December 17, 2009.

10.11*

Agreement date March 17, 2010 between the Company and Sonnen Corporation,

incorporated hereto by reference to the Form 10-K filed with the Commission on September

13, 2011.

10.12*

Agreement dated April 30, 2010 between the Company and Mr. Buschor, incorporated hereto

by reference to the Form 8-K filed with the Commission on May 11, 2010.

10.13*

Commercial lease agreement date June 1, 2010, between Powdermet and MesoCoat,

incorporated hereto by reference to the Form 10-K filed with the Commission on September

13, 2011.

10.14*

Stock Purchase Agreement dated June 29, 2010 between the Company and Kennametal,

incorporated hereto by reference to the Form 8-K filed with the Commission on September

15, 2010.

10.15*

Employment agreement dated August 20, 2010, between the Company and Mr. Takkas,

incorporated hereto by reference to the Form 8-K filed with the Commission on August 26,

2010.

67



10.16*

Amendment No. 1 to Stock Purchase Agreement between the Company and Kennametal

dated September 7, 2010, incorporated hereto by reference to the Form 8-K filed with the

Commission on September 15, 2010.

10.17*

Amendment to the Investment Agreement dated December 8, 2010, between the Company,

MesoCoat and Powdermet, incorporated hereto by reference to the Form 10-Q filed with the

Commission on January 19, 2011.

10.18*

Cooperation Agreement between MesoCoat and Petroleo Brasileiro S.A. dated January 11,

2011, incorporated by reference to the Form 8-K/A-3 filed with the Commission on March 6,

2012. (Portions of this exhibit have been omitted pursuant to a request for confidential

treatment.)

10.19*

Amendment No. 2 to Stock Purchase Agreement between the Company and Kennametal

dated January 19, 2011, incorporated hereto by reference to the Form 8-K filed with the

Commission on July 13, 2011.

10.20*

Accord and Satisfaction Agreement dated March 21, 2011 between the Company and

Kennametal, Inc., incorporated hereto by reference to the Form 8-K filed with the

Commission on March 25, 2011.

10.21*

Assignment Agreement dated March 25, 2011 with Polythermics LLC and MesoCoat,

incorporated hereto by reference to the Form 10-Q/A filed with the Commission on

September 27, 2011.

10.22*

Exclusivity Agreement between MesoCoat and Mattson Technology, Inc. dated April 7,

2011, incorporated hereto by reference to the Form 8-K/A-3 filed with the Commission on

March 6, 2012. (Portions of this exhibit have been omitted pursuant to a request for

confidential treatment.)

14*

Code of Business Conduct & Ethics adopted on June 13, 2012, and incorporated hereto by

reference to the Form 10-K filed with the Commission on September 13, 2013.

21

Subsidiaries of the Company, attached.

31.1

Certification of the Chief Executive Officer pursuant to Rule 13a-14 of the Exchange Act as

adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, attached.

31.2

Certification of the Chief Financial Officer pursuant to Rule 13a-14 of the Exchange Act as

adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, attached.

32.1

Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted

pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, attached.

32.2

Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted

pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, attached.

99

Powdermet audited financial statements for the period ended May 31, 2013, attached.

101. INS      XBRL Instance Document

101. PRE     XBRL Taxonomy Extension Presentation Linkbase

101. LAB    XBRL Taxonomy Extension Label Linkbase

101. DEF     XBRL Taxonomy Extension Label Linkbase

101. CAL    XBRL Taxonomy Extension Label Linkbase

101. SCH     XBRL Taxonomy Extension Schema

*

Incorporated by reference to previous filings of the Company.

Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed “furnished”

and not “filed” or part of a registration statement or prospectus for purposes of Section 11 or

12 of the Securities Act of 1933, or deemed “furnished” and not “filed” for purposes of

Section 18 of the Securities and Exchange Act of 1934, and otherwise is not subject to

liability under these sections.

68